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Abstract
TRF2 is one of the main telomere binding proteins and a key regulator in 
protecting the telomere, the end of a linear chromosome. The telomere can be 
artificially “ uncapped”  by expression of myc-TRF2ABAM, a myc tagged dominant 
negative version of the protein. Both myc-TRF2 Full Length (FL) and myc- 
TRF2abam were retrovirally-infected into cells as part of an IRES-GFP construct. 
NHEK expressing GFP (and therefore either myc-TRF2 FL or myc-TRF2ABAM) were 
selected at early time points using flow-sorting and this allowed either low or 
high expression levels to be isolated.
Low or high levels of expression of myc-TRF2ABAM altered colony morphology, 
reduced clonogenicity and almost completely prevented proliferation of NHEK. 
Several markers of DNA damage were investigated and a small amount of p53- 
phosphoS15 was detected 2 days after expressing myc-TRF2ABAM in NHEK. The 
number of small colonies containing senescent cells was increased in NHEK 
expressing myc-TRF2ABAM compared with Vector only controls. Induction of DNA 
damage responses is undoubtedly a contributing factor and senescence at least 
one cellular outcome of uncapped telomeres in NHEK.
Low levels of myc-TRF2 FL expression in NHEK also caused a reduction in cell 
proliferation, but not as severe as seen by expression of myc-TRF2ABAM. High 
levels of myc-TRF2 FL demonstrated an even greater reduction in proliferation, 
equivalent to myc-TRF2ABAM. Despite the reduced cell proliferation, NHEK 
expressing myc-TRF2 FL did not demonstrate any p53-phosphoS15. Excessive 
telomere processing may play a role in the dramatic effect seen in NHEK 
following expression of myc-TRF2 FL.
The majority of human cancers are of epithelial derivation. As a major focus of 
cancer therapy is centered on exploiting the properties of the telomere, a full 
understanding of it's properties in an epithelial context is warranted. This thesis 
examines the effects of uncapping telomeres in Normal Human Epidermal 
Keratinocytes (NHEK), the first time an investigation into telomere status has 
taken place with a primary epithelial cell system.
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Chapter 1: Introduction
1.1 Background
In the early 1930s, pioneering work with chromosomes was being performed in 
the maize plant by Barbara McClintock and in drosophila by Hermann Muller. 
Recounted in a historical perspective essay (McKnight and Shippen 2004), both 
scientists were investigating the consequences of broken chromosomes and 
recognised that the natural end of the chromosome was unique. Muller coined 
the term telomeres, from the Greek word “ telos” meaning end, and “ meros” 
meaning part.
Performing crosses between mutated and normal chromosomes, McClintock 
characterised the Breakage/Fusion/Bridge, B/F/B cycle, and described the 
formation of sister chromatid fusion and the formation of a di-centric 
chromosome. However, McClintock also found that dependent on what allele 
the zygote inherited after the unequal di-centric breakage, instead of 
proceeding through a B/F/B cycle, a ruptured end would ‘heaT and therefore 
thought it  likely that the healing process represented the formation of a new 
telomere where the chromosome had ruptured. McClintock recounted in her 
1983 Nobel Prize seminar an observation that became the foundation in the 
study of the telomere; “A cell capable of repairing a ruptured end of a 
chromosome must sense the presence of this in the nucleus. This sensing 
activates a mechanism that is required for replacing the ruptured end with a 
functional telomere” (McClintock 1984). With the discovery of telomerase in 
1985 (Greider and Blackburn 1985), and the recognition that a telomere actively 
communicates its status to the cell, a new field specifically investigating 
telomere biology emerged.
1.2 The Telomere
The telomere has been functionally defined as a region of DNA at the molecular 
end of a linear chromosome that is required for the replication and stability of 
the chromosome (Blackburn 1984). The exact sequence of non-coding repeats 
differs slightly between species; in humans the G rich strand sequence is 
[TTAGGG]n (Moyzis et al. 1988), and the complementary, C rich strand sequence
- 1 4 -
is [CCCTAA]n. The integrity of this sequence is a requirement for the formation 
of a human telomere, as slightly altered sequences of telomeric DNA are not 
capable of seeding new telomeres (Hanish et al. 1994). The G rich strand 
overhangs the complementary strand in what is referred to as the G rich or 
3’overhang. This single stranded DNA then folds back to invade the upstream 
telomeric sequence forming what is known as a T-loop, detailed in Section 1.10.
1.3 Telomeric Binding Proteins
A telomere is much more than just DNA. The length, 3’overhang, T-loop and 
correct binding proteins are all key elements of a functional, capped telomere.
Telomeres form nuclear matrix-associated, high order chromatin complexes at 
dispersed sites throughout the nuclear volume (Luderus et al. 1996). However, 
digestion of chromatin in cell lines with shorter telomeres revealed a pattern 
that suggests they have different nucleosomal packaging (Tommerup et al.
1994). One of the telomeric proteins about to be discussed below, TRF1, has 
recently been reported as specifically recognising and altering the nucleosomal 
structure, possibly allowing the nucleosomes to contribute to the function of 
telomere capping (Galati et al. 2006). In addition to associating with 
nucleosomal proteins, telomeres are bound by their own unique set of complex 
proteins.
Analogous to other chromosomal protein complexes, shelterin is a newly adopted 
term to refer to the 6 major telomeric binding proteins that shape and safeguard 
the telomere, (Figure 1). TRF1, TRF2 and POT1 all directly recognise and bind 
the telomeric repeat, whereas the other three components of shelterin, TIN2, 
TPP1 and hRapI, interconnect them. Despite inclusion of both TRF1 and TRF2 
into the shelterin complex, they can be isolated separately and are therefore 
considered sub-complexes of shelterin. Not all proteins found at the telomere 
are part of shelterin, only the proteins that are abundant at the telomere and do 
not accumulate elsewhere in a cell under normal circumstances (de Lange 2005). 
Table 1 provides the details of the main human telomere binding proteins. It 
includes proteins which associate with the telomere through direct or indirect 
interaction, many of which are more traditionally associated with DNA damage 
repair. Characterisation of many of these proteins has been achieved through
-15  -
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Figure 1. The telomere binding proteins and telomere structure.
The above illustrations were taken from:
de Lange, T. T-loops and the origin of telomeres. Nat Rev Mol Cell Biol. 2004 
Apr;5(4):323-9.
de Lange, T. Shelterin: the protein complex that shapes and safeguards human 
telomeres. Genes Dev. 2005 Sep 15;19(18):2100-10.
(a) An illustration of the six main telomere binding proteins that are proposed to 
combine to form shelterin. Their characteristic domains and protein interaction sites 
are noted within the linear representations of the proteins.
(b) The telomere binding proteins in the different ways they are known to associate. A 
TRF1 and TRF2 complex have been established, however components from each are 
also known to associate and bind the telomere as shown in the shelterin model.
(c) Substantial evidence suggests that telomeres fold into a Telomere Loop, T-loop, 
largely aided by TRF2 which is seen in larger amounts where the 3’overhang strand 
invades the duplex telomeric DNA.
T-iocp
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RNA interference, RNAi; the experimental manipulation of selectively removing 
one protein by designing a small RNA molecule complementary to the mRNA 
sequence of the protein to be “ knocked down” such that it is degraded instead 
of being expressed.
Process the 
protein is 
traditionally
Table 1: Human Telomere Binding Proteins
associated
with Protein Name (first reference of protein in a telomere context)
TRF1 (Chong et al. 1995), (Figure 1) (a).
Te
lom
er
e 
bi
nd
in
g
Telomere Repeat binding Factor 1, TRF1, contains a large TRFH 
(TRF Homology) domain used for homo-dimerisation and an acidic 
domain at its N-terminus. Each TRF1 protein within the dimer 
contributes a myb domain which binds double stranded telomeric 
DNA and bends it to an angle of 120° (Bianchi et al. 1997). TRF1 
controls telomere length in c/s by inhibiting the action of 
telomerase at the ends of individual telomeres: over-expression of 
TRF1 results in progressive shorter telomeres whereas inhibition of 
TRF1 increases telomere length (van Steensel and de Lange 1997).
PIN2 (Shen et al. 1997)
Te
lom
er
e 
bi
nd
in
g
Pin2 is identical to TRF1 apart from an internal deletion of 20 amino 
acids generated by alternate splicing. Pin2 forms homo and hetero­
dimers with TRF; both types of dimer are localised at telomeres. 
The level of Pin2 is strikingly increased in G2+M and decreased in G1 
cells (Shen et al. 1997). Although Shen et al state that Pin2 is the 
major expressed product compared with TRF1, other groups do not 
differentiate between TRF1 and PIN2, referring to them both as 
TRF1 (Broccoli et al. 1997).
- 1 7 -
PINX1 (Zhou and Lu 2001)
Experiments over-expressing PinX1 in HeLa cells demonstrate co­
localisation with TRF1/PIN2 at the telomere. PINX1 also localised to 
the nucleolus. HT1080 (telomerase positive fibrosarcoma cell line) 
cells over-expressing PINX1 had shortened telomeres after 20-30 
Population Doublings, PD, resulting in crisis and senescence (Zhou 
and Lu 2001).
TIN2 (Kim et al. 1999), (Figure 1)(a).
TIN2 binds the TRF1 homo-dimer forming a tertiary structure: this is 
speculated to aid the ability of TRF1 to induce pairing or higher 
order interactions between telomeric DNA tracts by causing 
conformational changes in TRF1 (Kim et al. 2003). As part of the 
TRF1 complex, TIN2 prevents Tankyrase from ADP-ribosylating TRF-1 
which causes the complex to disassociate from the telomere (Ye and 
de Lange 2004), (Figure 2). A mutant version of TIN2, lacking its 
amino-terminal sequences, allows elongation of human telomeres in 
a telomerase-dependent manner indicating that TRF1 alone is 
insufficient for control of telomere length in human cells and TIN2 is 
an essential mediator (Kim et al. 1999). TIN2 has also been shown 
to bind the TRF1 and TRF2 complexes simultaneously and stabilise 
the TRF2 complex on telomeres (Ye et al. 2004a).
- 1 8 -
(a)
TRF1
(c)
TRF1
TRF1
= ADP
Figure 2. TIN2 and Tankyrasel regulation of TRF1.
(a) When TIN2 is bound to TRF1 at the telomere, it prevents Tankyrasel from 
catalysing the addition of ADP to TRF1.
(b) When TIN2 is deleted from cells, Tankyrasel ADP-ribosylates TRF1. When bound 
by ADP, TRF1 is longer capable of binding the telomere (c).
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POT1 (Loayza and De Lange 2003), (Figure 1)(a).
Protection Of Telomeres, POT1, is a single stranded telomeric 
binding protein that interacts with the TRF1 complex in human cells 
to control telomerase-mediated telomere elongation (Loayza and De 
Lange 2003). POT1aob (lacking the oligo-nucleotide binding (OB) 
fold of POT1) is still capable of associating with the TRF1 complex, 
but is no longer capable of binding the 3’overhang; expression of 
this mutated protein results in elongation of the telomere (Loayza 
and De Lange 2003). In vitro binding experiments, determined the 
optimal substrate to be [TTAGGG]n, (n>2) and binding was enhanced 
by the proximity of a 3' end. However, POT1 was able to bind a 
[TTAGGG] 5  array when positioned internally, indicating that POT1 
can bind both the 3’overhang and the displaced TTAGGG repeats at 
the base of the T-loop (Loayza et al. 2004). Two forms of human 
POT1 are generated by alternative splicing; POT1 and POT1-55. It is 
estimated that POT1 is approximately 10X more abundant than 
POT1-55. Using RNAi that targeted either both POT1 and POT1-55, 
or only POT1, in human cells (IMR90, BJ, BJ/hTERT, HeLa, HCT116, 
HTC75 - all defined in Table 2) the result was the same: the 3’ 
overhang was decreased and telomeres elicited a transient DNA 
damage response, surprisingly without cell cycle arrest or telomere 
fusions. It was therefore concluded that the less abundant POT1-55 
protein does not perform a distinct function within the cell.
Random positioning of the 5* end that normally ends on the 
sequence ATC-5’ resulted in a reduction in the amount of bound 
POT1 (Hockemeyer et al. 2005).
It has also been reported that in fibroblasts, RNAi knockdown of 
POT1 resulted in apoptosis, chromosomal instability and senescence 
(Yang et al. 2005). This report also offered evidence that POT1 and 
TRF2 interacted, since expression of TRF2ABAM stripped the telomere 
of POT1 as well as endogenous TRF2 (Yang et al. 2005).
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TPP1
Discovered simultaneously as PIP1 (Ye et al. 2004b), PTOP (Liu et al. 
2004) and TINT1 (Houghtaling et al. 2004), this protein has now 
been renamed TPP1 (de Lange 2005). It tethers POT1 to TIN2 as 
part of the TRF1 complex. The knockdown of TPP1 results in 
telomere elongation thus mimicking the effect of POT1 deficiency.
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Tankyrasel (Smith e ta l. 1998), (Figure 1)(a).
Tankyrasel is a human telomeric poly(ADP-ribose) polymerase 
initially identified through its interaction with the telomeric protein 
TRF1 (Smith et al. 1998). ADP-ribosylation of TRF1 by tankyrase 
diminished its ability to bind telomeric DNA in vitro (Smith et al. 
1998), (Ye et al. 2004a) (Figure 2). Long-term over-expression of 
Tankyrasel in HeLa cells resulted in a gradual and progressive 
elongation of telomeres (Smith and de Lange 2000). The diminished 
level of TRF1 is thought to allow telomerase access to the telomere. 
During interphase, tankyrasel is localised to the telomere, but in 
mitosis, tankyrasel relocates to the periphery of the centrosome 
(Smith and de Lange 1999). Tankyrasel lacks its own nuclear 
localisation sequence and there is evidence to support its reliance 
on TRF1 for nuclear import as well as telomere binding (Smith and 
de Lange 1999).
Knockdown of Tankyrasel caused mitotic arrest: sister chromatids 
separated at centromeres and arms, but remained associated at the 
telomere, possibly through a proteinaceous bridge (Dynek and Smith 
2004; Chang et al. 2005).
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Tankyrase2
Tankyrase 2 is a highly conserved version of Tankyrasel which also 
interacts with TRF1 in vivo and in vitro, regulating it through ADP 
ribosylation (Cook et al. 2002). Both Tankyrasel and 2 interact with 
TRF1 through its acidic domain (Cook et al. 2002).
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TRF2 (Broccoli et al. 1997), (Figure 1)(a).
This second telomere repeat protein, TRF2, also contains a large 
TRFH domain and a myb domain. TRF2 homo-dimer formation 
allows the two myb domains to bind the telomere (Broccoli et al. 
1997). TRF2 differs from TRF1 in that its N terminus is basic rather 
then acidic. Despite investigation, no evidence has been found for 
hetero-dimerization of TRF1 and 2 (Broccoli et al. 1997). Crystal 
structures of the TRFH domain in TRF1 and 2 have revealed that the 
interfaces have unique interactions that prevent hetero- 
dimerization (Fairall et al. 2001).
TRF2 is considered the protein responsible for protecting the 
telomere. As the work presented in this thesis all involves 
expression of TRF2 and its dominant negative form, TRF2ABAM, a 
more detailed section on TRF2 and the consequences of its 
expression are in the text, Section 1.7 and 1.8.
hRapI (Li et al. 2000), (Figure 1)(a).
hRapI is recruited to the telomere by TRF2 and affects telomere 
length (Li et al. 2000). Despite containing a myb domain, hRapI 
cannot bind the telomere without TRF2 which it uses as a bridging 
protein. Cells over-expressing hRapI in the HTC75 inducible system 
(derived from HT1080 fibrosarcoma cell line) elongated their 
telomeres over a period of 100 population doublings (PD) (Li et al.
2000). However, a further publication by the same author 
speculates that this finding might be an artefact of the excess 
hRAP1 sequestering other important telomerase suppressing 
proteins away from the telomere. Expression of a mutant version of 
hRAP1, lacking the RCT domain required for interaction with TRF2, 
also resulted in a longer, more homogeneous telomere population 
(Li and de Lange 2003). This suggests that hRAP1 suppresses 
telomerase activity at the telomere through its BRCT and myb 
domains.
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Ku (Bianchi and de Lange 1999)
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The hetero-dimeric Ku (70 and 80/86 kDa), known for its role in Non 
Homologous End Joining, NHEJ, was shown to be capable of binding 
telomeric DNA in vitro (Bianchi and de Lange 1999). A 50% 
reduction of Ku86 levels using RNAi in HeLa, SAOS and U20S cells 
results in a marked loss of telomere sequences, increased 
chromatid-type fusions by leading strand synthesis, an increase in 
apoptosis and a decrease in cell proliferation (Jaco et al. 2004). 
The colorectal carcinoma cell line HCT116, is heterozygous for 
Ku86. Functional inactivation of the remaining allele of Ku 86 
resulted in profound telomeric shortening, longer 3*-overhangs, an 
increase in chromosome fusions, translocations and genomic 
instability resulting in the cells only being capable of limited 
proliferation prior to apoptosis (Li et al. 2002), (Myung et al. 2004).
DNA-PK (d'Adda di Fagagna et al. 2001)
This interaction partner of Ku provides catalytic serine/threonine 
protein kinase activity (Collis et al. 2005) and has been found to 
associate in vivo with the telomere in human HeLa cells by 
Chromatin Immunoprecipitation, CHIP.
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Apollo (also named hSnmB1(Freibaum and Counter 2006))
Localising to the telomere through its interaction with TRF2, Apollo, 
an Artemis-Related Nuclease, has 5’exonuclease activity (Lenain et 
al. 2006). Apollo is speculated to contribute to the resection of the 
C rich blunt end produced during DNA replication of the leading 
strand, see Section 1.10. RNAi directed against Apollo result in 
Telomere Induced dysfunction Foci, TIFs, (see Section 1.13) 
primarily during S phase, further implying that Apollo may have a 
role in telomere processing. Human fibroblasts senesce after 12 
days without Apollo expression (van Overbeek and de Lange 2006).
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RAD51D (Tarsounas et al. 2004)
RAD51D, one of the five RAD51 paralogs (RAD51B, RAD51C, RAD51D, 
XRCC2 and XRCC3) involved in genetic recombination, has been co­
localised with TRF2 in both HeLa (cervical carcinoma) cells and Wl- 
38 cells (fibroblasts that use Alternative Lengthening of Telomere, 
ALT, see Section 1.15.ii) (Tarsounas et al. 2004). Inhibition of 
RAD51D using RNAi in WI-38 cells results in telomere erosion and 
chromosome fusion (Tarsounas et al. 2004).
RAD50 (Zhu et al. 2000)
RAD50 is stably associated with MRE11 and NBS1 in a complex that
C
00 o functions in response to double strand breaks (DSBs) in mammals
O (0 on c
5  5 (Carney et al. 1998). RAD50 is located at the telomere during
8 E 
o 8 interphase as indicated by indirect immunofluorescence. Evidencew V
indicates that RAD50 binds the telomere through TRF2 as opposed to
directly binding the telomeric DNA (Zhu et al. 2000).
MRE11 (Zhu et al. 2000)
c MRE11 is located at the telomere during interphase as indicated by
=3 -r;
a  «on r immunofluorescence (Zhu et al. 2000). However, there is no
1  e evidence for direct interaction between MRE11 and TRF2,
o 8X  (D suggesting MRE11 is located to the telomere through a different
a: telomeric protein.
Nbs1 (Zhu et al. 2000)
Immunofluorescence and western blotting show Nbs1 is associated
cf/% with TRF2 and telomeres in S phase, but not in G1 or G2 (Zhu et al.vl3  -MO ro on c 2000). Nbs1 is capable of partially unwinding the DNA duplex and
5  5  
8 E has an endonuclease specificity that allows Mre11/Rad50/Nbs1, the£ °  o u
x # MRN complex, to cleave a 3'-protruding strand at a double-/single­Q_
strand transition (Pauli and Gellert 1999). It is not understood
exactly what function the MRN complex performs at the telomere.
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ERCC1/XPF (Zhu et al. 2003)
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ERCC1 /XPF is a nucleotide excision repair endo-nuclease associated 
with TRF2 at the nucleus (Zhu et al. 2003). When TRF2 function is 
inhibited in immortalised normal fibroblasts, (using TRF2ABAM, as 
discussed in Section 1.7) the cells show a reduction in their 3' 
overhang. In revealing contrast, inhibition of TRF2 in immortalised 
XPF deficient cells (cell lines derived from human XPF patients), 
does not cause a reduction of 3’overhang (Zhu et al. 2003), 
suggesting this is the endo-nuclease responsible for resecting the 
3’overhang when telomeres are uncapped.
BLM (Opresko et al. 2002)
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BLM, the gene defective in patients with Bloom's syndrome, co- 
localises and complexes with TRF2 in cells that employ the 
recombination-mediated mechanism of telomere lengthening known 
as ALT, see Section 1.15.11 (Lillard-Wetherell et al. 2004). The co­
localisation increases in late S phase and G2/M (Lillard-Wetherell et 
al. 2004). TRF2 stimulates unwinding of telomere DNA and non- 
telomeric substrates by BLM, whereas TRF1 inhibits unwinding of 
telomere substrates by BLM (Lillard-Wetherell et al. 2004).
WRN (Opresko et al. 2002)
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The Rec-Q family member, WRN, co-localises and physically 
interacts with TRF2, stimulating the 3’-» 5' helicase activity of WRN 
(Opresko et al. 2002), (Machwe et al. 2004). Cells lacking WRN, 
from Werner syndrome patients, exhibit deletion of telomeres from 
single sister chromatids on telomeres replicated by lagging strand 
synthesis (Crabbe et al. 2004).
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ATM (Karlseder et al. 2004)
Ataxia telangiectasia is a disease characterised by characterized by 
chromosomal instability, cancer predisposition, radiation sensitivity, 
and cell cycle abnormalities. The gene mutated in this disorder has 
been named, Ataxia Telangiectasia Mutated, ATM (Savitsky et al.
1995), which is now known to play a very important role in 
recognising DNA double strand breaks and implementing their 
repair. TRF2 can directly interact with a region of ATM (containing 
S1981) and inhibit ATM’s activation in response to DNA damage 
(Karlseder et al. 2004).
1.4 Telomere bouquet in meiosis
Although the function of some of the proteins bound to the telomere may not be 
immediately obvious, it  is important to remember the context in which we 
observe them will affect our interpretation of their purpose. In addition to the 
important role the telomeres have in protecting the genome, they also serve in 
the early stages of meiosis, the process by which male and female -derived 
genomes are recombined and halved to form gametes (reviewed in (Scherthan
2001)). Before undergoing meiosis, telomeres attach to the nuclear envelope 
and gather near the centrosome (Tomita and Cooper 2006). In Maize plants 
during prophase of meiosis I, telomeres attach to the nuclear envelope and 
gather at one pole of the nucleus to form the ‘bouquet’ structure (Bass et al. 
1997). Highly expressed in testis during meiotic prophase I, Tankyrasel, which 
associates with the centrosome, is suspected of playing a role in meiosis (Smith 
and de Lange 1999).
1.5 O ther Proteins and factors  th a t Influence the Telomere
The complex list of human telomere binding proteins in Table 1 is intended to be 
comprehensive; however it does not include all the proteins that regulate the 
human telomere. Proteins capable of regulating the telomere binding proteins 
in the table will also have considerable influence on the structure of the 
telomere. For example, over-expression of Fbx4 (a substrate-specific adaptor of 
ubiquitin ligase) promotes the ubiquitination and degradation of endogenous
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Pin2/TRF1, resulting in progressive telomere elongation in human cells (Lee et 
al. 2006).
Another factor shown to affect the telomere is oxidative stress, which has been 
shown to increase the erosion and loss of telomeric DNA in human fibroblasts 
(von Zglinicki et al. 1995), (Tchirkov and Lansdorp 2003). Oxidative damage in 
telomere DNA, specifically a single 8-oxo-guanine lesion, has been shown to 
reduce the percentage of telomere bound TRF1 and TRF2 by at least 50%, 
compared with undamaged DNA. Multiple lesions to the DNA resulted in more 
dramatic effects of TRF1 and TRF2 binding (Opresko et al. 2005).
The DNA damage-dependent poly(ADP-ribose) polymerase 2, PARP-2, plays an 
active role in the base excision repair process and also associates through its N 
terminal domain with the myb domain of TRF2 (Dantzer et al. 2004). PARP-2 
activity regulates the DNA binding activity of TRF2 via both a covalent hetero­
modification of the dimerization domain of TRF2 and a non-covalent binding of 
poly-ADP ribose to the myb-domain of TRF2 (Dantzer et al. 2004).
1.6 Model systems
Model systems are an essential means for performing experiments that involve 
gene manipulation that are either very difficult or impossible to do in human 
cells. Experiments in less complicated organisms such as yeast allow a more 
straightforward evaluation of mechanisms altered as a result of the 
experimental manipulation, particularly as they minimise issues like redundancy 
which can complicate experimental interpretation in more evolved organisms. 
Once the function of a protein is established, protein homologues can then be 
assessed in more sophisticated organisms to see if they have a similar function.
1.6.i Yeast
In S.pombe (Fission yeast), telomere repeats are bound by Taz1, a regulator of 
diverse telomere functions considered to be the homologue of both human 
proteins TRF1 and TRF2 (Cooper et al. 1997). Taz1 is crucial for efficient 
replication fork progression, as loss of Taz1 leads to stalled replication forks at 
telomeres and internally placed telomere sequences, regardless of whether the 
DNA synthesis is leading or lagging strand (Miller et al. 2006).
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Again using S.pombe, it  has been shown that telomeres play an important role in 
meiosis: at early stages all the telomeres in the cell attach to the nuclear 
envelope and gather near the spindle pole body, SBP (centrosome in mammals), 
forming what is known as a ‘bouquet (Chikashige et al. 1994). Expressed during 
meiosis, the recently discovered proteins, Bqt1 and Bqt2, are essential for 
connecting the telomeric protein Rap1 to the SPB (Chikashige et al. 2006).
Over the next several years, it  w ill be interesting to see if any of the telomere 
binding proteins emerge as being associated with DNA replication and to 
determine what the mammalian homologues for Bqt 1 and 2 do within 
mammalian cells.
In S.Cerevisiae (budding yeast), studies of the replication intermediates of a 
linear plasmid in rad27delta cells are consistent with the idea that only one end 
of the plasmid acquires extensive G-tails, presumably the end made by lagging- 
strand synthesis (Parenteau and Wellinger 2002). How the 3’overhang on the 
lagging strand of telomeric DNA is generated in human cells has still not been 
fully elucidated (discussed in Section 1.10).
When deleted, Rap1, which binds the telomere directly in S.cerevisiae results in 
frequent fusion between telomeres of near wild type length by NHEJ (Pardo and 
Marcand 2005). Although still associated with the telomere in humans through 
TRF2, this protein has changed considerably during the evolution from yeast to 
human.
1.6.H Rat
An interesting study examined the effects of the adenoviral infection of TRF2ABAM 
in proliferating and non-proliferating rat brain cells. In proliferating neural cells 
(primary astrocytes and neuroblastoma), jRF2ABAM triggered phosphorylation of 
H2AX, activated ATM and p53 and induced p21 as well as excess B-galactosidase 
staining (Zhang et al. 2006). In contrast, in non-proliferating neurons (primary 
embryonic hippocampal), jRF2ABAM triggered phosphorylation of H2AX, activated 
ATM, and an induced p21, but neither p53 nor senescence were induced and 
there was no evidence of apoptosis (Zhang et al. 2006). These results suggest 
that at least a certain amount of cell proliferation must occur before TRF2ABAM 
can induce the senescent phenotype (Zhang et al. 2006).
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f  .6.717 Mouse
Before the discovery of RNAi as a tool for knocking down a particular protein of 
interest, finding cells deficient in a particular protein was difficult. Through 
genetic engineering, mouse cells can be altered to lack a particular gene and is 
a common method that is still used to ask experimental questions. However, 
some major differences between the mouse and human must be considered 
when using mouse cells (or the whole animal) as a model for telomere 
alteration. Two strains of mice are commonly used for scientific study: Mus 
Musculus, an inbred mouse strain contains telomere lengths of up to several 
hundred kilobase pairs (Kipling and Cooke 1990). On the other hand, the 
outbred strain, Mus Spretus, contains telomere lengths more similar to those in 
humans, below 30 kbp (Prowse and Greider 1995). In contrast to human tissues, 
most mouse tissues have active telomerase at levels easily detected (Prowse and 
Greider 1995). Unfortunately, publications often fail to comment which mouse 
strains their cells are derived from.
The following experiment had to be performed in p53 null (p53/')  cells, 
otherwise the cells arrested before the difference in DNA ligase 4 expression 
could be evaluated. Mouse Embryo Fibroblasts, MEFs p53'7', either with DNA 
ligase IV (Lig47+) or without (Lig47 ), were infected with TRF2ABAM. Lig4+/ + cells 
frequently contained telomere fusions, e.g. 51 telomeric fusions in 30 
metaphases. In contrast, Lig4/ ' cells contained 25 fold less telomere fusions 
(Smogorzewska et al. 2002). As DNA ligase IV is involved in NHEJ, this is likely to 
be the main mechanism by which telomeres are fused after TRF2 inhibition.
ERCC1/XPF is a nuclease that cleaves away sections of DNA damaged by UV light. 
Xeroderma pigmentosa, the human condition of ERCC1/XPF deficiency, is 
characterised by a propensity for skin cancer. MEFs deficient for ERCC1 contain 
circular extrachromosomal elements with telomeric DNA, termed double minute 
chromosomes and terminally short telomeres which fuse (Zhu et al. 2003). 
Based on this result, it seems clear that ERCC1 /XPF plays a role in processing the 
telomere. It has been suggested that when the telomere is capped, ERCC1/XPF 
snips away inappropriate telomere loops and when the telomere is uncapped it is 
susceptible to being re-sected back by the nuclease (Zhu et al. 2003).
In KU70'7' MEFs, in which the TRF2 gene can be deleted through the addition of 
Cre recombinase, telomeres had a normal DNA structure and did not activate a
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DNA damage signal. However, on removal of TRF2, sister chromatid fusions 
occurred at approximately 15% of the chromosome ends (Celli et al. 2006). 
Combined deletion of TRF2 and another element of the NHEJ pathway, DNA 
ligase IV, did not elicit this phenotype, indicating that TRF2 and Ku70 act in 
conjunction to suppress homologous recombination at the telomere, at least in 
the mouse (Celli et al. 2006).
Conditional deletion of TRF1'7' from mouse embryonic stem cells, results in a 
growth defect and chromosomal instability. In addition to these changes, TIN2 is 
lost from the telomere and TRF2 showed decreased association (Iwano et al. 
2004).
Despite the length of the mouse telomere, TRF2ABAM caused a growth arrest and 
senescent morphology in p53 proficient mouse cells. However, in contrast to 
human cells, loss of p53 alone is enough to circumvent the arrest of mouse cells 
indicating that the p16,NK4A /RB response to telomere dysfunction is not active in 
mouse cells (Smogorzewska and de Lange 2002). Another investigation using 
TRF2abam in mouse liver cells established that low levels of telomere uncapping 
induced cell senescence and high levels of telomere uncapping caused apoptosis 
(Lechel et al. 2005).
MEFs triply deficient for RB1, RBL1 (RB Like 1) and RBL2 demonstrate decreased 
tri-methylation of histone H4 at Lysine 20 at both pericentric and telomeric 
chromatin, independent of the E2F family function (Gonzalo and Blasco 2005). 
This tri-methylation is consistent with compacted, repressed DNA and therefore 
alleviation of the compacted state by loss of RB allows a more open chromatin 
structure, making the telomeric DNA more permissive to sister chromatid 
exchanges and possibly also affect the ability of telomeric proteins to bind.
1.6.iv Mouse - Whole Animal
The generation of knockout mice lacking a particular gene can be created in 2 
different ways. Mice either completely lack the gene or its removal can be 
controlled by a conditional circumstance.
TRF2 null mice are embryonic lethal before embryonic day 13.5 (E13.5) and 
could not be rescued by p53 deficiency (Celli and de Lange 2005). Mice lacking
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TRF1 (Karlseder et al. 2003) or TIN2 (Chiang et al. 2004) were also embryonic 
lethal on days E5 - E6.
Tankyrase2 null mice were generated and surprisingly found to have normal 
telomere lengths and capping, but did exhibit reduced growth (Hsiao et al. 
2006), (Chiang et al. 2006). The most likely explanation for this is redundancy 
of Tankyrase2 protein function with Tankyrasel.
Humans have one gene for POT1, that is alternatively spliced (See Table 1, 
POT1). In contrast, 2 POT1 paralogs have been found to bind to the mouse 
telomere. Single knockouts and complementation experiments show that POT1b 
has the ability to regulate the amount of single stranded DNA at the telomere 
terminus while POT1a is required to repress a DNA damage signal at the 
telomere (Hockemeyer et al. 2006). Another report demonstrates that Potla 
deficient cells exhibit an overall telomere length and 3’overhang elongation, as 
well as aberrant Homologous Recombination manifested in increased telomere 
sister chromatid exchanges and formation of telomere circles (Wu et al. 2006).
To generate mice with shorter telomeres, Mus Musculus engineered to lack the 
RNA component of telomerase, mTR'7', must be bred for four generations before 
chromosome ends lacking detectable telomere repeats, aneuploidy and 
chromosomal abnormalities including end-to-end functions are observed. A cross 
between mTR'7' Generation 6 mice, which have short telomeres, and mTR+7' 
mice which have long telomeres, results in some telomerase null offspring with 
half of their telomeres very short (Blasco et al. 1997). Loss of telomere function 
occurred preferentially on the critically short telomeres (Hemann et al. 2001). 
This indicates that it  is the shortest telomeres that dictate the fate of the cell, 
and not the average telomere length. It has also been demonstrated that short 
telomeres even in the presence of telomerase lim it tissue renewal capacity (Hao 
et al. 2005).
The absence of Ku86 and telomerase at the mouse telomere prevents end-to-end 
chromosome fusions that result from critical telomere shortening in telomerase 
deficient mice and apoptosis in the male early germ cell (Espejel et al. 2002). 
However, in cells where telomerase is present, Ku86 deficiency results in 
telomerase dependent telomere elongation and in fusion of random pairs of 
chromosomes (Espejel et al. 2002). Gene expression in the testis of 3-5 month
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old mice were compared in the following phenotypes: mTR Generation 3, 
Ku86'7', a combination of both knockouts or the wild type equivalents. This 
study established a change in the expression levels of genes involved in cell 
adhesion, cell-to-cell and cell-to-matrix communication as well as increased 
metabolic turnover and augmented anti-oxidant response (Franco et al. 2005). 
Transcriptional changes affecting chromatin remodelling such as retinoblastoma 
binding protein 7 (a histone deacetylase), the linker Histone 1 H2bc and the 
histone deacytlase 6, suggesting epigenetic remodelling associated with short 
and dysfunctional telomeres (Franco et al. 2005). Telomeres in mouse 
embryonic stem cells lacking DNA methyltransferases, such as DMNT1 or DMNT3a 
or 3b have dramatically elongated telomeres (Gonzalo et al. 2006).
Overexpression of TRF2 in the mouse epidermis results in telomere shortening, 
loss of the telomeric G-strand overhang and increased chromosomal instability. 
The epidermis suffered phenotypes resembling Xeroderma pigmentosum (human 
condition), and the telomere loss was mediated by XPF, the structure specific 
nuclease involved in UV-induced damage, nucleotide excision repair and 
mutated in individuals with Xeroderma pigmentosum (Munoz et al. 2005).
1.6.v Drosophila
Drosophila telomeres are unlike other eukaryotic telomeres in that they are 
made of repeats of Het-A and TERT retrotransposons that are maintained by 
transposition rather than telomerase activity and are protected by the binding of 
two proteins, heterochromatin protein 1 (HP1) and HP1 ORC2 associated proteins 
(HOAP) (Purdy and Su 2004). Despite the difference in mechanism for telomere 
length maintenance, Drosophila homologs defective for either ATM, Mre11 or 
Rad50 demonstrated increased telomere fusions (Bi et al. 2004) (Ciapponi et al.
2004).
1.6.vi Muntjac Deer
Chromosome fusions have had a dramatic effect of the karyotype of the muntjac 
deer. The Indian muntjac (2N= 6 chromosomes in female, 7 in male) has the 
lowest known chromosome number among mammals, the result of centric and 
tandem chromosome fusions. In contrast, the closely related Chinese muntjac 
still contains a higher number of chromosomes (2N = 46 chromosomes) (Wang 
and Lan 2000). Both species of muntjac deer still express both TRF1 and TRF2, 
ruling out the loss of either protein playing a role in the chromosome fusions
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that occurred in the Indian muntjac (Hartmann and Scherthan 2005). 
Interestingly, TERT expression could not be detected in either muntjac species, 
yet the TRAP assay revealed functional telomerase in Chinese muntjac testis 
tissue, suggesting muntjacs harbour a diverged telomerase species (Hartmann 
and Scherthan 2005).
1 .7  Uncapping the human telom ere , experim ents w ith
In the de Lange lab, a dominant negative version of the TRF2 protein was 
created: TRF2ABAM, missing both its basic and myb domain, (Figure 1). Another 
dominant negative version of TRF2, TRF2ABAC (lacks the N and C terminal domains 
which contain the basic and myb domains, respectively) has been used by 
another group. (Based on the molecular weight of i t ’s product it is fair to 
speculate it actually is the same as the jrf2abam construct, however the authors 
do not define which amino acids are missing nor make reference to the other 
widely used construct.)
TRF2abam dimerises with endogenous TRF2, but because it is lacking a myb 
domain, the dimer is no longer capable of binding the telomere since a minimum 
of two myb domains are required for such an interaction. jrf2abam acts as a 
dominant negative and its expression is thought to mimic the uncapped 
telomere.
Table 2 lists the effects of expression of TRF2ABAM, TRF2ABAC and TRF2AB in various 
human cell types. Apoptosis is the result in 3 different immortal cancer cell 
lines, HeLa, MCF7 and JR5, none of which had functional p53 or p16,NK4A. In 
contrast, another p53 and p16INK4A deficient, immortal cancer cell line; M14, did 
not result in apoptosis. Immortalised B cells with functional p53 and p16INK4A 
underwent apoptosis, however B cells which also contained functional p53 and 
p16INK4A, but lacked ATM did not apoptose. This illustrates the point that 
without functional proteins upstream or downstream of p53 or p16,NK4A, the 
status of these two tumour suppressor proteins may be irrelevant. Mortal 
primary CD4+ T cells also entered apoptosis, suggesting that the mortality status 
does not affect the cells decision to commit apoptosis or not. The other 
phenotype typically seen in human cells expressing TRF2ABAM, e.g. HTC75 and 
IMR90, was chromosome end fusions and senescence. Apoptosis and senescence
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Table 2: Experiments Involving Manipulation of TRF2 in Various Human Cell Types
Cell Line
(site of 
derivation)
Mortality
lm=lmmortal 
M= Mortal
p53
status
p16INMA
status
TRF2
construct
expressed
Result Reference
HeLa
(Cervical
carcinoma)
Im -ve
(HPV18)
-ve
(HPV18)
ABAM Apoptosis (Karlseder et 
al. 1999)
MCF7
(breast
carcinoma)
Im +ve -ve ABAM Apoptosis (Karlseder et 
al. 1999)
JR5 
(melanoma) 
- 5kbp 
telomere 
length
Im -ve -ve ABAC Apoptosis and 
reduced 
tumorgenicity
(Biroccio et al. 
2006)
M14 
(melanoma) 
~ 9kbp 
telomere 
length
Im -ve -ve ABAC No apoptosis and 
no reduced 
tumorgenicity 
(No comments 
regarding senescence 
or end-to-end ligations 
are made.)
(Biroccio et al. 
2006)
B cells Im +ve +ve ABAM Apoptosis (Karlseder et 
al. 1999)
B cells 
(ATM')
Im +ve +ve ABAM No Apoptosis (Karlseder et 
al. 1999)
BJ
(foreskin
fibroblast)
Im -ve
(SV40)
-ve
(SV40)
ABAM Reduced cell 
proliferation and 
increased growth 
in soft agar, but 
not in nude mice.
(Brunori et al. 
2006)
HTC75 
(inducible 
cell line 
based 
fibrosarcoma 
HT1080 
cells)
Im +ve -ve ABAM Chromosome end 
fusions and 
involving ligation 
of telomeres that 
lost their 
3'overhang.
(van Steensel 
et al. 1998)
[HT1080 - p53/ 
p 1 6 INK4A status 
(Chang et al. 
1999)]
Primary 
CD4+ T cells
M +ve +ve ABAM Apoptosis (Karlseder et 
al. 1999)
IMR90
(embryo
lung
fibroblast)
M +ve +ve ABAM Chromosome end 
fusions
(Smogorzewska 
and de Lange 
2002)
IMR90
(embryo
lung
fibroblast)
M +ve +ve AB Dramatically 
shortened 
telomeres, T-loop 
sized telomeric 
circles, a DNA 
damage response 
and senescence.
(Wang et al. 
2004)
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are the common outcomes of uncapping the telomere in a range of human cells, 
however, neither a specific cell type, p53/ p16INK4A status, nor mortality can be 
associated with a particular cellular outcome.
Another method of experimentally creating an uncapped telomere within a cell 
is to introduce DNA oligonucleotides homologous to the telomere 3* overhang, T- 
oligos (Eller et al. 2002). One-week exposure to T-oligos resulted in a senescent 
phenotype in cultured human fibroblasts, mimicking both telomeres shortened 
through replication and the TRF2ABAM (Li et al. 2003).
1.8 How TRF2 Over-expression Regulates the Human Telomere
Other experiments have investigated the effects of over-expressing TRF2 in 
human derived cell lines. Over-expression of TRF2 is able to prevent the cell 
cycle arrest that would normally be induced following ionising radiation in 
fibroblasts (Karlseder et al. 2004). Typical post-translational modifications that 
should occur as a result of DNA damage such as the phosphorylation of ATM (at 
Serine1981), Nbs1, p53 and the up-regulation of p53 target genes were not seen 
in the TRF2 over-expressing cells, offering an explanation to the lack of cell 
cycle arrest (Karlseder et al. 2004).
Over-expression of TRF2 results in progressive telomere shortening similar to the 
phenotype observed with TRF1 over-expression (Smogorzewska et al. 2000). 
However, expression of exogenous TRF2 became extinguished in culture after 50 
to 75 population doublings, despite continued selection pressure (Smogorzewska 
et al. 2000). This suggests that not only is increased telomere shortening an 
outcome, but also that there is a selective advantage to no longer over­
expressing TRF2.
1.9 TRF2 involvem ent in the DNA damage response
It is likely that, in addition to its role at the telomere, TRF2 also plays a role at 
non-telomeric sites of DNA damage since TRF2 is rapidly phosphorylated in 
response to DNA damage. The phosphorylated form is not found bound to 
telomeric DNA, but is localised to sites of DNA damage (Tanaka et al. 2005). 
ATM is implicated in the phosphorylation of TRF2 which is largely dissipated
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after two hours (Tanaka et al. 2005). In human fibroblasts, TRF2 protein has 
been shown to associate with DSB induced by pulsed laser microbeam irradiation 
within 2 seconds, as judged by co-localisation with y-H2AX (Bradshaw et al.
2005). The response requires the basic domain of TRF2, but not its myb domain, 
and occurs in the absence of functional ATM, the MRN complex, Ku70, WRN and 
BLM repair proteins (Bradshaw et al. 2005). However, contrary evidence has 
also reported that TRF2 does not re-localise to sites of DNA damage as judged by 
co-localisation with MRN (Zhu et al. 2000). The authors of the latter paper do 
not indicate at what time they began to look for co-localisation, so it is possible 
they missed the early pattern of protein interaction.
1.10 The End replication  problem  and generation o f the 3 ’ 
overhang
The inability of the ends of linear chromosomes to be fully replicated during 
each round of replication was realised and first hypothesised as the cause of cell 
cycle arrest in senescent cells in a theoretical paper (Olovnikov 1971). DNA 
polymerases responsible for replicating genetic material require a RNA or DNA 
polynucleotide primer with a 3’hydroxyl (3’ -OH) group, and are only capable of 
catalysing the addition of nucleotides to growing DNA strands in a 5’-»3’ 
direction, (Figure 3). When the primer is RNA, it is later removed once DNA 
synthesis has been primed. A consequence of this is a 3' overhang of telomeric 
DNA on the parental strand complementary to the newly formed lagging strand 
resulting in a small loss of telomeric DNA at each round of cell division. 
Telomeres have been shown to shorten by 50-200 bp per cell division (Cooke and 
Smith 1986), (Harley et al. 1990) (Allsopp et al. 1995) and this is known as the 
end replication problem, (Figure 3).
The 3’overhang folds back to invade the upstream telomeric sequence forming 
what is known as a Telomere loop, T loop, which have been found in cross-linked 
telomeric DNA purified from human (and mouse) cells when analysed by electron 
microscopy (Griffith et al. 1999), (Figure 4). Experiments investigating the role 
of telomeric binding proteins in the formation of the T-loops found that addition 
of TRF2 can remodel -50% of a linear telomeric sequence DNA containing a 
3’overhang into T loops. Where the linear DNA was remodelled, TRF2 was found 
at the tail loop junction, (Figure 4)(b). Without incubation of TRF2 protein,
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Figure 3. The end replication problem and generation of the 3’overhang.
(a) DNA polymerases only catalyse the addition of nucleotides in a 5’-» 3’ direction, 
after being primed by a small RNA primer. During semi-conservative replication, on 
the lagging strand Okazaki fragments are joined by DNA polymerase acting on an 
upstream Okazaki fragment and the DNA replaces the interceding RNA primers, 
except at the telomere of the lagging strand.
(b) This results in a gradual shortening of telomeres and is referred to as the end 
replication problem.
(c) What is still not completely understood is how the blunt ended telomere from 
leading strand synthesis get resected to have a 3’ overhang. Recent evidence now 
implicates the telomere binding/NHEJ protein Apollo in this role (See Table 1).
(d) The 3’overhang then invades the upstream telomeric DNA, a process thought to be 
largely aided by the binding of multiple components of the shelterin complex.
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(b)
Bar = 1 kb
Figure 4. Telomere Loop Structure.
(a) Only the telomere binding proteins proposed to aide in the formation of the T loop by 
shaping the DNA into the correct formation are shown. TRF2 has been shown to 
increase the amount of T loops formed by 50% using linear telomere sequence DNA 
with a 3’overhang. In similar experiments, TRF1 on its own only can only remodel 2% of 
the DNA into T loops. However, it has recently been proposed that the ternary complex 
formed with TRF1 and TIN2 may aide in the folding the DNA back on itself.
(b) Taken from: Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, de 
Lange T. Cell. 1999 May 14;97(4):503-14. Mammalian telomeres end in a large duplex 
loop.
This image demonstrates the scanning electron microscope image of piece of linear 
telomere DNA remodelled with the aid of TRF2. TRF2 is the large globular shaped 
structure at the site of the 3’overhang inversion and is thought to aide in this process.
TRF2 TRF1
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only -1% of the same DNA could be remodelled. Incubating the DNA with TRF1 
resulted in formation of T loops in only -2% of the population and TRF1 was 
never observed at the tail-loop junction. Formation of the T-loop in vitro was 
dependent upon the 3’overhang. A 3’overhang of at least 6 nucleotides is 
required for loop formation and termini with a 5* overhang, blunt end or a 
3’overhang with non-telomeric sequence at the junction are not capable of 
forming a T-loop (Stansel et al. 2001). The ternary complex between TRF1 and 
TIN2 is suggested to aid in pairing of the duplex DNA and TRF2 is proposed to 
regulate the actual invasion of the 3* overhang. The T loop model puts forward 
an architectural solution to the end of the linear chromosome (Griffith et al. 
1999).
The 3’overhang averages 130 - 210 bases in length in >80% of telomeres present 
in mortal primary fibroblasts, umbilical vein endothelial cells and leukocytes, as 
well as in immortalised fibroblasts (Makarov et al. 1997). The end replication 
problem is likely to be a contributing factor to generation of the 3’ overhang. 
Exactly how the 3’overhang is generated during leading strand DNA synthesis in 
human cells is still unknown. It has been proposed that TRF2 enhances the 5’ 
exonuceolytic processing of telomere ends, for instance by recruiting an 
exonuclease (Karlseder et al. 2002), possibly Apollo (Lenain et al. 2006). A 
recent report demonstrates that where MRN levels are reduced, a transient 
shortening of the 3’ overhang is seen in telomerase positive cells, yet the 
terminal nucleotides of both the G-rich and the C-rich strands remain unaltered, 
indicating that MRN is not responsible for specifying the final end processing 
event (Chai et al. 2006b). Cultured normal human diploid cells have longer G 
overhangs at telomeres generated by lagging strand synthesis than at leading 
strand synthesis; whereas elongated overhangs are found in leading daughter 
telomeres in human cells expressing telomerase (Chai et al. 2006a).
In telomerase negative fibroblasts, Mre11, phosphorylated Nbs1 and ATM, are 
recruited to the telomere in every G2 of the cell cycle, an event that correlates 
with the partial release of POT1 (Verdun et al. 2005). Degradation of Mre11 
using RNAi leads to increased accessibility to a terminal transferase, implying 
the MRN complex might regulate accessibility to the telomere during G2. 
Inhibiting ATM using caffeine in fibroblasts expressing HPV-E6 and E7, leads to 
telomere dysfunction. It has therefore been proposed that a localised DNA
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damage response at telomeres during G2 involving both the MRN complex and 
ATM, is essential for recruiting the processing machinery that promotes 
formation of a capped telomere (Verdun et al. 2005).
Expression of jRF2ABAM results in at least a partial loss of the 3’ overhang, 
whereas over-expression of TRF2 resulted in accelerated telomere shortening 
and a 15% increase in the 3’ overhang (Karlseder et al. 2002). These results 
suggest that although TRF2 is not directly responsible for the end processing of 
the newly replicated telomere, it may be involved in recruiting the protein(s) 
that are.
1.11 The Double Strand Break (DSB) R epair Pathways
Many of the telomere binding proteins listed in Table 1 are more traditionally 
associated with DNA DSB repair. At first, the realisation DSB proteins were 
located at the telomere seemed counter intuitive since the entire purpose of the 
telomere is to prevent it from being recognised as a DNA double strand break. 
With the understanding that the telomeric DNA requires processing before it can 
fold into a capped form, the presence of the DNA damage proteins does not 
seem so illogical. Summarised below and in (Figure 5) are the two different 
pathways known to repair DSBs and the proteins involved in the process:
• Homologous Recombination, HR. During late S and G2, a cell can employ 
HR, a more accurate method of DNA repair. Activated ATM recognises the 
double strand break and then a series of proteins including the MRN 
complex, RPA, RAD51 family, RAD 52, BRCA1 and 2 initiate a single strand 
overhang that can invade the sister chromatid. DNA transcription then 
occurs by correctly replacing the DNA that was lost using the undamaged 
sister chromatid as a template (van Gent et al. 2001).
• Non-homologous end joining, NHEJ. During G1 and early S phase, NHEJ 
rejoins two broken chromosomes without checking the fidelity of the DNA 
sequence, typically resulting in a small deletion. The Ku heterodimer and 
DNA-PKs binds the DSB. The MRN complex is then recruited, and it  is 
thought to use its helicase and endonuclease activity to create blunt ends
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Figure 5. The two pathways of Double Strand Break (DSB) Repair.
These illustrations are taken from:
van Gent DC, Hoeijmakers JH, Kanaar R. Chromosomal stability and the DNA 
double-stranded break connection. Nat Rev Genet. 2001 Mar;2(3): 196-206.
(a) Homologous Recombination
After the DSB is formed, ATM kinase is activated. Subsequent events include the 
recognition of DNA ends, which might include RAD52, and possibly then 
processing by the MRN complex. RAD51 polymerizes onto single stranded DNA 
to form a nucleoprotein filament with the aid of RPA and RAD52. Other proteins 
implicated in the response include BRCA1 and 2 and the RAD51 paralogues, 
XRCC2, XRCC3, RAD51B, RAD51C and RAD51D.
(b) Non-Homologous End Joining
Once the DSB is formed, the KU-DNA-PKs complex is probably involved in the 
initial recognition of the DSB and in the juxtaposition of the DNA ends. The ends 
might be processed, which results in the removal or addition of base pairs. The 
ends are then ligated by the DNA ligase IV-XRCC4 complex.
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Figure 5. The Two Pathways of DSB Repair
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suitable for ligation. XRCC4 and ligase IV are then (directly or indirectly) bound 
by the DNA-PK mediated phosphorylation (van Gent et al. 2001).
Although the exact logistics of what each of the DNA damage response proteins 
do during normal telomere processing has not yet been established, it is easy to 
imagine how the process may require helicases and endonucleases.
1.12 End-joining o f uncapped telomeres
Although the properties of some of the proteins involved in NHEJ and HR are 
thought to be bound to the telomere for processing purposes, their exact role 
has not yet been fully determined. Unfortunately, these processing events can 
go wrong either when the proteins involved are de-regulated or when telomeres 
become critically short.
Telomere reduction occurs with aging and prior to crisis in human cancers 
(Hastie et al. 1990). Biopsies from ulcerative colitis patients (a chronic 
inflammatory disease of the colon associated with a high risk of developing into 
colorectal carcinoma), also reveal shorter telomeres than in control patients, 
presumably caused by a higher cell turnover. The study correlates short 
telomere length with chromosomal instability and a higher frequency of 
anaphase bridges (O'Sullivan et al. 2002).
Spontaneous telomere loss on a single chromosome in a human tumour cell line 
can result in sister chromatid fusion and prolonged periods of chromosome 
instability through breakage/fusion/bridge (B/F/B) cycles (Lo et al. 2002). 
Another study has shown that at the chromosome end missing a telomere, non­
reciprocal translocation from one telomere to another resulted in telomere loss 
for the donor chromosome which consequently underwent additional 
translocations. In contrast, telomere donation through duplication, i.e. that did 
not involve telomere loss, stabilised the genome (Sabatier et al. 2005).
After expression of TRF2ABAM in HTC75 cells, under the control of a doxycycline- 
repressible promoter, telomere fusions were identified as anaphase bridges using 
the DNA intercalating dye; DAPI (van Steensel et al. 1998). Using the same 
inducible cell line, five days after expression of TRF2ABAM, 44 out of 154 mitotic 
cells exhibiting end-to-end chromosomal fusions were detected using CO-FISH.
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Figure 6. Mishaps during the cell cycle which lead to di-centric 
chromosomes.
(a) In S phase, each chromosome is duplicated during DNA replication. Each 
chromosome will contain one new strand (produced from leading or lagging 
strand synthesis) and one parental strand of DNA. The two chromosomes will 
be held together during throughout G2 at the centromere. During mitosis, 
microtubules align at the metaphase plate and are then pulled apart by 
microtubules that attach to the centromere.
During late S phase or G2, at least four different processes can occur that lead to 
the formation of di-centric chromosomes.
(b) If the telomeres are not processed properly, i.e. generation of the 3’overhang 
and correct coating of telomere binding proteins, it can be interpreted by the cell 
as a double strand break and hastily be “repaired” by Non-Homologous End 
Joining, NHEJ.
(c) As above, if the 2 telomeres were uncapped from different sister chromatid 
pairs, for example due to a problem with processing the leading strand 
synthesised during DNA replication, again improper NHEJ could occur resulting 
in a di-centric chromosome.
(d) Another process occurring at the telomere, possibly during the telomere 
lengthening mechanism used in ALT cells, is Homologous Recombination, HR. 
If the chromatid invasion, known as a holiday junction were not resolved, a di­
centric chromosome would form.
(e) The Breakage/ Fusion /Bridge, (B/F/B) cycle, occurs when a DSB fuses with 
another chromosome and forms a bridge. The DSB could form at the telomere 
or arise elsewhere in the cell. The newly formed chromosome has two 
centromeres and will continue to form bridges and consequently break.
Telomeric DNA in incorrectly trapped between the 2 centromeres can lead to 
further HR events which again may not be resolved properly.
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Figure 6. Mishaps during the cell cycle which lead to di-centric chromosomes.
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After one round of replication in the presence of TRF2“D“m, the telomere fusions 
were leading-to-leading strand (Bailey et al. 2001). Further work by another 
group established that TRF2 not only suppressed NHEJ of leading-to-leading 
strand, but also NHEJ of sister chromatids. Both types of end-joining were 
dependent upon DNA ligase IV (Smogorzewska et al. 2002) (Figure 6).
NHEJ of sister chromatids or different chromatids involving the lagging strands 
would require end resection of their 3’overhangs. When TRF2 function is 
inhibited in immortalised normal fibroblasts using TRF2ABAM, the cells show a 
reduction in their 3’overhangs. In revealing contrast, inhibition of TRF2 in 
immortalised XPF deficient cells (cell lines derived from human patients), does 
not cause a reduction of 3’overhang (Zhu et al. 2003), suggesting this is the 
endo-nuclease responsible for resecting the 3’overhang when telomeres are 
uncapped.
In contrast, the mutant version of TRF2 that retained both its myb and TRFH 
domain, but no longer expressed the basic domain, TRF2AB, still repressed NHEJ 
(Wang et al. 2004). However, expression of TRF2AB was not without 
consequence; Human cell lines IMR90, WI-38, HS68, BJ/hTERT, HT1080 and HeLa 
all demonstrated a reduction in mean telomere length. Both the C-rich and G- 
rich strands became shortened upon the expression of TRF2AB, but the 
3'overhang remained unchanged (Wang et al. 2004). Using Chromosome 
Orientation Florescent in Situ Hybridization, CO-FISH, it was determined that the 
telomere deletion was shown to be preferentially generated in leading strand 
DNA synthesis and the deletions relied upon XRCC3 and NBS1. Relaxed, double­
stranded DNA circles of telomeric DNA, called double minute chromosomes, 
were found in human cells expressing TRF2AB. Double minute chromosomes are 
also found in human cells that use ALT to maintain their telomeres and are 
known to contribute high-copy gene amplifications found in cancers (Hahn 1993).
1.13 Senescence
When placed in tissue culture, normal human cells can only undergo a limited 
amount of cell divisions, even under optimal conditions, before they stop 
proliferating. Cellular senescence was first defined by Leonard Hayflick as cell 
cycle arrest that accompanies the exhaustion of replicative potential in cultured
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human fibroblasts (Hayflick and Moorhead 1961). Senescent cells are unable to 
respond to mitogenic signalling, which distinguishes them from quiescent cells 
(Dimri et al. 1996). Despite no longer proliferating, senescent cells remain 
metabolically active and display characteristic changes in cell morphology and 
gene expression. An up-regulation of the Beta-galactosidase gene is among 
these changes, resulting in senescent cells staining blue, after incubation with X- 
galactose at sub-optimal conditions (Dimri et al. 1995). Senescence is an 
extremely stable state, and this is thought to be attributed to formation of a 
distinct heterochromatin structure termed Senescence Associated 
Heterochromatin Foci, SAHF (Narita et al. 2003).
Senescence is the biological outcome of two different sets of circumstances:
(1) Oncogene Induced Senescence/ Premature Senescence/ Stasis -MO - are all 
terms that refer to the same phenomena of cells entering a senescent state in 
response to: inappropriately activated oncogenes, DNA damage, oxidative stress 
or sub-optimal cell culture conditions (Serrano et al. 1997),(Campisi 2000)}. In 
addition to being shown in tissue culture, oncogene induced senescence has also 
been seen in vivo (Chen et al. 2005), (Braig et al. 2005). This type of 
senescence, typical of a naevi, is associated with increased p16INK4A levels, but 
not necessarily in every single cell (Michaloglou et al. 2005).
(2) Replicative Senescence - M1 - Replicative senescence is an established 
consequence of progressive telomere shortening, (Harley et al. 1990) (Counter 
et al. 1992). Tumour suppressor proteins p53 and p16INK4A act as Proliferative 
Lifespan Barriers, PLB, and regulate the onset of senescence (Wynford-Thomas 
1999). Evidence has established both a p53 dependent (dAdda di Fagagna et al.
2003), (von Zglinicki et al. 2005) and p53 independent (Jacobs and de Lange
2004) DNA damage responses in detecting the uncapped telomere(s) and 
instigating cell senescence in human fibroblasts (Figure 7).
Speculation that the DNA damage response pathway may mediate the effect of 
critically short telomeres has been a hypothesis for more than 10 years (Dulic et 
al. 1993). The over-expression of TRF2 increased the rate of telomeric 
shortening in primary cells without accelerating senescence, and reduced the
- 4 7 -
Figure 7. Proliferative Lifespan Barriers in primary human cells.
(a) “Mortality Stage 0 or 1 (M0/M1)” or “Senescence” is a viable proliferative arrest 
(at about 70 PD in human fibroblasts).
Senescence occurs when short telomeres are recognised by the p53 pathway. Rb 
remains hypo-phosphorylated preventing progression from G1 to S. p16 levels 
increase with passage in tissue culture and also increase in response to short 
telomeres. p16 prevents the phosphorylation of Rb, and can also cause 
senescence. Cells can escape from senescence through mis-regulation of both 
p53 and Rb (e.g. p53 mutation and p16 loss). MO and M1 are biologically 
indistinguishable.
“Mortality Stage 2 (M2)” or “Crisis” is the result of critically short telomeres and 
causes cell death rather than growth arrest.
Cells within a human body are prevented from uncontrolled cell growth as they are 
regulated by these Proliferative Lifespan Barriers, PLBs, as are primary human cells 
(e.g. fibroblasts or epithelial cells) grown in tissue culture. Very rare cells which 
have lost p16, p53 and managed to activate either telomerase or the ALT pathway 
continue proliferating.
(b) This image is taken from the publication:
Preto A, Singhrao SK, Haughton MF, Kipling D, Wynford-Thomas D, Jones CJ. 
Telomere erosion triggers growth arrest but not cell death in human cancer cells 
retaining wild-type p53: implications for anti-telomerase therapy. Oncogene. 2004 
May 20;23(23):4136-45.
K2 is a human thyroid cancer cell line that retains wt p53. Expression of a dominant 
negative version of hTERT inhibits telomerase activity and instigates a reduction in 
telomerase activity. Where cells express E6 (from HPV 16) their p53 is no longer 
functional and cells bypass senescence and proliferate until they reach crisis, 
demonstrated in panel * with a marker of apoptosis (TUNEL). In contrast, where 
p53 is still functional, the telomere shortening results in senescence and not 
apoptosis °.
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average telomere length at which point the cells start to senesce from 7 to 4 kbp 
(Karlseder et al. 2002). It was therefore hypothesised by Karlseder et al that 
replicative senescence is induced by a change in the protected status of 
shortened telomeres rather then by a complete loss of telomeric DNA. 
Uncapped telomeres in human fibroblasts were created using jrf2abam and then 
analysed for expression of DNA damage response factors. 53BP1, y-H2AX, and 
activated. Rad17, ATM and Mre11 each co-localised with TRF1 signifying 
uncapped telomeres in what were branded Telomere-Induced dysfunctional Foci, 
TIF’s (Takai et al. 2003). The presence of 53BP1 within a TIF was reduced by 
phosphatidylinositol 3-kinase inhibitors which affect ATM, ATR and DNA-PK. A 
cell line derived from an Ataxia Telangiectasia (AT) patient (a syndrome with 
mutations in the ATM protein) also demonstrated a diminished 53BP1 TIF 
response. However, these cells still senesced indicating an additional ATM 
independent pathway was also capable of recognising uncapped telomeres and 
instigating cell senescence. Phosphorylated H2AX, 53BP1, MDC1 and NBS1 are all 
proteins associated with the DNA damage response found activated in senescent 
human fibroblasts (dAdda di Fagagna et al. 2003). It has also been established 
using Chromatin Immunoprecipitation or whole genome scanning approaches 
that the telomeres directly associate with some, but not all, DNA damage 
response proteins (Gire et al. 2004). Moreover, inactivation of DNA damage 
checkpoint kinases (pATM, pATR, pCHK1 and pCHK2- using microinjection of 
plasmids expressing kinase dead versions of protein) in senescent cells resulted 
in up to 20% of cells progressing to S phase (d'Adda di Fagagna et al. 2003). 
These publications were the first to provide evidence that critically short or 
uncapped telomeres were capable of initiating senescence through the DNA 
damage response pathway.
Not only are activated ATM and y-H2AX readily observed in late-passage 
fibroblasts, but these signals can be abrogated with the addition of telomerase 
(Bakkenist et al. 2004), providing further evidence that it is the critically short 
telomere instigating the senescence. Once cells become fully senescent in the 
absence of telomerase, the activated ATM and y-H2AX signals disappeared, 
indicating that their constitutive signalling is not required for the maintenance 
of senescence (Bakkenist et al. 2004). Although the signal for initiating 
senescence may not be required, the signals for maintaining it are. Micro- 
injecting p53 antibodies into human fibroblasts that had been senescent for at
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least 19 days resulted in reversion to a much more compact morphology 
accompanied by a marked reduction in B-Gal and 14-17% of the cells 
incorporating BrdU (Gire and Wynford-Thomas 1998).
In naturally senescent human fibroblasts, loss of the 3* overhang has also been 
proposed as the altered telomere state that activates the cell senescence 
pathway (Stewart et al. 2003). However a conflicting report shows that normal 
human fibroblasts can maintain their 3’overhang at senescence and do not lose 
their overhangs when they bypass senescence after the inactivation of p53 and 
Rb (Chai et al. 2005).
1.14 Cell cycle regulating proteins associated with senescence
The progression from G1 to S phase during the cell cycle is controlled to a large 
extent by the Retinoblastoma protein, Rb. Hypo-phosphorylated Rb binds to the 
E2F proteins and prevents Polymerase II and other elements of the transcription 
machinery gaining access to the site. When hyper-phosphorylated, Rb is no 
longer capable of binding E2F and transcription of the genes required for 
progression to S phase takes place (Figure 8). Two well characterised cell cycle 
inhibitors known to work independentlyof one another are p16INK4A and p21. 
p16INK4A can prevent cell cycle progression from G1 to S by inhibiting CyclinD- 
Cdk4/6 from phosphorylating Rb. Likewise, directly downstream from activated 
p53, p21 prevents CyclinE-Cdk2 from further phosphorylating Rb (Figure 8).
The contribution of p16INK4A in response to uncapped telomeres in human cells 
has been a subject of great debate. As both fibroblasts (Morris et al. 2002) and 
human keratinocytes (grown with or without feeders, see Section 1.19) (Morris 
et al. 2002) age in culture, their protein levels of p16INK4A increase, resulting in 
growth arrest independent of telomere length. This has substantially 
complicated attempts to determine the interactions of the uncapped telomere 
and P16INK4A.
In Herbig et al’s studies, they identified TIFs by co-localising y-H2AX and a 
peptide nucleic acid labelled probe against the telomere in a process called 
immunoFISH; in addition to identifying TIFs, they also stained for p21, as a 
downstream marker of p53 activation. TIFs were found predominantly in either
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Figure 8. Cell cycle regulation by tumour suppressor proteins p16 and p21.
(a) Cell cycle progression from G1 to S phase is largely governed by the 
Retinoblastoma protein, Rb. It is phosphorylated by two separate Cyclin / Cyclin 
dependent kinase complexes: Cyc 01 cdk 4,6 and Cyc E/ cdk 2. The enzyme 
activity of both of these complexes can be inhibited by cyclin dependent kinase 
inhibitors, p16 and p21, respectively.
(b) When Rb is either not phosphorylated (Rb) or hypo-phosphorylated (Rb-P), it 
remains bound to the E2F transcription factor family proteins and prevents DNA 
transcription machinery from transcribing the G1 S genes.
(c) When Rb is hyper-phosphorylated (Rb-PPP), it can no longer bind the E2F 
family proteins. E2F are then capable of recruiting the DNA transcription machinery 
(i.e. Pol II and associated proteins) and transcribing the genes required for 
progression from G1 to S phase.
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A plate of senescent human fibroblasts
Senescence 
inducing pathway
p16 negative and p21 positive cells with TIFs P21
p16 positive and p21 positive cells with TIFs Either p16 or p21
( ^ )  p16 positive cells without TIFs P16
Figure 9. p16 and p21 response to critically short telomeres.
In both naturally senescent cells or cells artificially uncapped by TRF2ABAM, TIFs are 
thought to form quickly after the telomere becomes uncapped, and then disappear. 
The above cartoon illustrates the results of Herbig et al (see text), who found that 
p21 positive cells with TIFs could either be p16 negative or positive.
p16 up-regulation is also thought to be a consequence of uncapped telomeres, but 
at a later time. It is possible that in p16 positive, TIF negative cells, the uncapped 
telomere had induced the senescence, but was no longer present in the senescent 
cell assayed for p16.
A further publication by Jacobs et al (see text) found that p16 was induced in most 
young fibroblasts as a result of expressing TRF2ABAM. Cells deficient in p53 still 
exhibit a partial response to telomere uncapping and knocking down p16 ablates 
that partial response. Therefore, the p16 and p21 pathway responses to uncapped 
telomeres are capable of inducing senescence in conjunction and independently.
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pZ1 -positive or pZ1/ p i6 doubly positive cells, while p16 -positive (only)
cells remained largely TIF free, illustrated in a cartoon (Figure 9). As the 
number of p21 /  p16INK4A doubly positive cells with TIFs was roughly equal to the 
number of p16INK4A only cells without TIFs, they concluded that: (a) p16INK4A is 
regulated in a telomere independent manner; whereas p21 regulation is 
telomere dependent (b) both pathways could be up-regulated at the same time 
(Herbig et al. 2004). As further proof, it was shown that inhibition of ATM in 
senescent cells that contain TIFs results in cell cycle re-entry, indicating not 
only that stable arrest requires continuous signalling, but also that p16INK4A is not 
responding to the uncapped telomere(s) in these cells (Herbig et al. 2004).
The de Lange lab used the introduction of TRF2ABAM into fibroblasts to induce 
uncapped telomeres in ‘young* human fibroblasts and found p16INK4A was induced 
in the majority of cells as detected by immunohistochemistry (Jacobs and de 
Lange 2004). They also established that fibroblasts deficient in p53 still 
demonstrated a partial response to telomere uncapping (Jacobs and de Lange 
2004), and that inhibition of p16,NK4A in the p53 deficient cells resulted in an 
almost complete bypass of telomere directed senescence (Jacobs and de Lange
2004). This led to the conclusion that, in addition to a p53 response, p16INK4A 
also plays a major role in telomere directed senescence. However, the 
induction of p16INK4A as a consequence of telomere dysfunction appears to be a 
very slow process, taking one to two weeks before p16INK4A is readily detectable 
(Jacobs and de Lange 2004). As Herbig et al used TIFs, an established early and 
transient mechanism of detecting telomere dysfunction it is not surprising that 
the p16,NK4A staining they witnessed did not necessarily correlate with TIF 
detection (Jacobs and de Lange 2004).
ATR, an ATM-related DNA damage response protein more commonly associated 
with single DNA strand breaks, was also shown to play a minimal role in the 
response to the uncapped telomere. However, when the ATM response was 
removed, the ATR response became more prominent and the fibroblasts elicited 
a delayed G2 phase arrest (Herbig et al. 2004).
When neither the p53 nor Rb/p16INK4A proteins are functioning properly, human 
cells continue to proliferate, bypassing senescence. When an increased number 
of their telomeres become critically short, the cells w ill undergo crisis, large
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scale apoptosis (Macera-Bloch et al. ZUUZ), (Preto et al. ZUU4) (Figure 9). uniy 
the very rare cell which has also managed to activate either telomerase or the 
ALT pathway is immortalised and capable of continued proliferation.
1.15 Telomere Elongation Mechanisms, ALT vs. Telomerase
As has already been established, proliferating cells experience telomere 
shortening and this ultimately leads to cell senescence or apoptosis. As 
mentioned in (Figure 7), rare cells down-regulate both p53 and p16INK4A in 
addition to up-regulating a telomere lengthening mechanism to achieve 
immortality. Two mechanisms have been characterised and account for nearly 
all the ways in which telomeres are extended: Telomerase activation and ALT.
1.15.i Telomerase activation
Telomerase is a large multimeric ribonucleotide protein whose core components 
are (1) hTR, an RNA template that associates with (2) hTERT, the reverse 
transcriptase that adds nucleotides to the end of the telomere (Nakamura et al. 
1997). Telomerase is up-regulated in >85% of all human cancers (Kim et al. 
1994), (Shay and Bacchetti 1997).
Short telomeres are preferentially elongated by telomerase and a low cellular 
concentration of telomerase is critical to achieve preferential elongation of 
short telomeres and telomere length homeostasis (Cristofari and Lingner 2006). 
Long telomeres do not permanently adopt a structural state that is non- 
extendable: when telomerase levels are increased in fibroblasts expressing 
hTERT, the level of telomere-bound TRF1 and TRF2 increase proportionally 
(Cristofari and Lingner 2006). In addition to binding the telomere, Ku70/80 
associate physically with hTERT (Chai et al. 2002), suggesting this interaction 
might be part of the way telomerase gains access to the telomere.
Until 2003, telomerase was only considered to be active in germ cells, stem cells 
and cancer cells. However, that changed when evidence was published that 
hTERT is expressed during S phase of cycling primary pre-senescent human 
fibroblasts (Masutomi et al. 2003). The authors also established that disruption 
of telomerase activity in normal human cells slows cell proliferation, restricts 
cell lifespan and alters the maintenance of the 3* single stranded telomeric
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overhang without changing the rate ot overall telomere shortening (Masutomi et 
al. 2003).
Whether these effects are generated by telomerase per se or the telomere being 
elongated by telomerase is difficult to distinguish. Ectopic expression of hTERT 
leads to transcriptional alterations of a subset of genes and changes in the 
interaction of telomeres with the nuclear matrix, after telomerase has 
interacted with telomeres (Sharma et al. 2003). In addition to acting at the 
telomere, hTERT expression improves DNA damage repair at non-telomeric sites. 
Higher mRNA levels of some DNA repair genes were seen in cells expressing 
hTERT; thus a possible explanation for the increased DNA repair capacity is the 
increased level of nucleotides found in the ectopic hTERT expressing cells 
(Sharma et al. 2003). Suppression of hTERT using RNAi in human fibroblasts does 
not alter telomere integrity in the short term, but instead affects the overall 
configuration of chromatin. Cells lacking hTERT exhibit increased radio 
sensitivity, diminished capacity for DNA repair and fragmented chromosomes, 
demonstrating that loss of hTERT impairs the DNA damage response (Masutomi et 
al. 2005).
Finally, the telomere must be accessible to elongation by telomerase for active 
telomerase to have an effect. Both TRF1 and 2 have been shown to regulate 
such access (See Table 1). Drugs such as BRAC019 are capable of inducing the 
formation of G quadruplexes throughout the DNA, but particularly in the 
telomere, preventing active telomerase from interacting with and therefore 
elongating the telomere (Neidle and Parkinson 2002).
Alternative Lengthening of Telomeres, ALT
The presence of ALT is deduced from the combination of no detectable
telomerase activity and telomeres that have a characteristic heterogeneity of 
length, ranging from short to abnormally long (Bryan et al. 1995). ALT accounts 
for - 1 0 % of telomere maintenance in tumours and is commonly used by 
astrocytic brain tumours and osteosarcomas (reviewed by (Muntoni and Reddel
2005)). It has been suggested that, in human tumours where abundant amounts 
of extra-chromosomal telomeric repeats are found in linear and circular form, 
ALT is a deregulated version of an aspect of normal mammalian telomere 
homeostasis (Muntoni and Reddel 2005).
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7 . 7 6  Dyskeratosis Congenita
Dyskeratosis Congenitia, DC, is the result of defective telomerase activity 
(reviewed in (Marrone et al. 2005)). Patients develop critically short telomeres 
characterised phenotypically by abnormal skin pigmentation, leukoplakia, nail 
dystrophy, an increased disposition to cancer and bone marrow failure.
Two types of mutation lead to DC:
In patients with an X-linked recessive version of the disease, mutations generate 
a defective form of dyskeratin, a protein known in other species to have a 
significant role in ribosomal RNA folding (Heiss et al. 1998), therefore effecting 
the ability of the RNA component of telomerase, hTR, to function properly.
An autosomal dominant (AD) mutation in the gene-encoding human telomerase 
RNA (TERC), results in telomere shortening. In one family carrying such a 
mutation, T cells were found to over-express senescence markers, including 
CD57 and Fas receptor and were moderately reduced in cell number. AD DC 
lymphocytes display a markedly reduced proliferative capacity, and an increased 
basal apoptotic rate (Knudson et al. 2005).
AD-DC has recently been associated with progressive telomere shortening. The 
disease becomes more severe in succeeding generations with a median age of 
diagnosis of 37 years in the parental generation and 14.5 years in the second 
generation (Vulliamy et al. 2004). Patients with more severe phenotype had 
shorter telomere lengths (Vulliamy et al. 2004).
1 .17  D ifferen t cells respond d iffe ren tly  to the same stim uli
Although model organisms are invaluable in providing information about the 
consequences of genetic manipulation in systems that can be both quicker and 
easier to manipulate, they do not always provide the most relevant information 
when treatment for a particular disease is being considered. For example, in 
contrast to human cells, loss of p53 alone is enough to abrogate the arrest of 
mouse cells indicating that the p16INK4A /RB response to telomere dysfunction is 
not active in mouse cells (Smogorzewska and de Lange 2002).
- 57-
Even cells from different tissues of the same organism can respond differently to 
the same stimulus. For example, keratinocytes and fibroblasts were shown to 
respond differently to early Epstein Barr viral proteins; a G(1)/S block in cell 
cycle was seen in fibroblasts, but not in keratinocytes (Mauser et al. 2002).
Furthermore, expression of oncogenic Ras in human fibroblasts results in a 
permanent G1 arrest associated with accumulation of p53 and p16INK4A (Serrano 
et al. 1997). In contrast, Ras induces a proliferative phenotype in normal human 
thyroid epithelial cells (Gire and Wynford-Thomas 2000).
A final example of the different signalling pathways activated by different cell 
types is Smurf2, an E3 ubiquitin ligase thought to be up-regulated as a specific 
consequence of telomere attrition, in human fibroblasts. However, expression 
of TRF2ABAM in early pass fibroblasts did not result in an up-regulation of Smurf2, 
indicating that Smurf2 up-regulation is a specific consequence of short 
telomeres, not a dysfunctional telomere (Zhang et al. 2003). Expression of 
Smurf2 in early pass fibroblasts resulted in premature senescence (Zhang et al. 
2003). However, Smurf2 levels have been shown to remain constant in 
populations of human mammary epithelial cells, HMECs, during their progression 
to replicative senescence (Zhang et al. 2003). A microarray study examining 
HMEC at senescence grown with either (1) a feeder layer, (2) on plastic alone in 
defined culture conditions or (3) senescent fibroblasts, showed surprisingly few 
expressed genes in common, even between the HMEC grown using 2 standard 
tissue culture methods (Zhang et al. 2004). These results indicate that 
replicative senescence is heterogeneous, rather then a unique process and also 
forewarns that use of the JRF2ABAM to mimic the uncapped telomere may not 
necessarily result in activating the same pathways that a senescent cell with 
reduced telomeres might.
1.18 The Epidermis
The largest organ in the human body, skin, consists of two layers: the dermis and 
the epidermis (Figure 10). The outer epidermis layer is composed of keratinized 
stratified squamous epithelium and contains 4 principal cell types:
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Figure 10. Haematoxylin and Eosin stained section of normal skin
The above picture was taken from the Dept, of Dermatology - University of Iowa College of Medicine (M. S. 
Stone and T. L. Ray) http://trav.dermatoloqy.uiowa.edu/DPT/Hist/Nrml-001.htm
The below text is taken from Principles of Human Anatomy, Eighth edition, Tortora, pg.90- 97.
Stratum corneum - the outer most level of the epidermis, contains in excess of 20 
rows of dead, flattened keratinocytes which further add to the protective function of 
skin.
The stratum granulosum and stratum lucidum both contain flattened keratinocytes 
which produce granular proteins and lipids that serve in the epidermis’ protective 
function.
Stratum spinosum -  Layers of keratinocytes that fit closely together with long 
projections of melanocytes extending between them. In tissue culture, these would be 
referred to as the transit amplifying cells.
Stratum basale -  a single row of cuboidal or columnar shaped keratinocytes (referred 
to in Chapters 3, 4 and 5 as basal cells), capable of continuous cell division. 
Melanocytes, merkel cells and langerhan cells are scattered among the keratinocytes 
of the basal layer.
Dermal-Epidermal Junction - Desmosomes bind basal cells to each other and to the 
adjacent epidermal layer. Desmosomes also bind to hemi-desmosomes, which bind 
the keratinocyte to the basement membrane which separates the epidermis from the 
dermis.
Papillary dermis -  composing one fifth of the dermis and consisting of areolar 
connective tissue containing fine elastic fibres produced by fibroblasts within the 
region. Surface area of the dermis is increased by dermal papillae which project into 
the epidermis and contain many loops of capillaries and Meissner’s corpuscles, tactile 
receptors sensitive to touch. The dermal papillae cause the ridges in the overlaying 
epidermis that cause fingerprints.
Reticular dermis -  a dense, irregular connective tissue that contains interlacing 
bundles of collagen and elastic fibres interspersed by adipose tissue, hair follicles, 
nerves, oil glands and sweet gland ducts. Varying thickness of this region contribute to 
the different levels of thickness seen in skin.
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Keratinocytes - these cells produce the protein keratin which helps to protect 
the skin and underlying tissues from light, heat, microbes and many chemicals 
and make up about 90% of the epidermis.
Melanocytes - produce the pigment melanin (brown-black pigment that 
contributes to skin colour and absorbs UV light) and constitute about 8 % of the 
epidermal cells. Long slender projections extend between keratinocytes, 
transferring melanin granules to them.
Langerhan cells - arising from red bone marrow, these cells interact with helper 
T cells and are easily damaged by UV radiation.
Merkel cells - located in the stratum basal, these cells attach to keratinocytes 
(see below) by anchoring junctions and make contact with the flattened portion 
of the ending of a sensory neuron.
Keratinization is the accumulation of increasing amounts of keratin and loss of 
cytoplasm, nucleus and other organelles as the cells migrate and differentiate 
from the stratum basale to the stratum corneum. Undifferentiated 
keratinocytes contain numerous microtubules, which radiate out from a 
centrosomal organisation centre. Differentiating keratinocytes, which leave the 
basal layer begin to synthesise involucrin and display an altered cytoskeleton 
(Lewis et al. 1987).
1.19 Keratinocyte Growth in Tissue Culture
Keratinocytes isolated from human epidermis can be successfully grown in serial 
culture for 20-50 cell generations when grown with proliferation arrested 
fibroblasts, which are referred to as feeders (Rheinwald and Green 1975). Cells 
less then 1 1  pm in diameter form rapid growing colonies in culture whereas 
those larger then 1 2  pm are irreversibly committed to further enlargement and 
terminal differentiation (Barrandon and Green 1985).
Keratinocytes are heterogeneous in their proliferative potential. Three 
classifications have been established (Barrandon and Green 1987b):
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(1)Holoclone - the greatest reproductive capacity, tewer then dYo or the 
colonies formed from the cells of a holoclone abort and terminally 
differentiate.
(2) Paraclone - cells with a short replicative lifespan (not more than 15 cell 
generations), after which they uniformly abort and terminally 
differentiate.
(3) Meroclone - a mixture of cells of different growth potential and is a 
transitional stage between the holoclone and the paraclone.
The incidence of the different clonal types is affected by aging, since cells 
originating from the epidermis of older donors give rise to a lower proportion of 
holoclones and a higher proportion of paraclones (Barrandon and Green 1987b).
Each keratinocyte colony ultimately forms a stratified squamous epithelium in 
which the dividing cells are restricted to the lower layer (Rheinwald and Green 
1975). Hydrocortisone is added to the medium to make keratinocyte colony 
morphology more orderly and distinctive, particularly in secondary and 
subsequent cultures. This not only helps during subsequent feeder removal, but 
hydrocortisone also maintains proliferation at a slightly higher rate (Rheinwald 
and Green 1975). Increases in the cAMP levels (which can be achieved through 
the use of cholera toxin, dibutyryl cAMP, methyl isobutyryl cAMP or 
isoproterenol) increase the rate of proliferation of epidermal cells, including 
keratinocytes (Green 1978). The presence of cholera toxin increases the 
proportion of small cells which have a higher proliferation potential (Green 
1978). The culture lifetime of epidermal cells of newborn humans is increased 
from 50 to 150 Population doublings by addition of Epidermal Growth Factor, 
EGF, to the medium (Rheinwald and Green 1977). Whereas cholera toxin 
increases the number of cells in growing colonies, EGF enlarges small colonies by 
flattening the cells (Green 1978). Intracellular adhesion of keratinocytes is 
mediated by desmosomes and non-disjunction cadherins which are dependent on 
calcium for their functions. Standard tissue culture concentrations of calcium 
range from 1.2 - 1.8 mM, and at these concentrations keratinocytes are capable 
of stratification. In limited concentrations of calcium, such as 0.05-0.10 mM; 
keratinocytes proliferate, but are unable to stratify and hence grow as a 
monolayer (Hennings et al. 1980).
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Cell migration is essential for sustained growth of keratinocyte colonies, as tney 
grow larger they increase in radius at a constant rate over time. The rate is 
increased 8 -fold in the presence of epidermal growth factor (Barrandon and 
Green 1987a). Keratinocytes are able to migrate during wound healing and early 
neoplastic invasion (Natarajan et al. 2006). Plating keratinocytes on the y-2 
precursor form of laminin 5 immediately induces directional hypermotility 
followed by p16INK4A expression and growth arrest (Natarajan et al. 2006). Cells 
deficient in p16INK4A and either p14 or p53 become hypermotile, but do not 
growth arrest (Natarajan et al. 2006).
As human keratinocyte age in culture, protein levels of p16INK4A increase, 
resulting in growth arrest independent of telomere length, known as telomere 
independent senescence (Darbro et al. 2005). p16INK4A induction can be delayed 
and keratinocytes grown for longer in culture when grown with a post-mitotic 
fibroblast feeder cells (Darbro et al. 2005). Not only do feeder cells provide 
better growth conditions for normal human keratinocytes, they have also been 
established as a necessity in the culture of some Squamous Cell Carcinomas 
(Rheinwald and Beckett 1981). Two independent normal human keratinocyte 
cell strains expressing exogenous telomerase and co-cultured with feeder cells 
resulted in efficient extension of lifespan without an apperent crisis (Darbro et 
al. 2006). When the cells were transferred to plastic alone, they experienced a 
period of slow growth. Those that experienced p16INK4A promoter methylation 
achieved immortality and re-introduction of p16INK4A into those immortal cell 
lines resulted in rapid cell growth arrest (Darbro et al. 2006).
1.20 Keratinocyte DNA damage response
Epidermal keratinocytes specifically express genes that protect from UV light 
(Gazel et al. 2003). The response of the keratinocytes to UV irradiation has 
been better investigated than the response to y-irradiation, which is not 
surprising as investigations into UV rays from the sun are a larger natural threat 
than y-irradiation. UV irradiation is more likely to cause single strand DNA 
breaks which operate through different DNA damage response pathways, 
compared to double strand breaks that are induced by y-irradiation or telomere
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uncapping. This needs to be considered when making comparisons between the 
effects of DNA damage on keratinocytes.
UV-light induces DNA damage in keratinocytes in organotypic cultures of normal 
human skin. Activation of p53 triggered apoptosis, firstly in the basal layer 
within 2 hours and in the suprabasal layers after around 8  hours (Qin et al. 
2002). The same publication also demonstrated that cultured keratinocytes 
undergoing spontaneous senescence constitutively contained low levels of p53 
which were neither increased nor phosphorylated or acetylated after UV 
exposure.
In keratinocytes, UVB inhibits differentiation; but in HPV-16, E6/7-immortalized 
keratinocytes, UVB induces apoptosis (Simbulan-Rosenthal et al. 2005). 
Investigation into the differential effect found that Id2 expression was up- 
regulated in keratinocytes, but not in immortalized keratinocytes. It is possible 
that the up-regulation of Id2 by UVB might predispose keratinocytes to 
carcinogenesis by preventing their normal differentiation program (Simbulan- 
Rosenthal et al. 2005).
When wild type p53 is reintroduced into a Squamous Cell Carcinoma, SCC15, a 
transient G1/S arrest is seen. When these cells are irradiated, a G2/M arrest is 
seen (Niemantsverdriet et al. 2005). This study demonstrates that p53 is 
capable of causing two different types of arrest in the same cells in response to 
different types of stimuli.
1.21 PhD background
Cancer is a disease of uncontrolled cell proliferation, most commonly derived 
from human epithelial tissues. A Cancer Research UK 2002 study showed three 
epithelial tissues are the most prevalent sites of a primary tumour: breast, lung 
and colon. Interestingly, the ratio of mesenchymal to epithelial patients is 1:10 
in the normal ageing population, compared to 1:1 in Werner's syndrome patients 
(Goto et al. 1996), further implicating the different cell proliferation control 
processes that become de-regulated in different cell types resulting in cancerous 
cells. Historically, genetically unaltered human epithelial cells have been 
harder to maintain in culture and perform experiments with, so with good 
justification laboratories have traditionally used fibroblasts. However, as
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indicated above (Section 1.17) in any 2 given cell types, even from the same 
organism, cellular responses are still not necessarily the same, e.g. SMURF2 in 
fibroblasts vs. HMEC; or JRF2ABAM in fibroblasts vs. lymphocytes. Even the same 
cell type grown different ways, e.g. HMECs grown in serum-free medium without 
feeders or with feeders in medium with serum, can alter the transcriptome of 
the cells (Zhang et al. 2004).
Strategies to specifically inhibit cancer cell growth by targeting telomerase 
activity work on the premise that after a small period of proliferation 
(dependent upon telomere length of the tumour cells) telomeres w ill become 
critically short and thereby cause either cellular senescence or apoptosis. 
Senescent tumour cells are not necessarily a satisfactory cancer treatment 
outcome. Senescent cells are still viable and as such may continue to 
deregulate the organ they are invading. In addition to that, in unfavourable 
circumstance, senescence can be reversed through genetic alteration (Herbig et 
al. 2004). It is therefore a risky strategy, given the genetically unstable 
environment in which the tumour cells exist, to leave senescent tumour cells 
susceptible to mutation within the body. However, having stated that, although 
apoptosis of cancer cells is preferable to senescence, senescent tumour cells 
would still preferable to the uncontrolled cell growth which will result in patient 
death.
With a new found understanding of the importance not only in the length of the 
telomere, but also in the ability of the telomere binding proteins to regulate the 
telomeres structure; levels of telomere binding proteins are now being 
scrutinised in human cancers for evidence of mis-regulation. One study of POT1 
mRNA levels in 51 gastric cancers found significantly higher levels of POT1 in 
later stage cancers (stage III/ IV) compared with tumours at an earlier stage 
(stage I/ll) (Kondo et al. 2004). This result correlates with the telomere 
stabilisation seen during cancer development. Other studies have found TRF2 
up-regulation in immortally transformed human mammary epithelial cells 
(HMECs), as well as in 11/15 breast tumour cell lines (Nijjar et al. 2005). The 
up-regulation of TRF2 is most likely due to differences in post-translational 
regulation, as mRNA levels were comparable in finite lifespan and immortal 
HMECs (Nijjar et al. 2005). An increase in levels of TRF2 has also been reported 
in some human skin basal or squamous cell carcinomas (Munoz et al. 2005).
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1.22 Aim and Objectives
The effect of critically short telomeres has not been previously investigated in a 
normal human epithelial cell system. As such, we have chosen to examine the 
effect of uncapping the telomere in Normal Human Epidermal Keratinocytes, 
NHEK. As referred to earlier in this chapter, natural elevation of p16INK4A and 
p53 provide a barrier to long term culture of epithelial cells referred to as 
M0/M1. Although this can be overcome by knockdown using RNAi, we wanted to 
be able to assess the contribution of p16INK4A and p53 to the effect of an 
uncapped telomere. It is known that long term propagation of primary cells 
results in some genetic heterogeneity which can influence the cellular outcome. 
This was another drawback we hoped to avoid, by using NHEK.
The overall aim of this PhD has been to characterise the response of NHEK to 
uncapped telomeres using TRF2ABAM. The specific objectives were as follows:
• Optimise a system to retrovirally infect NHEK allowing for selection of 
cells at early time points.
• Observe and characterise the effect of uncapped telomeres on colony 
morphology and proliferation.
• Determine if the DNA damage pathway is activated as a result of 
uncapping the telomere in NHEK as in fibroblasts.
- 6 5 -
Chapter 2: Materials and Methods
Manufacturers' and Suppliers' details are listed in Appendix I.
2.1 Cells and Medium
Table 3: Cells and Medium
Cells Catalogue
Number
Supplier Medium and Culture Notes
NHEK
(Normal Human 
Epidermal 
Keratinocytes) are 
derived from a pool of a 
minimum of 3 neonatal 
foreskins and are 
prepared by digestion 
overnight at 4°C with 
dispase. The epidermis 
is then peeled from the 
dermis and the 
keratinocytes released 
from the epidermis by 
digestion with Trypsin- 
EDTA.
12332-011 Invitrogen FAD medium.
(Flavin Adenine Dinucleotide) 
medium supplemented with 1 0 % 
(v/v) FBS, 2 mM L-Glutamine, 
0.4 pg/mL hydrocortisone, 5 
pg/mL insulin, 5 pg/mL 
transferrin, 10' 10 M cholera 
toxin, 1.8 x 10’ 4  M adenine, and 
10 ng/mL epidermal growth 
factor (added at the first 
medium change).
20% FAD contained 20% (v/v)
FBS and was used during 
infections.
3T3 Swiss Albino 
mouse fibroblasts 
‘Feeders'
CCL92 ATCC
(Distributed 
by LGC)
10C medium supplemented 
with 10% (v/v) FBS, 2mM L- 
Glutamine and 20 mM Hepes.
Phoenix E 
(E, Ecotropic 
Receptor)
Beatson
Institute
Cell
Stocks
Cells 
originate 
from: Dr G P 
Nolan
10% medium (v/v) FBS and 2mM 
L-Glutamine.
Or during infections,
20% medium (v/v) FBS and 2mM 
L-Glutamine.
Phoenix A
(A, Amphotropic
Receptor)
Beatson
Institute
Cell
Stocks
Cells 
originate 
from: Dr G P 
Nolan
10% medium (v/v) FBS and 2mM 
L-Glutamine.
Or during infections,
20% medium (v/v) FBS and 2mM 
L-Glutamine.
PT67s
(NIH-3T3 based 
retroviral packaging 
cell line with both 
Ecotropic and 
Amphotropic 
Receptors)
Beatson
Institute
Cell
Stocks
Cells
originate
from:
Becton
Dickinson
10% medium (v/v) FBS and 2mM 
L-Glutamine.
Or during infections,
20% medium (v/v) FBS and 2mM 
L-Glutamine.
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2 . 2  Routine Tissue Culture
In this thesis, NHEK are grown with lethally irradiated Swiss 3T3 feeders, 
referred to as feeders from here on in. (Later in the thesis, PT67s are also used 
as feeders during the NHEK infection process, but to clarify, they w ill be 
referred to as ‘ infectious PT67s.) All tissue culture was performed using aseptic 
technique inside a laminar flow hood. Retroviral infection of NHEK was 
performed in a category II containment suite, with safety precautions approved 
by the HSE and Beatson Institute Safety Committee. All cells were incubated at 
37°C in a wet atmosphere containing 5% (v/v) CO2 , except when incubated at 
32°C instead, in which case it is clearly denoted. Tissue culture plastics were 
supplied Falcon culture dishes (Becton Dickinson).
2.2.1 Feeder Preparation
Between 2 to 20 flasks (T-75) of feeders were cultured every other week. The 
feeders were harvested and concentrated to a cell density between 1 - 4 
x106/mL in a universal. Feeders were then kept either at 4°C or on ice until 
receiving 60Gy y-IR, a lethal irradiation dose, the purpose of which was to 
prevent further replication during co-culture with NHEK. Although growth 
arrested, the cells are still capable of adhering to the tissue culture plate and 
produce extra cellular proteins which aid the growth and development of the 
NHEK. The feeder cell preparations were stored at 4°C and used for up to one 
week (at which point they were discarded and a fresh stock prepared). Every 3- 
4 months new vial of feeders were thawed from liquid nitrogen to replace the 
current stock.
2.2.W Initial plating and continued culture of NHEK
Prior to an experiment, NHEK were resurrected from liquid nitrogen by being
transferred from (liquid nitrogen) immediately into a 37°C water bath. The cells 
were then transferred to 9 mL of medium and centrifuged for 5 min at 4°C at 
1000 RPM (to form a cell pellet). Re-suspended in fresh medium without the 
cryo-preservation agent DMSO, the NHEK were plated at an appropriate density 
with feeders in FAD medium, see Table 4. The following day, the medium was 
changed to include EGF, denoted FAD\
- 6 7 -
2.2./II Feeder removal and trypsimsation
Feeders were removed prior to trypsinisation by directing a stream of PBS:0.02% 
EDTA, PE, (Provided by Central Services at the Beatson) against the plate with 
an element of force. Defining a certain point on the plate as 12 o'clock, the PE 
would firstly be directed around the edges of the plate, before concentrating on 
each quarter, e.g. 12 to 3 o'clock. The PE was then removed, and fresh PE 
applied before the plate was quickly scanned at low power at the light 
microscope for any remaining feeders. The cells were then washed with PBS and 
subjected to trypsinisation for 30 min at 37°C. (30 min is extremely long
compared to normal tissue culture practices, however this length of time was 
required for the trypsin to get into the colonies to create the desired single cell 
suspension.) Worthington's Trypsin (Cat no. LS3703, distributed by Lome 
Laboratories) was prepared in bulk, frozen into concentrated aliquots and used 
at a final concentration of 1 mg/mL, prepared in either PBS alone for feeders, or 
0.01% PE for NHEK. After 30 min the trypsin was inhibited by the addition of 
FAD medium and the cells centrifuged for 5 min at 4°C, 1000 RPM. NHEK were 
then re-suspended and re-plated with an appropriate amount of feeders as listed 
in Table 4.
Table 4: Plating densities of NHEK and Feeders
Tissue Culture Dish/ 
Coverslip Diameter
Cell density of NHEK Cell density of feeders
9 cm plate 1 - 1 0  x 1 0 ’ 1 x 1 0 ’
14 cm plate 1 -2 5 x1 0 ’ 2.5 x 10°
(3T3 conditioned) 
15 mm coverslip
0.5 -1.0 x 10’ 1 x 1 0 ’ , 
for removal 2-3 days 
prior to NHEK plating
When required, population doublings, PD, were determined according to the 
equation: PD = 3.32 [logio (Cell Yield) - logio (Cell Input)].
2.2 .iv  3T3 conditioning coverslips fo r NHEK
Swiss 3T3 fibrblasts were grown to confluence on Thermanox 15 mm plastic 
round coverslips (Cat no. L4353, Agar Scientific) in a 12 well dish. The Swiss 3T3 
cells were then removed after 5 min of incubation with PE by pipetting the PE 
up and down with force. The PE washes were repeated and then the coverslips 
incubated in 5 mL of water for 30 min to lyse any Swiss 3T3 that may remain. 
The coverslips were then rinsed with PBS and the NHEK added (without feeders).
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2 . 2 .v Culturing retroviral packaging cell lines
Phoenix E and A were cultured in a standard 10% medium. As both cell lines 
adhered poorly to plates and single cell suspensions were not a necessity, 
neither were trypsinised. Instead, exhausted medium was removed and the cells 
were then sprayed off using fresh medium. Once suspended, the cells were 
pipetted up and down vigorously to break up as many cell clumps as possible 
before being re-plated. Cell splits of 1 in 10 were performed every 3-4 days to 
keep cells sub-confluent.
PT67s were also cultured in a standard 10% medium. However, these cells did 
require trypsinisation for re-plating. 1mg/mL trypsin (prepared in PBS) was used 
and inactivated by the addition of 10% medium. Cells were not centrifuged to 
remove trypsin prior to re-plating.
2 . 3  Telom erase Repeat Am plification Protocol, TRAP
Cell extracts were prepared by lysing NHEK in CHAPs buffer (supplied with 
TRAPeze kit, see below) at 200pL per 1 x106 cells for 30 min on ice. Lysates 
were separated from cell debris by centrifugation at 10,000 RPM for 20 min at 
4°C. Bicinchoninic Acid, BCA, Protein Assay was used to determine the protein 
concentration of the lysates. A standard protein curve was prepared using 2 
mg/mL Bovine Serum Albumin, BSA (Cat no. 23209, Pierce), and 10 pL samples 
of lysate were incubated with 200 pL of a BCA mix [BCA mix: 10mL Bicinchoninic 
Acid, (Cat no.B9643) + 200 pL CUSO4  (Cat no.C2284), both supplied by Sigma] for 
45 min at 37°C before being scanned for absorbance at 495nm in a plate reader.
Telomerase activity was determined using the TRAPeze Telomerase detection kit 
(Cat no. H08355, Flowgen Instruments), as per the manufacturer's 
recommendations. The PCR products were separated on a 12.5% polyacrylamide 
gel and visualised under UV light after 15 min incubation in 100 mL of 10mg/mL 
ethidium bromide, followed by 2x15 min washes with tap water.
2 . 4  Telomere Restriction Fragment, TRF, A ssay
Cell pellets (1 x106) were lysed and digested overnight by 100 pg/mL Proteinase 
K (Cat no. BN016333, Melford Labs) at 37°C in TESN buffer (0.1M TRIS pH8 .8 ,
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5mM EDTA pH7.5, 0.2% SDS and 0.2M NaCl) overnight with agitation at 37 C. An 
equal volume of ice cold isopropanol was added to the proteinase K cell solution 
and then the DNA spooled out as a white gelatinous precipitate using a flamed, 
sealed glass pipette. DNA was then dipped into 70% alcohol and allowed to air 
dry, before being dissolved in TE buffer pH 7.5 (0.1M TRIS, 1mM EDTA). 8  pg 
of genomic DNA was digested overnight at 37°C with restriction enzymes HinF1 
and Rsa1, (Cat no. 1097067 and 1047671, respectively, Roche) in a One-Phor-all 
Buffer (Cat no. 27-0901-02, Amersham). The TRFs were then separated on a 1% 
agarose gel using pulse field electrophoresis (CHEF-DR II System; Bio-Rad) at 6  
V/cm with an initial switch time of 1 s and a final switch time of 6  s for 16 h. The 
gel was transferred to Zeta-Probe GT membrane (Cat no. 162-0197, Bio-Rad) by 
capillary action in 0.4 N NaOH for 16 h. The membrane was rinsed in distilled 
water, and the DNA cross-linked to the membrane using a UV cross-linker 
(Stratagene) before being detected using the TeloTAGG kit (Cat no.2209136, 
Roche), as per the manufacturer's recommendations.
2.5 Sub-Cloning Vectors
Kindly donated by Titia de Lange (Rockfeller University, NYC, USA), pLPC- 
NMYCTRF2 (#2428) and pLPC-NMYCTRF2ABAM (#2431) were sub-cloned into the 
(IRES vector) pMIG (Van Parijs Lab, MIT Boston, Ma, USA), derived from 
pMSCVneo (Figure 11). pMIG was opened with restriction enzyme Bgl II (Cat no. 
567639, Roche) and then blunt ended using DNA polymerase (Cat no. D0602H, 
Epicentre) prior to being cut with Xho I (Cat no. 899 194, Roche). Both TRF2 
Vectors were opened with restriction enzyme Hind III (Cat no. 15207-020, 
Invitrogen) and then blunt ended using DNA polymerase (Cat no. D0602H, 
Epicentre) prior to be cut with Xho I (Cat no. 899 194, Roche). TRF2 coding DNA 
was then separated from its Vector backbone by running it out on an agarose 
gel, TRF2 and TRF2ABAM bands sized -1500 bp were excised. Both TRF2 vectors 
were then phosphatased (Cat no. M820A, Promega).
pMIG and TRF2/TRF2ABAM, were incubated overnight in ice water with agitation 
and ligated using the Rapid DNA ligation Kit (Cat no. 1 635 379, Roche). The 
newly cloned vectors were transformed into Max Efficiency Stbl2 Competent 
E.Coli Cells (Cat no. 10268-019, Invitrogen), spread onto ampicillian resistant 
plates and left at 30°C for 48 hours (no colonies had appeared after 24 hours, so
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Figure 11 . Sub-cloning TRF2 and JRF2ABAM into pMIG.
The de Lange lab cloned TRF2 (amino acids 2-50) and TRF2ABAM (amino acids 45- 
453) into a pLPC-NMYC (5.6 kbp) Vector, such that it was preceded by a Kozak 
sequence and in frame with a N terminal Myc- tag. During the sub-cloning for this 
thesis, the pLPC-NMYCTRF2 and pLPC-NMYCTRF2ABAM were digested with Hind 
III (Kozak site retained), blunt ended with DNA polymerase and then cut with Xho I. 
pMIG was digested with Bgl II, blunt ended using DNA polymerase and then cut 
with Xho I. The pMIG vector backbone was then ligated to the myc-TRF2 and myc- 
TRF2ABAM inserts.
The sub-cloned:
pMIG-mycTRF2 -IRES-GFP is referred to as: myc-TRF2 FL 
and
pMIG-mycTRF2ABAM-IRES-GFP is referred to as :myc-TRF2ABAM 
for the duration of this thesis.
the plates were left a further 24 hours). Colonies were selected and cultures 
expanded. Glycerol stocks were prepared using 0.5 mL of newly created pMIG- 
TRF2-IRES-GFP Vectors and 0.5 mL of 80% glycerol and stored at -70°C in cryo- 
preserve tubes. The DNA was purified from the Stbl2 cells using Qiafilter 
Plasmid Midi Kit (Cat no. 12162 , Qiagen).
The de Lange lab Vectors were not used again during this thesis. The sub-cloned 
pMIG-mycTRF2 FL-IRES-GFP and pMIG-myc-TRF2ABAM-IRES-GFP are referred to as 
myc-TRF2 FL and myc-TRF2ABAM for the duration of this thesis.
2 . 6  Optim ised Protocol o f Retroviral Infection (with Variables) for 
N H EK Using a 3T3 Based Feeders System
High infection rates of keratinocytes are notoriously difficult to obtain. 
Following the work of Fiona Watt (Levy et al. 1998), a 2 step infection protocol 
was devised to obtain a high proportion of NHEK expressing either Vector only, 
myc-TRF2 FL or myc-TRF2ABAM.
2 .6 . 7  Transfections
Phoenix E retroviral packaging cells were transfected with Vector only, myc- 
TRF2 FL or myc-TRF2ABAM Vectors. In a 9 cm dish, 15pg of DNA was prepared 
with 290 pL water and 500 pL HBS pH 6.9 (130 mM NaCl, 50 mM KCl, 5 mM 
Glucose, 21 mM Hepes and 2 mM NaHP0 4 .7 H2 0 ). CaCb was added to 0.29M and 
the DNA solution then mixed briskly, before being incubated for 30 min at 37°C. 
25 pM chloroquine was added to phoenix E cells, 5 min prior to the addition of 
the CaCU precipitated DNA. Transfections were left overnight at 37°C. The DNA 
was washed from the plate and replaced with 20% medium. Phoenix E cells were 
stored at 32°C for duration of infection process.
2 . 6 .7/ In fection: Phoenix E -> PT67
Routinely, the medium containing virus harvested from the phoenix E cells every 
12 hours for a period of 36 hours was used to infect -40% confluent PT67s. 
Alternatively, in some experiments a reduced time interval of every 4 hours for 
up to 12 hours was also used. The medium was passed through a 0.45 pM filter 
and then supplemented with 60 pg of polybrene (Cat no. H9268, Sigma).
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2 .6 . 7 7 7  In fection: P T67-* NHEK
Once confluent, the infectious PT67 cells were trypsined, resuspended in fresh 
20% FAD medium and given a 60Gy y-IR dose. The infectious PT67 were then re­
plated at the same confluent density with NHEK (e.g. 1.0 x 106 NHEK/ entire 
plate of confluent irradiated infectious PT67/ 9cm dish), this point being defined 
as day -1. Medium was then replaced every 12 hours with 20% FAD+, for a total 
co-culture time of 48 hours. Infectious PT67s were then removed from the plate 
in the same way as normal feeders would be (described in Section 2.2.iii). The 
medium was re-placed with FAD+ and fresh feeders were applied.
2 . 7  Flow  Sorting Cells
On the day of interest, the feeders were removed from the NHEK and trypsinised 
as described in Section 2.2.iii. To stop the trypsinisation, a 10% serum in Ca2+ 
and Mg2+ free-PBS solution was used. Cells were then centrifuged for 5 min at 
4°C at 1000 RPM and re-suspended in PBS with 50 Units/mL penicillin, 1 mg/mL 
streptomycin and 50ng/mL gentomycin. All cells were stored on ice while a 
waiting flow sorting. Immediately prior to being placed in the flow sorting 
machine, the cells were passed through a 0.70 pM filter.
The flow sorting was done by either Tom Gilbey or Margaret O’Prey as an ‘ in- 
house' service provided at the Beatson Institute. Briefly, the cells were taken 
into the FACSVanatage™ SE (Becton Dickinson) at a flow rate of approximately 
200 pL/min and were then stimulated with a 488 nm argon laser. Evaluations 
based on cell size (FSC-H) vs. GFP (FL2-H) were displayed. Low and high GFP 
expression was defined either side of the median GFP expression level (i.e. 102, 
(Figure 19) as it  was the middle value of GFP expression for most infections.
2.8 Western Blotting
2.8 .i Various Conditions for Controls
The y-IR source was Cobalt. The adjusted dose rate at 0.8 m with a build-up 
plate and field size of 30x30 ranged from 2.05 Gy/min (Dec 04) to 1.65 Gy/min 
(Aug 2006). NHEK were subjected to varying doses of y-IR and given varying 
recovery times, individual specifics are detailed in experimental results. NHEK 
were also treated for 24 hours with Cisplatin (Cat no. P4394, Sigma).
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2.8.11 Whole Cell E xtraction
Cell pellets were lysed by pipetting with cell lysis buffer (20 mM Hepes pH 7.0, 5 
mM EDTA pH 8.0, 10 mM EGTA pH 8.0, 5 mM NaF, 100 ng/mL Okadaic acid, 1 mM 
DTT, 250 mM KCl, 0.4% Triton X-100, 1% Glycerol, 20 mg/mL pepstatin A, 20 
mg/mL leupeptin, 300 nM PMSF, 1mM benzamidine and 50 mg/mL aprotinin A) 
for 30 min on ice. The extracts were cleared by centrifugation, and the 
supernatants stored at -70°C.
2 .8 . i i i SDS-PAGE gels fo r  Rb band s h ift
40% acrylamide (Cat no. 20-2000-05, Severn Biotech Ltd) and 2% w /v bis- 
acrylamide (Cat no. 20-2500-05, Severn Biotech Ltd) were used to make the 
following gels. The separating gel (0.24M TRIS pH 8 .8 , 7% (v/v) acrylamide, 0.1% 
(v/v) bis-acrylamide, 0.6% SDS, 0.8% ammonium persulfate and 0.1% Temed) was 
overlaid with water saturated butanol and allowed to polymerise. The butanol 
was then removed, the gel rinsed with water and overlaid with stacking gel 
(0.1M TRIS pH6 .8 , 3.6% acrylamide, 0.03% bis-acrylamide, 0.5% SDS, 0.8% 
ammonium persulfate and 0.1% Temed). Gels were run in buffer (25 mM TRIS, 
0.1% (w/v) SDS, 0.19M glycine). Typically, cell lysate from 0.5-1.0 x105 cells 
were prepared using a 4X Sample Buffer (0.64M TRIS pH 6 .8 , 7% (w/v) SDS, 18% 
(v/v) glycerol, 35% (v/v) mercaptoethanol and 0.5% bromophenol blue (w/v)) 
and denatured in a hot block at 100°C for 5 min.
2 .6 .7V  SDS-PAGE gels fo r  analysis o f  a ll o the r p ro te ins
Cell lysates were prepared as in the previous section and then separated on 12%
(Cat no. 345-0118), 10% (Cat no. 345-0112) or 4-12% gradient (Cat no. 345-0124) 
SDS-PAGE gels (all supplied by BIO-RAD). XT-MOPS (Cat no. 161-0788) running 
buffer was diluted 1 in 20. The all blue marker (Cat no. 161-0373) and the dual 
colour marker (Cat no. 161-0374) were used.
2 .8 .v  Western B lo tting
The proteins in the gel were then transferred to a PVDF membrane (Immobilin P, 
Cat no. ipvh00010, Millipore) that had been wetted with neat methanol and then 
soaked in transfer buffer for >3min. Protein transfer took place at 100V and 
<0.7 Amps for 1 hour. The PVDF membrane was then blocked in 5% (w/v) 
skimmed milk powder prepared in TRIS Buffered Saline-Tween 20, TBS-T for 1 
hour at RT. The membrane was then probed with the appropriate primary 
antibody overnight at 4°C, see Table 5. The following day the membrane was
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washed, four times in one hour with TBS-T and then incubated with an 
appropriate secondary solution, see Table 6 , prepared in 5% milk TBS-T, for 1 
hour at 20°C. The membrane would be washed again for four times in one hour 
with TBS-T before being developed as described below.
2 . 8 . v i  Developing Western Blots
Three different strengths of solutions were used to develop western blots, see 
below. Membranes were dried and developed firstly with a diluted Femto Max 
sensitivity solution. If the signal was very weak and required >30 min 
development time it was washed briefly with TBS-T and then incubated with 
Femto Max. Conversely, if  the initial signal was too strong the blot would be 
washed and incubated instead with ECL.
(1) For very weak strength signals: Femto Max. (Cat no. 34096, Perbio). 
Incubated for 5 min with a 1:1 mix of solutions 1 and 2 (as labelled by the 
supplier).
(2) For weak to medium strength signals: Diluted Femto Max. Incubated for 5 
min in a 1 in 1 0  dilution of the above solution.
(3) For medium strength signals: ECL (Cat no. 32209, Perbio). Incubated for 1 
min with a 1 : 1  mix of solutions 1 and 2 .
2.8 .v ii Stripping Blots
If, and only if, a second protein of a similar molecular weight to the first protein 
was to be examined, the membrane was stripped using Stripping buffer (0.2M 
Glycine-HCl pH2.5, 1% (w/v) SDS) for 30 min at RT. The membrane was then 
washed three times in 30 min with TBS-T and re-incubated with the secondary 
antibody used (as above) to detect the first protein, before being washed and 
developed. If the first antibody had been satisfactorily stripped, the membrane 
was re-probed. If it  had not been successfully stripped, the procedure was 
abandoned.
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2.9 Prim ary and Secondary Antibodies
Table 5: Primary Antibodies
Antibody raised 
against
Catalogue
Number
Supplier Dilution for 
Application
WB = Western Blotting 
IF = Immunofluorescence 
FACS = FACS analysis
53BP1 05-726 Upstate 1:200 (IF)
Brd-U M0744 DAKO Ltd. 1:50 (IF)
prepared in PBS and 
0.5% BSA
Brd-U 555627 Becton Dickinson 1:50 (FACS)
Chk1 sc-8408 Santa-Cruz 1:500 (WB)
Chk1 -phosphoS345 2341 Cell Signalling (distributed by 
New England BioLabs)
1:500 (WB)
Chk2 2662 Cell Signalling (distributed by 
New England BioLabs)
1:1000 (WB)
Chk2-phosphoT68 2661 Cell Signalling (distributed by 
New England BioLabs)
1:750 (WB)
Cleaved Caspase 3 9661 Cell Signalling (distributed by 
New England BioLabs)
1:250 (WB)
Nbs1 A300-187A Bethyl Laboratories 1:1000 (WB)
Nbs1 -phosphoS343 A300-189A Bethyl Laboratories 1:500 (WB)
p16 sc-9968 Santa Cruz 1:200 (WB)
p21 C24420 Transduction Laboratories 1:500 (WB)
p38 9212L Cell Signalling (distributed by 
New England BioLabs)
1:1000(WB)
p53 sc-126 Santa Cruz 1:500 (WB)
p53-phospho15S 9284L Cell Signalling (distributed by 
New England BioLabs)
1:500 (WB)
Rb- phospho608S 2181S Cell Signalling (distributed by 
New England BioLabs)
1:500 (WB)
Rb- phospho780S 9307S Cell Signalling (distributed by 
New England BioLabs)
1:500 (WB)
Rb- phospho795S 9301S Cell Signalling (distributed by 
New England BioLabs)
1:500 (WB)
Rb- phospho807S/811S 9308P Cell Signalling (distributed by 
New England BioLabs)
1:500 (WB)
SMC1 A300-055A Bethyl Laboratories 1:1000 (WB)
SMC-1 phosphoS966 A300-050A Bethyl Laboratories 1:500 (WB)
TRF1 " kindly donated by T.d. Lange 1:3000 (IF)
TRF2 05-521 Upstate 1:1000 (WB) 
1:3000 (IF)
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Table 6: Secondary Antibodies
Antibody raised 
against
Catalogue
Number
Supplier and Address Dilution for 
Application
WB = Western Blotting 
IF = Immunofluorescence 
FACS = FACS analysis
Rhodamine Red 
Donkey anti Rabbit
711-295-152 Jackson Immuno Research 
(Distributed by Stratech 
Scientific)
1 in 250 (IF)
Cy5 Donkey anti 
Mouse
711-175-150 Jackson Immuno Research 
(Distributed by Stratech 
Scientific)
1 in 50 (IF)
Rhodamine Red 
Donkey anti Mouse
715-295-150 Jackson Immuno Research 
(Distributed by Stratech 
Scientific)
1 in 250 (IF)
Cy5 Donkey anti 
Rabbit
711-175-152 Jackson Immuno Research 
(Distributed by Stratech 
Scientific)
1 in 50 (IF)
FITC Goat anti Mouse 12064D Pharmingen (distributed by 
Becton Dickinson)
1:50 (FACS)
HRP linked anti 
Rabbit
7074 Cell Signalling (distributed by 
New England BioLabs)
1 in 20,000 (WB)
HRP linked anti Mouse 7076 Cell Signalling (distributed by 
New England BioLabs)
1 in 20,000 (WB)
2.10 Proliferation Curves
On each day of interest, each NHEK variable was harvested in triplicate as 
detailed in Section 2.2.iii. The cells were re-suspended in 1 mL of medium and 
counted using a haemocytometer. Triplicates were then averaged and standard 
deviation calculated in Excel where the proliferation curves were plotted.
2.11 C lonogenicity A ssay/ Rhodam ine B Staining
After removing the feeders from the plate, NHEK were fixed for 10 min with 10% 
(v/v) Formaldehyde (Cat no. F/1500/PB15, Fischer) in PBS in a fumehood. All 
plates were then washed once with PBS prior to being overlaid with 1% 
Rhodamine B (Cat no. R6626, Sigma) prepared with water. Colonies were left to 
stain for 30 min in the fume hood. Plates were then washed with tap water and
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lett to drain and dry. Rhodamine B solution was retained atter staining tne 
plates and filtered immediately prior to subsequent use.
2.12 Colony Counting
Only GFP positive colonies were included during colony counting. Each plate 
was attached to a transparent grid of 40 different squares. [Prepared by Author 
by drawing a table in Windows Word program and printing to a transparency] of 
40 different squares. Within each square, a field of view was assessed and the 
number of GFP positive colonies judged and placed into one of three categories: 
0-5, 5-50 and >50 cells.
2.13 Brd-U  Incubation (48 hour) fo r Im m unofluorescent Analysis
On day 14 (12 days after being plated), the NHEK expressing Vector only, myc- 
TRF2 FL and myc-TRF2ABAM were fed FAD+ medium with 100joM 5-Bromo-2,-deoxy- 
uridine, Brd-U (Cat no. 550891, Becton Dickinson). The plates were left for 24 
hours and then re-fed for a further 24 hours. Plates were washed with ice cold 
PBS and feeders removed with ice cold PE. A final wash in ice cold PBS was also 
performed. NHEK washed in a 1:1 mix of acetone:methanol and then fixed for 
10 min using a fresh aliquot of acetone:methanol. Plates were air dried for 10 
min and then permeabilised for 5 min at RT with 0.25% tween 20 (Cat no.P5927, 
Sigma) in PBS. Plates washed 3 times with PBS in 10 min, then incubated for 5 
min with 1M HCl at 60°C, and finally they were washed for 30 min with 3 changes 
of PBS. At this point, the plates were processed as described in Section 2.14.ii.
2.14 Im m unofluorescence Protocols  
2.14A S tringent Protocol
NHEK grown on coverslips (Section 2.2.iv and 2.14.iv, for coverslip details) were 
rinsed with PBS and then extracted with Triton X-100 buffer (0.5% Triton X-100, 
20 mM Hepes-KOH (pH 7.9), 50 mM NaCl, 3 mM MgCb, 300 mM Sucrose) for 5 min 
on ice. Coverslips were then rinsed, twice in PBS and fixed using 3% 
paraformaldehyde (Cat no. P6148, Sigma)/2% sucrose prepared in PBS, for 10 
min at room temperature. Coverslips were rinsed twice with PBS, re- 
permeabilised for 10 min at RT and again rinsed twice with PBS. Cells were then
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blocked for 30 min with PBG [0.2% (w/v) cold water fish gelatine (Cat no. G7765, 
Sigma) and 0.5% (w/v) BSA (A2153, Sigma) prepared in PBS]. *2 Cells were then 
incubated for either 2 hours at 20°C or overnight at 4°C in the primary antibody 
solution at an appropriate dilution prepared in PBG. Cells were then washed 3 
times in PBG for 15 min and incubated with a secondary antibody solution 
prepared using PBG for 30 min at 20OC. Cells were again washed twice with PBG 
and then washed twice with PBS*1 before being mounted as described below, 
Section 2.14.iv.
When NHEK were labelled with 2 different antibodies, the above protocol went 
directly from 1 back to *2, using the second set of antibody conditions before 
being mounted for immunofluorescent examination. Only primary antibodies 
raised in different species were used, e.g. mouse and rabbit.
Note: Because the GFP in the NHEK does not bind a particular cellular protein 
and the cells are not fixed prior to permeabilisation, GFP is lost from the cells 
using this immunofluorescence protocol.
2 .14 .if  M ild  Protocol
NHEK were rinsed in PBS and then fixed in 2% paraformaldehyde (prepared in 
PBS) for 10 min at 20°C. Cells were rinsed again and then permeablised with a 
0.5% NP-40 buffer for 10 min. Cells were then blocked for 30 min in 10% donkey 
serum prepared in 0.5% NP-40/PBS before being incubated with the primary 
antibody diluted in 10% donkey serum/0.5% NP-40, for either 2 hr or overnight at 
4°C. Cells were washed three times for 5 min in 0.5% NP-40 prior to incubation 
with secondary antibody diluted in 10% donkey serum/0.5% NP-40/PBS for 45 
min, and finally washed three times in 0.5% NP-40/PBS, 5 min each time, before 
being mounted as described in Section 2.14.iv.
2.14 .Hi Immunofluorescence on tissue cu ltu re  p la te
In the experiments (Figures 23, 24, 25 and 26) it was necessary to perform the
immunofluorescence on the tissue culture plate. After fixation and at least one
wash, an area of the plate larger than a coverslip was chosen for analysis and an
area around it wiped dry. The dry circle would then be traced with a PAP pen
(Cat no. S2002, Dako). The protocols were followed as described above. A drop
of neat dapi vectashield (Cat no. H1200, Vector Laboratories, Peterborough) was
added before the cells were sealed with a glass coverslip and nail polish. To
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examine the processed cells under the microscope, the plate was then cut down 
to size in the fume hood, using a soldering iron. Samples were stored at 4°C 
until analysis.
2.14Av Immunofluorescence on thermanox coverslip
Subjected to either the stringent or the mild immunofluorescent protocol, the
coverslips were mounted as described (Figure 12). A diluted solution of dapi 
vectashield was used (1 dapi vectasheild: 1 normal vectashield (Cat no. H1000, 
Vector Laboratories) and sealed with nail polish. Samples were stored at 4°C 
until analysis.
2.14.V Con foca l Image Analysis
Up to 4 channels of the Olympus Fluorview FV1000 confocal microscope were 
used per experiment for the following dyes and protein (Excitation/Emission): 
Dapi (405 nm/461 nm), Rhodamine Red-X (561 nm/ 591 nm), Cy-5 (633 nm/ 664 
nm) and GFP (488 nm/ 510 nm). The sequential mode of scanning was line. Z- 
sections were stacked using Image J (Rasband, W.S., ImageJ, U. S. National 
Institutes of Health, Bethesda, Maryland, USA, http://rsb.info.n ih.gov/ij/, 1997- 
2006.) and colours re-assigned for the best projection of the image.
2.15 Senescence Associated Beta Galactosidase Staining
After removing the feeders, NHEK were fixed for 5 min with 3% (v/v) 
formaldehyde (Cat no. F/1500/PB15, Fischer) in PBS. The cells were then 
washed twice with PBS and then incubated with 5 mL of X-Gal staining solution 
(50 mM MES, 150 mM NaCl, 2 mM MgCl2, 5mM K4Fe(CN)6.H20 (potassium 
ferrocyanide), 5mM K3Fe(CN6) (potassium ferricyanide) and 10 mg/mL X-gal (5- 
bromo-4 chloro-3 indolyl-B-o-galactoside (Cat no. B4252, Sigma) at pH 6.0. 
Plates were then incubated for 16 hours in a humid box at 37°C, washed with 
water, photographed and the number of senescent colonies counted as described 
in Section 2.12.
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[Birds Eye View of] Coverslip Mounting Procedure:
4) Glass Slide
3) Thermanox Coverslip 
with cells fixed to it.
2) A drop of Dapi Vectorsheild
1) Glass coverslip
Side View of Mounted Coverslip:
Glass coverslip 
Dapi Vectorsheild Solution 
Cells being analysed
Thermanox coverslip
Microscope magnifying objective
Nail Polish
Figure 12. Procedure for Mounting Plastic Coverslips.
Prior to growing any cells on the thermanox coverslip, a small section was cut from 
it so that the ‘cell side up’ was always easily distinguished. Swiss 3T3 removal at 
the end of the conditioning process could result in the coverslip being flipped over.
A glass coverslip (of larger diameter then the plastic coverslip) is placed on a piece 
of tissue and a drop of Dapi Vectorsheild added to it. The thermanox coverslip is 
then added, cell side down, before being sandwiched by a glass slide. The excess 
dapi vectorsheild is then squeezed out by applying pressure as equally as possible 
to the glass slide and absorbed by the tissue. The slide and 2 coverslips are then 
turned over and sealed around the edge with nail polish.
The sideview demonstrates how the confocal microscope objective is then able to 
focus through the glass coverslip to the cells below.
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2.16 F low  Cytom etric Analysis (FACS)
2.16 .i  T reatm ent o f  Control Cells
NHEK were treated with varying concentrations of Hydroxyurea (Cat no. H8627, 
Sigma) to establish a G1 arrest FACS profile for NHEK. y-IR source described in 
2.8.i.
It is typical in FACS analysis to collect the dead cells floating in the medium and 
pellet them with the cells being analysed. Because the NHEK are grown with 
feeders, the cells floating in the medium were not collected as there would be 
no way to discern if they were NHEK or feeders.
2 .1 6 .i/ W ith Propidium  Iodide (PI)
The feeders were removed from NHEK and cells trypsinised as described in 
Section 2.2.iii. Trypsin was inhibited using 10% medium and the cells pelleted 
by centrifugation for 5 min at 4°C at 1000 RPM. About 5x105cells were then re­
suspended in 500 pL of PBS followed by 5 mL of ice cold methanol, allowed to fix 
for >30 min, pelleted again by centrifugation for 5 min at 4°C at 1000 RPM, and 
finally re-suspended in 400 pL of PI solution [50 pg/mL PI (Cat no. P3566, 
Molecular Probes) and 50 pg/mL RNaseA (Cat no.S23-24-26-36/37)] for a 30 min 
incubation in the dark at RT. A Becton-Dickinson FACS scan was used to analyse 
a minimum of 10,000 cells at 585 nm (PI).
2.16 .Hi FACS Analysis w ith  PI and Brd-U
NHEK were pulsed with for 30 min with 10pM 5-Bromo-2’ -deoxy-uridine, Brd-U 
(Cat no. 550891, Becton Dickinson). The feeders were removed from NHEK and 
cells trypsinised as described in Section 2.2.iii. Trypsin was inhibited using 10% 
medium and the cells pelleted by centrifugation for 5 min at 4°C, 1000 RPM. 
The ~5x105cells were then re-suspended in 100 pL of 70% ethanol for 30 min. 1 
mL of a wash buffer (0.5% Bovine Serum Albumin, BSA (A2153, Sigma)) in PBS 
was used to wash the cells. Cells were pelleted again by centrifugation for 5 
min at 4°C, 1000 RPM and re-suspended in 3N HCl solution and 0.5% Tween 20 
(Cat no. P5927, Sigma). 1 mL of wash buffer was again added prior to 
centrifugation. The cells were re-suspended in 0.5 mL of 0.1 M sodium borate pH 
8.5 (Na2 B4 0 7 , BORAX Cat no.S9640, Sigma) for a 2 min incubation at RT. Again, 1 
mL of wash buffer was again added prior to centrifugation. 100 pL of anti-Brd-U
(Cat. No. 33281 A, Pharmingen) was prepared at a dilution of 1:50 in U.57o iween 
20/PBS. Cells were incubated for 20 min at RT before 1 mL of wash buffer was 
added prior to centrifugation. Cells were then re-suspended in FITC conjugated 
goat anti mouse IgG (Cat no. 12064D, Pharmingen) prepared at 1:50 and 
incubated for 30 min, in the dark. 1 mL of wash buffer was again added prior to 
centrifugation and the pellet resuspended in 0.5 mL of 10 pg/mL PI prepared in 
PBS. A Becton-Dickinson FACS scan was used to analyse a minimum of 10,000 
cells at 585 nm (PI) and 530 nm (FITC).
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Chapter 3:
Infecting NHEK with myc-TRF2 FL and myc-TRF2ABAM
The aim of this thesis has been to characterise the cellular response to uncapped 
telomeres using myc-TRF2ABAM (a dominant negative form of the TRF2 protein) in 
a normal epithelial cell system for the first time. An IRES-GFP system was used 
so NHEK could be isolated as soon as they began to express the construct, 
thereby allowing evaluation of early time points. Not only did this allow 
examination of the effect of uncapping the telomere in NHEK, but also of the 
early downstream effects causing the cellular phenotype. Both the telomerase 
activity and the telomere lengths of the NHEK were established to determine the 
effects either may have on the experimental telomere manipulation.
3.1 Characterising telom erase activity in NH EK
Telomerase activity can be determined in vitro using a PCR based assay in which 
active telomerase from a cell extract extends a 50 base pair primer as if it were 
a telomere with the hexameric repeat: [TTAGGG]. When run out on a gel, the 
activity of telomerase can then be judged by how many hexameric repeats were 
added as indicated by the extent of the 6 bp ladder created within a set time 
and PCR cycle programme. To avoid saturating the assay, limited amounts of 
telomerase activity are used. Subjecting differently experimentally treated 
cells to the same TRAP conditions then allows comparisons of their relative 
telomerase activity to be drawn.
Telomerase activity can be found in the regenerative basal layer of the 
epidermis in human skin (Harle-Bachor and Boukamp 1996). As NHEK are a 
primary culture of the epidermis from newborn foreskin, it  was determined if 
the cultures contained any telomerase activity (Figure 13). Very little  
telomerase activity was found in NHEK at 20 Population Doublings, (PD). 
Expressing an hTERT construct in NHEK (hTERT expression from 14 PD, harvested 
at 16 PD) demonstrated far more telomerase activity than that found in NHEK 
without exogenous hTERT expression; therefore telomerase activity in NHEK is 
limited by hTERT expression. Most likely, only cultured cells derived from the
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Figure 13. Telomerase Repeat Amplification Protocol (TRAP) analysis of 
telomerase levels in NHEK (a) before and (b) after infection with hTERT expressing 
retrovirus. Varying concentrations of cell lysate are used to determine a sensitive range 
of lysate concentration for measuring telomerase activity within a cell culture. As a 
negative control, an equivalent amount of sample is Heat Inactivated (HI) to show the 
telomerase activity measured in each lane is heat sensitive. Each sample also contains 
a standard internal control (SIC) that will amplify a PCR product of 36bp. The SIC and 
telomerase primers actively compete for reagents and therefore the amount of SIC is 
inversely proportional to the amount of TRAP product generated. The CHAPS lane is a 
negative control and contains buffer only, no sample. TSR8 contains the TSPrimer 
extended with 8 telomeric repeats acting as a quantitation control lane, (a) Decreasing 
concentrations of NHEK (20 PD) shows a decrease in their telomerase activity, 
demonstrating the assay is not saturated and the telomerase activity detected in this 
sample is very small, (b) NHEK expressing hTERT (infected at 14 PD) and harvested at 
16 PD display considerably greater telomerase activity then NHEK not infected with 
hTERT retrovirus. The assay is saturated at 200 ng with these cell lysates.
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basal cells in the epidermis are expressing active telomerase and the population 
is a mix of both basal and transit amplifying keratinocytes. By infecting the 
entire population with hTERT, even the transit amplifying cells are capable of 
producing an active form of the telomerase enzyme and therefore more 
telomerase activity is seen in the population.
3.2 Characterising telom ere length in NHEK
Telomere length plays an integral role in determining the fate of a cell. Average 
telomere length can be determined for a cell system in a Telomere Restriction 
Fragment (TRF) blot in which genomic DNA is isolated and digested using 
restriction enzymes HinF1 and Rsa1 (Allshire et al. 1989). These restriction 
enzyme sites do not occur in the telomere or sub-telomeric sequence, so when 
the digest is run out on a gel, long tracts of telomeric and sub-telomeric DNA 
create a smear indicative of the range in length of all 92 telomeres within the 
cells harvested for analysis.
Being derived from newborn tissue, the NHEK have long telomeres (Figure 14). 
All NHEK have been co-cultured with a feeder layer (Swiss 3T3 cells) which have 
even longer telomeres, 9 to >23 kbp. Although the feeder layer is removed 
before NHEK are harvested, small levels of 3T3 contamination with the NHEK 
population may undoubtedly occur. For this reason, telomere lengths >9 kbp can 
not necessarily be attributed to the NHEK population. In (Figure 14), the 
telomere length of NHEK at 20 PD is between 8.5 and 10 kbp. As the NHEK 
undergo more PD, the lengths of the telomeres reduce as is expected in normal 
somatic cells without exogenous expression of hTERT (Bodnar et al. 1998). At 43 
PD, telomeres as short as 3 kbp are seen. Interestingly, although telomeres 
within the population are clearly getting shorter, a subset of the 43 PD NHEK 
population still has telomeres as long as 8.5 kbp, the length of the telomere at 
20 PD. It is possible that these are the telomeres from the telomerase positive 
basal layer keratinocytes.
Although NHEK at 20 PD have been shown to contain a trace of active 
telomerase, the reduction in telomere length during the growth of NHEK for 50 
PD demonstrated that this limited amount of endogenous telomerase activity is
kbp
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Figure 14. Telomere Restriction Fragment (TRF) blot of NHEK grown for 50 
Population Doublings (PD). 8pg of genomic DNA were loaded per lane, except in the 
control lane (DNA from feeder cells) where only 4pg were loaded. Higher molecular 
weights of DNA fragments are condensed at the top of the blot. This causes a 
concentration of the molecular probe used to identify the telomeric DNA giving a false 
impression that proportionally there are more of the longer telomere fragments then 
shorter telomere fragments. Even though feeder contamination is only likely to be 0.5 -  
5% of the total NHEK, telomeres from feeders are longer, 10- >23 kbp, and therefore give 
a stronger signal. As the NHEK in this work have all been grown with feeders, 
statements about telomere lengths greater then 10 kbp (i.e. above the orange line) can 
not necessarily be attributed to NHEK.
At 20 PD the average telomere length of the NHEK ranges from 8.5 - 10 kbp. A gradual 
reduction in telomere length is seen with increasing PD, as expected in cells with a 
limited amount of telomerase activity. By 43 PD, telomeres as short as 3 kbp are seen.
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not enough to prevent telomere length shortening with increasing population 
doublings.
3.3 Optim ising the process o f infecting NH EK with TRF2 retroviral 
expression vectors
Titia de Lange's lab (Rockfeller University, NYC) used an adenoviral system to 
infect fibroblasts with a myc tagged jrf2abam or myc tagged TRF2 FL and looked 
at early time points. Close to 100% infection is assumed as adenoviral systems 
are so effective. However, we were advised by the de Lange lab and others 
that, if  there was a choice, retroviral systems were preferable. Although easier 
to work with, a limitation of retroviral infection is that the percentage of cells 
infected is not as high as with adenoviral infection: therefore, traditionally drug 
selection is used (usually a minimum of 1 week) to ensure a pure population of 
cells expressing the gene of interest. As our interest is in early time points, to 
avoid this time-delay we sub-cloned myc-TRF2 FL and myc-TRF2ABAM retroviral 
constructs (generously donated to us by the de Lange lab) into the pMIG-IRES- 
GFP vector. As an Internal Ribosomal Entry Site (IRES) vector, pMIG is capable of 
translating both the gene of interest (i.e. myc-TRF2 FL or myc-TRF2ABAM) and 
Green Fluorescent Protein (GFP) as separate proteins from the same transcript.
After being sub-cloned, sequencing of the myc-TRF2 FL and myc-TRF2ABAM 
vectors revealed a discrepancy with the NCBI sequence. The NCBI TRF2 cDNA 
encodes alanines in amino acid positions 434 and 435, whereas sequencing of our 
vectors indicated only one alanine in that position. The de Lange lab 
subsequently confirmed that other labs had also found this anomaly and [it has 
been concluded] that the NCBI site is incorrect. Satisfied that the sequences of 
the vectors were acceptable, we continued to use them for the project. Only 
the pMIG-myc-TRF2 FL - IRES - GFP and pMIG-myc-TRF2ABAM- IRES - GFP vector 
were used for the rest of this thesis and will be denoted myc-TRF2 FL and myc- 
TRF2abam here after.
Prior to any experiments where NHEK are infected with myc-TRF2 FL and myc- 
TRF2abam, a stock of primary NHEK was expanded and frozen down at 7 PD. The 
NHEK used in each experiment for the remainder of this thesis have not been 
infected with hTERT retrovirus. Each experiment used a fresh ampoule of NHEK
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that was further expanded prior to infection with myc-TRF2 or myc-TRFz FL. 
At the point of infection, NFIEK would have only undergone a total of between 10 
and 14 PD, and therefore have a telomere length >8.5 kbp.
Infecting NFIEK with retrovirus did not prove straightforward. Adding medium 
from amphotropic retroviral producing cell lines such as Phoenix A to NFIEK 
resulted in very poor infection rates, less then 3%. The following protocol for 
infecting NFIEK was established based on Fiona Watt's publications (Levy et al. 
1998) and the optimised version used is outlined in (Figure 15). Each 
experiment described in this thesis starts on “ day 0” , when the expression of 
myc-TRF2ABAM or myc-TRF2 FL begins in the NFIEK. Days prior to this point are 
negatively numbered.
The optimised process for infecting NFIEK began with myc-TRF2 FL or myc- 
TRF2abam DNA being transfected into phoenix E, an ecotropic retroviral producing 
cell line using a CaCh protocol. The phoenix E cells were left for 12 hours, 
before being washed and fed with medium. Once transfected, the phoenix E 
cells were maintained in a 32°C incubator as the half-life of a retrovirus is 
greater when stored at this lower temperature. Medium from phoenix E was 
harvested 3 times at 12 hours intervals, filte r sterilised and used to infect PT67 
cells, an amphotropic retrovirus producing NIH-3T3 cell line. Once the PT67s 
became confluent, they were trypsinised and given a lethal 60 Gy y-IR dose (to 
prevent their further replication) before being re-plated with the NHEK at 
confluent levels. Retroviral infection is a more effective method of introducing 
genetic material into a cell line than transfection. By using phoenix E to 
retrovirally infect the PT67s, more PT67s produce the retrovirus than if PT67 
were directly transfected themselves and this extra step ultimately leads to a 
greater infection rate of NHEK.
NHEK were co-cultured with lethally irradiated infectious PT67s in medium 
without Epidermal Growth Factor (EGF) for 12 hours at 37°C. The medium was 
then supplemented with EGF and refreshed every 12 hours for a minimum of 24 
and maximum of 36 hours. EGF is not added until the cells have attached to the 
tissue culture plate as this aides cloning efficiency (Rheinwald and Green 1977). 
NHEK were co-cultured with infectious PT67 for a minimum of 36 hours and a 
maximum of 48 hours. Unless the NHEK were harvested immediately, as soon as
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Figure 15. Retroviral Infection of NHEK with TRF2 Constructs. In each 
experiment:
(1) Vector only, myc-TRF2 FL and myc-TRF2ABAM were transfected into phoenix E 
retroviral packaging cells using CaCI2.
(2) On each of the 2 subsequent days, medium containing retrovirus was then 
harvested from the phoenix E cells and used to infect PT67 cells, an NIH-3T3 
amphotropic packaging cell line.
(3) Infectious PT67 cells were then harvested and lethally irradiated with 60 Gy of y-IR.
(4) NHEK were trypsinised.
(5) NHEK re-plated using the lethally irradiated infectious PT67s as a feeder layer.
(6) Day 0 is designated the start point of each experiment, assuming one cell cycle is 
enough time for the retrovirus to be integrated and expressed.
(7) On the day of interest (different in each experiment) NHEK were flow sorted to 
isolate the GFP positive cells from the GFP negative cells. Day 2 was the most 
frequent day for flow sorting.
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the infectious PT67s were removed, they were replaced with feeders. Lo- 
culturing proved a highly effective way of introducing the TRF2 constructs into 
the NHEK: percentages of GFP positive cells ranged from 30 - 75%. The direct 
cell-to-cell contact between the PT67 and the NHEK allows the virus to pass 
straight from one cell to the other which is considered to be more efficient than 
retroviral infection of keratinocytes using viral supernatants.
As soon as NHEK began to express the GFP they could be isolated through flow 
sorting, allowing evaluation of the cells at early time points. However, despite 
these advantages there are some substantial drawbacks to flow sorting cells as a 
means of selection. The processing of flow sorting the cells leaves them 
vulnerable to bacterial contamination; therefore the cells are treated with 
antibiotics when plated after being flow sorted. Furthermore, a large 
percentage of cells are lost when flow sorted: on average, only 20% of GFP 
positive cells put through the flow sorter are returned. This is largely to do with 
the cells actually reaching the collection tube after being deflected by the laser.
3.4 M yc-TRF2 FL and myc-TRF2^Bm expression in NHEK
Western blotting allows assessment of the level of expression of proteins from a 
cell extract. Denatured cell lysates separated based on size on an acrylamide 
gel are transferred to a suitable membrane and then recognised with an 
appropriate antibody.
Both myc-TRF2ABAM and myc-TRF2 FL are expressed in NHEK as early as day 1, as 
shown by recognition with a TRF2 specific antibody (Figure 16). Myc-TRF2ABAM is 
missing both its basic (AB) and myb (m) domain which is why it  appears 12 kDa 
below myc-TRF2 FL. Endogenous levels of TRF2 are not seen on the western 
blots unless they are developed for a longer period of time, at which point the 
exogenously expressed TRF2 is so overexposed that it is impossible to decipher 
the signal contributed from each lane. The considerable over-expression of the 
constructs is an important aspect of how myc-TRF2ABAM is effective at creating a 
dysfunctional telomere. TRF2 binds the telomere as a homodimer, with each 
half of the dimer providing a myb domain to interact with the DNA. Myc- 
TRF2abam is proposed to reform the homodimer with endogenous TRF2 and 
therefore render endogenous TRF2 incapable of binding telomeric DNA. As this
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Figure 16. Detection of exogenous proteins myc-TRF2ABAM (50 kDa) and myc-TRF2 
FL (62kDa) expressed in NHEK by western blot.
On days 1, 2 and 3, GFP positive cells were harvested immediately after flow sorting. On 
day 4, cells were flow sorted and GFP positive cells were re-plated with feeders. On day 
13, these cells were harvested without further flow sorting.
The MAP kinase family member p38 is used as a loading control as it is a ubiquitously 
expressed protein that is regulated by phosphorylation, as opposed to up or down- 
regulation of its expression level.
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is the mechanism, it  is crucial that the myc-TRF2m,“'v‘ is expressed > i: i with 
endogenous TRF2.
3.5 Assessing phenotypes o f N H EK  expressing TRF2 constructs
NHEK infected with Vector only, myc-TRF2 FL or myc-TRF2ABAM were flow sorted 
on day 2 and then plated with feeders. On day 10, expression of Vector only and 
myc-TRF2 FL had no obvious effect on the NHEK colony morphology when 
evaluated using a light microscope at 25X magnification (Figure 17). The GFP 
image in the right hand panel clearly demarks the NHEK cells from the feeders 
they are grown with. Differences in the appearance of the NHEK expressing 
myc-TRF2ABAM were obvious. A lot of the cells were more spread out, multi- 
nuclear and the colony sizes were a lot smaller. Although widespread, this 
phenotype was not absolute and there were also colonies present that did not 
differ at all from those expressing Vector only or myc-TRF2 FL.
3.6 Sum m ary o f Chapter 3
In order to evaluate the early downstream effects of a dysfunctional telomere in 
the epithelial cell system NHEK, TRF2 constructs were sub-cloned into an IRES- 
GFP vector. GFP expression signified the moment the TRF2 constructs were 
expressed and allowed for identification and isolation of NHEK expressing the 
TRF2 constructs using flow cytometry. The retroviral infection protocol was 
optimised and proved effective at infecting the NHEK, as myc-TRF2ABAM or myc- 
TRF2 FL were shown to be expressed by the NHEK as early as day 1.
A phenotype was clearly apparent in the morphology of the NHEK expressing 
myc-TRF2ABAM by day 10. Smaller colonies were seen indicating reduced 
proliferation and the cells in some colonies appeared more spread out, a 
characteristic indicative of senescence.
Telomerase activity was determined in NHEK and shown to be limited by 
insufficient hTERT expression. As will be discussed in chapter 6, the telomerase 
status of the NHEK is important in the context of evaluating if it is a contributing 
factor in the DNA damage response.
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Figure 17. Representative colonies of NHEK expressing (a) Vector only, (b) myc- 
TRF2 FL and (c) myc-TRF2ABAM on day 10.
All images are shown at 25X magnification. Left panels are phase contrast images; right 
panels are photographs with longer exposure time under UV light illustrating their level of 
GFP expression. The feeders were not removed prior to the images being taken.
(a) Vector only (i.) 3 small adjoining colonies are shown, where the middle colony 
demonstrates more green fluorescence than the two either side, (ii.) 1 colony is shown. 
Both GFP positive Vector only colonies display the normal morphology seen in uninfected 
NHEK.
(b) myc-TRF2 FL. Again, (i.) and (ii.) both show colonies with morphology similar to 
uninfected NHEK.
(c) myc-TRF2ABAM- (i.) Cells within the colony display a flattened spread out morphology 
typical of senescent cells. Colonies in (ii.) and (iii.) are both considerably smaller than 
colonies seen in NHEK infected with either vector only or myc-TRF2 FL. (iv.) The entire 
colony is GFP positive although the differentiated cells on top of the culture in the middle of 
the colony are more green then the cells surrounding it. The colony itself appears normal, 
no different to that seen in either vector only or myc-TRF2 FL.
The altered colony appearance of NHEK expressing myc- TRF2ABAM is evident in colonies 
(i.), (ii.) and (iii.) but not in (iv.).
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When infected with the TRF2 constructs, the average telomere length of NHtK  
was shown to be greater then 8.5 kbp. Knowing this, there is confidence that 
the uncapped telomere phenotype being seen in the cells is created through the 
addition of myc-TRF2ABAM and not also being contributed to by critically short 
telomeres within the cell population.
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Chapter 4:
Characterising NHEK proliferation response to 
myc-TRF2 FL and myc-TRF2ABAM
Although the main objective of this project was to characterise the early 
downstream factors of dysfunctional telomeres, in order to establish the 
outcome for the cell, the effect of expressing myc-TRF2 FL and myc-TRF2ABAM 
was also examined over a period of 14 days.
4.1 Proliferation Curves o f NH EK expressing m yc-TRF2 FL or 
m yc-TRF2ABAM
NFIEK were infected with the TRF2 constructs, flow sorted and plated so that 
they could be counted in triplicate on harvest days (Figure 18). NFIEK 
expressing myc-TRF2 FL did not proliferate as well as NFIEK expressing the 
Vector only. NFIEK expressing myc-TRF2ABAM proliferated even less then myc- 
TRF2 FL and Vector only expressing cells. A lag in proliferation is seen in all cell 
variables from day 2 to day 8. This is inevitable as the NFIEK will require time 
regain homeostasis before proliferation will begin. Also, it  is inevitable that not 
all NFIEK plated will attach to the tissue culture plate. In an attempt to account 
for this cell loss, the medium was harvested the next day (day 3). After 
reducing the volume, the non-adherent cell counts were found to be between 
0.0- 1.0% of the NFIEK plated. There was no obvious pattern of less cells 
adhering where Vector only, myc-TRF2 FL or myc-TRF2ABAM were expressed, so 
the most likely explanation for the lag seen in proliferation is the sluggish 
recovery of the cells after flow sorting and an equal loss of cells between 
variables when re-plating.
4.2 Effects o f level o f expression o f TRF2 constructs on N H EK  
proliferation
Flow sorting showed a wide range in GFP expression level in NHEK infected with 
retroviral vectors, (Figure 19)(a). As it is possible to collect 2 separate 
populations of cells at the Cell Sorter, low or high levels of GFP expression were
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Figure 18. Proliferation curves of NHEK grown for 14 days with myc- TRF2 FL and 
myc- TRF2ABAM.
Cells were flow sorted on day 2. GFP positive NHEK were then plated at 1x104 /plate (9 
plates/ for each construct) with feeders. On each harvest day: 8, 11 and 14, the feeders 
were removed from 3 plates (per construct), the cells were trypsinised and the total 
number of NHEK counted using a haemocytometer. Error bars represent standard 
deviations.
(a) Typical exponential growth of NHEK is seen where Vector only is expressed. 
Expression of myc-TRF2 FL inhibits proliferation of the NHEK considerably and 
expression of myc-TRF2ABAM reduces further still the ability of the NHEK to replicate.
(b) The same data represented on a log scale.
- 97 -
(a) Cell Profile from Flow Sort of NHEK expressing Vector only
10
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Vector only 24% 34%
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Myc-TRF2ABAM 26% 38%
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Figure 19. Isolating NHEK expressing low or high levels of GFP.
(a) A profile from a flow sort where a low and high GFP expressing population of NHEK 
population are isolated.
(b) Western blot analysis of NHEK isolated on day 4 (and plated with feeders) were then 
harvested on day 8. Cells sorted on the basis of low or high GFP expression express 
corresponding low or high levels of TRF2 constructs, even after 4 days in culture.
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examined to see if this correlated with low or high expression of myc-1 Khz hL 
and myc-TRF2ABAM (Figure 19)(b). Cells sorted on day 4 and then plated with 
feeders were harvested on day 8 for western blot analysis. Correlation was 
seen, i.e. cells expressing low levels of GFP had low levels of myc-TRF2 FL 
expression.
The effects of low or high expression of myc-TRF2 FL and myc-TRF2ABAM on 
proliferation were then evaluated in NHEK (Figure 20). Again, the pattern was 
very similar to that seen in (Figure 18). Low or high levels of Vector alone did 
not cause much of a difference in the ability of the NHEK to proliferate. 
However, NHEK with low levels of myc-TRF2 FL were able to proliferate 
considerably more than cells expressing high levels of the same construct. This 
result could have three explanations. Higher levels of myc-TRF2 FL bound to the 
telomere may impede the cell's ability to separate the DNA at the telomere, 
thereby slowing down the rate the cells progress through DNA synthesis. 
Alternatively, as TRF2 has been shown to bind at non-telomeric DNA during the 
DNA damage response (Bradshaw et al. 2005), it  is possible that very large 
amounts of TRF2 protein within the cell induce a DNA damage response. 
Thirdly, the large amounts of TRF2 within the cell which possibly don’t  have 
room to bind at the telomere, may still interact with other TRF2 binding proteins 
and prevent them from localising to the telomere and performing their function 
there.
Similarly, with myc-TRF2ABAM, less proliferation is seen in cells expressing high 
levels of construct than in cells expressing low levels. The most likely 
explanation for this is that higher levels of myc-TRF2ABAM are more effective at 
stripping endogenous TRF2 from the telomere. However, it  is also possible that 
higher levels of myc-TRF2ABAM induce apoptosis as witnessed by Lechel et al and 
discussed in Chapter 6 (Lechel et al. 2005). If so, since it is unlikely that a cell 
undergoing apoptosis w ill make it through the flow sorting process, apoptosis 
would need to be occurring after the NHEK are plated. Attempts at assessing 
cell death within the population subsequent to flow sorting and plating are 
described later.
As there is a differential effect in NHEK between low levels of myc-TRF2 FL vs. 
low levels of myc-TRF2ABAM, the effects on cell proliferation are specifically
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Figure 20. Proliferation curves of NHEK grown for 14 days with low or high levels 
of myc- TRF2 FL and myc- TRF2ABAM.
Cells were flow sorted on day 2 and plated as described in Figure 19. Here the NHEK 
were plated at the higher density 2x104. Error bars represent standard deviations.
(a) The pattern of proliferation does not alter much when either low or high levels of GFP 
are expressed in the Vector only cells. Higher expression levels of myc-TRF2 FL prevent 
the NHEK from proliferating more then low levels of the same construct. In NHEK 
expressing myc-TRF2ABAM, low expression levels drastically reduce their ability to 
replicate and high amounts prevent proliferation even more dramatically.
(b) The same data represented on a log scale.
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being generated by the TRF2 construct rather than “ non-specific effects of 
protein over-expression. Where high levels of myc-TRF2 FL vs. high levels of 
myc-TRF2ABAM are being compared, it is more difficult to make the same claim as 
both variables have such a large effect on the cell proliferation; however, a 
differential effect was still seen.
In total, proliferation experiments with NHEK expressing TRF2 vectors were 
performed three times, once with total expression and twice where the cells 
were separated into low and high expressing fractions. Patterns of proliferation 
were similar in all experiments.
4.3 Clonogenicity o f NHEK expressing low  o r high levels o f m yc -  
TRF2 FL o r myc-TRF2*BM
Clonogenicity was evaluated using Rhodamine B staining in NHEK expressing low 
and high levels of myc-TRF2 FL or myc-TRF2ABAM. Plates of colonies scanned as 
images on day 14 after infection and cell sorting are shown in (Figure 21) and 
the numbers and sizes of colonies from a separate experiment are quantitated in 
(Figure 22). There was very little  difference in the number and size of colonies 
in NHEK expressing either low or high levels of Vector only. Both Vector only 
plates displayed more colonies and larger colonies than any of the four plates 
expressing TRF2 constructs. More colonies are seen where NHEK express low 
levels of myc-TRF2 FL than high levels; this was also the case with plates that 
expressed low or high levels of myc-TRF2ABAM. All plates contained a proportion 
of small colonies of 1-5 cells, known as abortive colonies. The numbers of 
abortive colonies did not increase in NHEK expressing myc-TRF2 FL or myc- 
TRF2abam when compared to NHEK expressing high levels of Vector only as might 
have been expected. Instead, the expression of myc-TRF2ABAM, and myc-TRF2 FL 
to a lesser extent, limits the colonies' ability to become larger than 6 cells.
Colony sizes were only quantitated in one experiment; however the 
clonogenicity pattern was determined in 4 separate experiments and found to be 
similar in all.
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Figure 21. Clonogenicity of NHEK grown for 14 days with low and high levels of 
myc- TRF2 FL and myc- TRF2ABAM.
Cells were flow sorted on day 2, those expressing low and high levels of GFP were 
collected separately and then plated at 1x104 with feeders. Cells were grown until day 16, 
at which point the feeders were removed, the NHEK were fixed and stained with 
Rhodamine B.
Images outlined in red are enlarged insets from their associated pictures.
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Figure 21. Clonogenicity of NHEK grown for 14 days with low and high levels of 
myc- TRF2 FL and myc- TRF2ABAM.
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Figure 22. Quantitation of colony numbers and sizes.
Cells were flow sorted on day 2 and then plated at 1x104 with feeders. Cells were 
grown until day 12 and then colony counts performed. Each 9cm plate was placed on 
a transparent grid with 40 boxes. A field of view was then assessed for each grid and 
only GFP positive colonies were scored.
(a) 2 plates were assessed per variable, except for Vector only low for which only one 
plate was available. The bars represent the individual values.
(b) Summary of the number of colonies with >6 cells for all variables using the same 
data.
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4.4 DNA synthesis in N H EK  expressing low  o r high levels o f myc- 
TRF2 FL o r m yc-TRF2ABAM
Brd-U is a nucleotide analogue that can be incorporated into DNA instead of 
thymidine during DNA synthesis. As NHEK expressing myc-TRF2 FL and myc- 
TRF2abam contained a mixture of colony sizes, the ability of these differently 
sized colonies to proliferate was determined by Brd-U incorporation. NHEK have 
a population doubling time of approximately 24 hours. To determine if the 
smaller colonies found on plates were replicating, they were incubated with 
medium containing 100pM Brd-U for 48 hours (Figure 23). As anticipated based 
on colony size, by day 16 all large colonies evaluated on all plates incorporated 
Brd-U, but small colonies did not. This shows that the small colonies were not 
undergoing DNA synthesis within a 48 hour period. As 48 hour Brd-U incubation 
confirmed the clonogenicity pattern seen on the plate where the cells had been 
cultured for 2 weeks, it was only performed once.
4.5 Understanding Colony Size Variation
These collective experiments show that expressing myc-TRF2 FL or myc-TRF2ABAM 
in NHEK reduces their ability to proliferate to varying degrees. However 
clonogenicity studies clearly demonstrate that some colonies on these plates are 
capable of continuing to proliferate, seemingly uninhibited.
The possibility that the colonies which are able to continue proliferating have 
managed to down regulate the myc-TRF2 FL or myc-TRF2ABAM was investigated 
using immunocytochemistry, (Figures 24, 25, 26 and 27). For these 
experiments, cells were fixed prior to being permeabilised as part of the mild 
immunofluorescence protocol. As a result, it is not possible to visualise 
endogenous punctate TRF2 staining and the exogenous expression of myc-TRF2 
FL and myc-TRF2ABAM is dispersed throughout the nucleus. To try to investigate 
the differential effect of myc-TRF2 FL and myc-TRF2ABAM, experiments using low 
levels of expression of constructs were evaluated. For each variable, 10 images 
were taken: 5 of small colonies and 5 of large colonies.
In the Vector only samples, (Figure 24), both small and large colonies display 
diffuse GFP expression throughout the cell.
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Figure 23. Brd-U incorporation into NHEK grown for 14 days with low levels of 
myc- TRF2 FL and myc- TRF2ABAM.
Cells were flow sorted on day 2. Cells expressing low levels of GFP were collected, 
plated at 1x104 with feeders and grown until day 14 without Brd-U. On days 14 and 15, 
the medium was changed to include 100 pM Brd-U. Cells were fixed on day 16 and the 
Brd-U detected using immunofluorescence.
In the large colonies found on (a) Vector only plate, (d) myc-TRF2 FL plate and (g) 
myc- TRF2ABAM plate, Brd-U incorporation can clearly be seen, (b), (e) and (h) all show 
dapi staining, a DNA interacting molecule that fluoresces demarking the nucleus, (c),
(f) and (i) show the overlay between Brd-U and dapi staining differentiating the cells that 
have incorporated the Brd-U from those which have not. (j), (k) and (I) show a small 
colony on the myc- TRF2ABAM plate that has not stained for Brd-U.
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Figure 24. TRF2 levels in NHEK grown for 14 days with low levels of Vector only.
Cells were flow sorted on day 2. Cells expressing low levels of GFP were isolated and 
plated at 1x104 with feeders, grown for 14 days and then fixed. Dapi staining was used to 
identify the top and bottom of the nucleus, defining a depth the confocal was to take 
images through. 1pm Z stacks were taken and merged using the image J program.
In (a), (d) and (g) no signal can be seen from the TRF2 staining, using this mild 
immunofluorescence staining protocol where cells are fixed prior to being permeabilised. 
In (b), (e) and (f) GFP present within the cells can easily be detected, (c), (f) and (i) all 
show the nuclei of each cell as marked by dapi staining nestled within the intensely GFP 
positive colony.
- 107 -
TRF2 GFP Merge with dapi
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Figure 25. TRF2 Levels in NHEK grown for 14 days with low levels of myc-TRF2 FL.
Cells processed as detailed in figure 24.
In (a)-(f) TRF2 staining can be clearly seen in all the GFP positive cells. The TRF2 
staining co-localises with the dapi, illustrating it’s nuclear localisation. In (g), (h) and (i), 
the TRF2 staining is not as strong and only the TRF2 positive cells are GFP positive. 
Dapi staining reveals TRF2 and GFP negative cells within the colony.
In (c) and (f) there are nuclei stained with dapi at the periphery of each colony that are 
neither TRF2 or GFP positive. Because of their distribution in relation to the TRF2/GFP 
positive colony it is likely that these are feeders that were not sufficiently removed from 
the plate.
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Figure 26. TRF2 Levels in small colonies of NHEK grown for 14 days with low 
levels of myc- TRF2ABAM.
Cells were processed as detailed in Figure 24.
Note: The images in (a) -  (c) are at a higher magnification then the other images taken.
In all images, TRF2 staining can be clearly seen in all the GFP positive cells. The 
merged images with dapi (c), (f), (i) and (I) show the TRF2 signal co-localising with the 
nucleus, detected using dapi. In both images (i) and (I) nuclei are seen that have not 
stained positive for TRF2. These cells might either be NHEK that have down-regulated 
both the TRF2 and the GFP or these are feeders that were not removed from the plate.
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Figure 27. TRF2 levels in large colonies of NHEK grown for 14 days with low levels 
of myc- TRF2ABAM. Cells were processed as detailed in Figure 24.
(a) -  (c) In large colony 1, TRF2 staining can be seen in 5 cells (cluster of 3 and 2). The 
GFP distribution shows how their cytoplasm has spread out. The merged image reveals 
that these 5 cells are residing either on top or below a much larger colony that does not 
stain positive for GFP or TRF2.
(d) -  (f) In large colony 2, TRF2 staining is extremely weak. The GFP staining remains 
quite bright. In the merged image, the weak TRF2 staining is not strong enough to 
contribute to the image.
(g) -  (I) In large colonies 3 and 4 there is no TRF2 staining. Large colony 3 is still 
expressing GFP, however large colony 4 is not.
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In NHEK expressing low levels of myc-TRF2 FL, (Figure 25), both small and large 
colonies still express both GFP and myc-TRF2 FL. However, a few large colonies 
(e.g. large colony 3) appear mosaic in that some cells express myc-TRF2 FL and 
GFP, but not all.
In NHEK with low levels of expression of myc-TRF2ABAM, (Figure 26), all small 
colonies are both GFP and myc-TRF2 FL positive. In all images, but particularly 
well illustrated in the magnified small colony 1, (Figure 26)(a) - (c), it is 
possible that large nucleoli are present, however this would need to be 
confirmed with a nucleoli marker such as nucleophosmin. If the large non-dapi 
stained structure in the middle of the cell is the nucleolus it  would indicate that 
the cells are arrested in either G1, S or G2, but not stuck in mitosis. In all 
images of small colonies expressing myc-TRF2ABAM there was no evidence of 
aberrant mitosis. This indicates that although dysfunctional, the telomeres are 
unlikely to be arresting the cell cycle in anaphase.
Large colonies found in NHEK expressing low levels of myc-TRF2ABAM, (Figure 
27), do not express myc-TRF2ABAM despite being GFP positive, thus explaining 
how these colonies are able to grow to such sizes. In large colony number 1, 5 
cells stain positive for myc-TRF2ABAM and the GFP in their cytoplasm 
demonstrates how spread out the cells are. The rest of the colony has down- 
regulated both myc-TRF2ABAM and GFP. In large colony 2, the entire colony 
stains very weakly for myc-TRF2ABAM, but positive for GFP. This indicates only 
very low expression of myc-TRF2ABAM, which might possibly not be enough to 
strip the endogenous TRF2 away from the telomeres. In both large colonies 3 
and 4, no myc-TRF2ABAM is seen. In large colony 3 GFP is still being expressed, 
however in large colony 4 even the GFP is no longer expressed. Large colony 4 
was probably derived from a cell that had down-regulated the myc-TRF2ABAM 
construct; however it is possible that this was always a rare GFP/myc-TRF2ABAM 
negative cell that was not gated out of the cell population properly during cell 
sorting. Each of the 4 large colonies shown in (Figure 27) demonstrate that the 
large colonies on the myc-TRF2ABAM plate have only managed to grow to such 
proportions by down-regulating the myc-TRF2ABAM expression to either low levels 
or by completely turning it off. Undoubtedly, these cells that no longer 
represent an uncapped telomere population contribute a proportion of the cells 
counted in the proliferation curves in (Figure 18) and (Figure 20).
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4 . 6  Identifying Senescent Colonies
Senescence Associated Beta-Galactosidase (B-Gal) activity has been used as an 
assay for determining senescent fibroblasts and keratinocytes since 1995 (Dimri 
et al. 1995). Normally contained in the lysosomal compartment and active at pH 
4.0, in senescent cells excess amounts of B-Gal are produced resulting in activity 
in areas outside the lysosome at sub-optimal conditions, such as pH 6.0.
B-Gal activity was assessed in NHEK expressing the TRF2 constructs, (Figure 28). 
Naturally differentiated cells within the NHEK population also stain positive for 
B-gal. As the cells had been plated at very low density 14 days prior to being 
analysed, any colony larger then 50 cells was clearly proliferating and any B-gal 
staining it contained could be attributed to differentiation. In addition to that, 
almost every colony greater than 50 cells contained a “ cuff”  of displaced feeder 
layer (Rheinwald 1980) that also stained B-gal positive (e.g. Figure 28(a)(ii)).
For this reason a strict criteria had to be devised in order for B-gal quantitation 
to be meaningful. To be scored as a senescent colony, the colony had to (1) 
contain at least one B-Gal positive cell and (2) contain less then 50 cells. 
Although most of the NHEK that satisfied the criteria had a flattened, spread out 
morphology, it  was not used as part of the criteria used to score the colonies as 
senescent.
The Beta-Gal staining was very difficult to reproduce. In total, 7 attempts were 
made in 3 separate experiments to visualise the Beta-Gal staining; however only 
two attempts proved successful. In both of these 2 experiments, X-galactose 
was used at 10 mg/mL, more concentrated than in the other 5 experiments 
where the X-galactose solution was 1 mg/mL, as per the original protocol 
published by Dimri et al (Dimri et al. 1995). As the integrity of this assay relies 
on sub-optimal conditions, it  would be fair to criticise this modification. 
However, the clarity of B-gal retention in the lysosome of cells in colonies larger 
than 50 cells and in other small colonies indicates that excess levels of X- 
galactose is not giving false positives.
Images from the first experiment are shown in (Figure 28)(a)-(c). The second 
experiment was performed similarly except that the cells were plated at a 
higher density and were analysed on day 12, (Figure 28)(d). Vector only plates
Figure 28. Beta-Galactosidase staining of NHEK expressing low levels of myc- 
TRF2 FL and myc- TRFZ*8^ .
Cells were flow sorted on day 2 and those expressing low levels of GFP were isolated 
and plated at 1x104 with feeders. On day 16, the cells were stained for senescence 
associated Beta-Galactosidase (B-gal). Images outlined in black are all at 25X 
magnification and those outlined in red are enlarged insets from within the images as 
marked.
(a) (i) and (ii) Vector only plates contained mostly large colonies that were not B-gal 
positive, although (iii) some naturally senescent colonies did occur.
(b) (i) and (ii) Myc-TRF2 FL plates also contained a mixture of B-gal negative and (iii) 
positive colonies.
(c) (i), (ii) and (iii) The myc-TRF2ABAM plates contained many B-gal positive colonies.
(d) In a different experiment, cells were flow sorted on day 2, but plated at the higher 
density of 2x104 with feeders and harvested on day 12. B-gal positive colonies were 
scored looking at 40 separate fields of view on each plate as described in Chapter 2. 
Two plates were considered for each variable and the bars represent the numbers of 
positive colonies on duplicate plates.
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Figure 28. Beta-Galactosidase staining of NHEK expressing low levels of 
myc- TRF2 FL and myc- TRF2ABAM.
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contained mostly large colonies that were not B-gal positive, although some 
naturally senescent colonies did occur. Myc-TRF2 FL plates also contained a 
mixture of B-gal negative and positive colonies. In contrast, the myc- jrf2abam 
plates contained many B-gal positive colonies.
The relative numbers of senescent colonies were similar in each experiment with 
the exception that not as many senescent colonies were found in the NHEK 
expressing high levels of myc-TRF2 FL.
As senescent colonies are known to arrest with a G1 DNA content (Chen et al. 
1998) the next investigation was to determine where in the cell cycle the non­
proliferating NHEK were arrested, in order to confirm a G1 arrest.
4.7  Cell Cycle Analysis o f Keratinocytes
Flow Assisted Cell Sorting (FACS) analysis of cells can determine the DNA content 
of individual cells within a population when they have been labelled with a DNA 
binding dye such as Propidium Iodide (PI). Cells in the G1 phase of the cell cycle 
are said to contain 2N DNA content, cells in G2 contain 4N DNA content and cells 
in S phase contain a DNA content in between 2N and 4N.
Before evaluating the DNA content of NHEK expressing the TRF2 constructs, 
control experiments were performed to establish cell cycle profiles of NHEK 
treated with different cell cycle inhibitors. Cells were either arrested using 
Hydroxyurea (HU) or subjected to low and high doses of y-IR to assess where 
cells arrest in the cell cycle as a result of multiple double strand breaks (Figure 
29). Treating NHEK with 1.0 mM HU for 24 hours was enough to growth arrest 
the cells at the G1/S boundary, (Figure 29)(a). This control was helpful in 
determining a profile of NHEK arrested with a 2N DNA content. Treating NHEK 
with a low, 2 Gy y-IR dose, resulted in a small accumulation of cells in G2 at 6 
hours and then a return to a “ normal” (i.e. a cell cycle distribution as seen in 
untreated cells) cell cycle profile by 12 hours. NHEK subjected to a high, 20 Gy 
y-IR dose resulted in a build-up of cells in G2, 18 hours after the y-IR. What is 
not clear in this Figure is whether or not the cells in G1 are arrested in G1 or if 
these cells were repaired after the y-IR dose was administered and these cells 
are cycling normally. It was unexpected to see normal cells with wild type p53
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(a) NHEK treated with varvinq doses of Hvdroxvurea for 24 hours
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Figure 29. Cell cycle analysis profiles of NHEK treated with Hydroxyurea or y-IR.
(a) (i.) Cell cycle profile determined by FACS in untreated NHEK. (ii.) 0.5 mM HU slows 
the cell cycle and prevents entry into S phase, (iii.) 1 mM and (iv.) 1.5 mM HU causes 
cell cycle arrest at the G1/S boundary.
(b) (ii.) 6 hours after 2 Gy of y-IR a small accumulation of NHEK in G2 can be detected, 
(iii.) 12 and (iv.) 18 hours after 2 Gy of y-IR, NHEK resume normal profiles.
(c) (ii.) 6 hours after 20 Gy of y-IR an accumulation of NHEK in S phase is observed, 
(iii.) 12 hours later the majority of NHEK are either in G1 or G2 and (iv.) 18 hours later 
most of the NHEK are in G2.
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arresting in G2 as opposed to G1 after y-IR, however this is not unprecedented 
(Scott et al. 2004). It has been shown that the exposure of normal human 
fibroblasts to genotoxic agents provokes permanent cell cycle exit in the G2 
phase of the cell cycle, whereas mouse embryo fibroblasts and transformed 
human cells progress through mitosis and arrest in G1 without intervening 
cytokinesis (Baus et al. 2003).
Current literature has established that naturally occurring (d'Adda di Fagagna et 
al. 2003) or experimentally created (Takai et al. 2003) dysfunctional telomeres 
are recognised as DNA double strand breaks, resulting in human fibroblasts 
arresting in G1. Given that the NHEK with double strand breaks caused by 
exposure to y-IR arrest in G2, it  was of interest to determine where in the cell 
cycle the NHEK arrest after the exogenous expression of myc-TRF2 FL or myc-
■pj^ p^ ABAM
4.8 Cell Cycle Analysis o f Keratinocytes expressing m yc-TRF2 FL  
and m yc-TRF2*BAM
In addition to labelling cells with PI to determine their DNA content, the 
percentage of cells in S phase can be measured after a limited exposure to Brd-U 
(e.g. 30 min). By staining cells for Brd-U during FACS analysis it  is then possible 
to better define the proportion of cells in S phase and obtain more accurate 
percentages of cells in G1 or G2.
10 days after infection with myc-TRF2 FL or myc-TRF2ABAM, NHEK were given a 30 
min Brd-U pulse immediately prior to being harvested for cell sorting. Being 
aware of the growth advantage shown by NHEK that have managed to either 
partially or completely down-regulate the myc-TRF2ABAM/GFP expression on day 
16, day 10 was chosen for this cell cycle analysis (Figure 30). The rationale was 
that the ratio of cells growth arrested by the myc-TRF2ABAM would still be high 
enough at this point to dominate the FACS analysis cell cycle profile. Labelling 
NHEK with Brd-U prior to FACS analysis provided good cell cycle analysis profiles, 
but unexpectedly did not provide evidence of a G1 or G2 cell cycle arrest 
(Figure 30). The variation in the cell cycle distribution was not considerably 
different in cells expressing Vector only, myc-TRF2 FL or myc-TRF2ABAM.
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Figure 30. Cell cycle profiling of NHEK 10 days after expression of (a) and (b) 
Vector only, (c) myc-TRF2 FL and (d) myc-TRF2ABAM.
All GFP positive NHEK were seperated from GFP negative cells on day 10 immediately 
after Brd-U labelling of cells for 30 min [except in (a)]. The cells were then fixed and cell 
cycle profiling was performed by FACS analysis.
R1 = Whole cells are defined based on cell granularity vs. cell size.
R2 = Single cells are defined and cell doublets and triplicates are excluded.
R3 = NHEK with a G1 (or 2N) DNA content. (Except in (a) where no Brd-U is used.)
R4 = NHEK that stain positive for Brd-U and are therefore considered to be is S phase 
with a DNA content between 2N and 4N. (R4 was defined in (a)(iii) where the cells were 
not incubated with Brd-U and the region is therefore empty.)
R5 = NHEK with a G2 (or 4N) DNA content. (Except in (a) where no Brd-U is used.)
(a) Control sample in which Vector only cells were not labelled with Brd-U. (iv.) Cell cycle 
histogram shows a normal distribution.
(b) Vector only shows (iii.) a clear incorporation of Brd-U in R4 and cell cycle distribution 
percentages indicate a normal cell cycle profile (iv.).
(c) myc-TRF2 FL. The distribution of cells (iii.) and (iv.) is almost unchanged from NHEK 
containing Vector only.
(d) myc-TRF2ABAM. The distribution of cells (iii.) and (iv.) is almost unchanged from NHEK 
containing Vector only or myc-TRF2 FL.
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(a) Vector Only, No BrdU. 35,428 total events, 25.6% gated in R1 and R2.
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Figure 30. Cell cycle profiling of NHEK 10 days after expression of (a) and (b) 
Vector only, (c) myc-TRF2 FL and (d) myc-TRF2ABAM.
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One explanation for this might be that cell cycle arrested TRF2 construct 
expressing cells might be “ lost”  during cell cycle analysis. The fact that the 
percentage of cells being gated in TRF2 construct expressing cells is reduced 
suggests that this is the case. 25.6% of NHEK expressing Vector only, with or 
without Brd-U label were gated in R1 and R2. In NHEK expressing myc-TRF2 FL, 
that percentage decreased to 11.3% and in myc-TRF2ABAM it fell to 7%. The 
amount of cell debris clearly increases in both these samples, (Figure 30), 
indicating that the cells were not stable enough to remain intact for both the 
flow sorting and the FACS analysis. Based on the images obtained in (Figure 
27), it  appears that the only cells being assayed from the myc-TRF2ABAM 
population are those which are GFP positive and myc-TRF2ABAM negative. As part 
of the same experiment, NHEK were flow sorted and then harvested on days 8 
and 12 for western blot analysis, (Figure 31). Myc-TRF2 FL is expressed on day 
8, but considerably less is expressed on day 12, whereas a small amount of myc- 
TRF2abam expression is still seen on day 8, however by day 12 it  has disappeared.
In another experiment (not shown), NHEK were flow sorted into low and high 
GFP expressing fractions and plated on day 2 and then analysed using FACS 
analysis on days 8, 12 and 15, i.e. without further flow sorting immediately prior 
to FACS analysis. Normal cell cycle profiles were seen in each sample; however 
the pattern of increased cell debris when progressing from cells expressing 
Vector only to myc-TRF2 FL to myc-TRF2ABAM also increased as described in 
(Figure 30).
It should be noted that there is an apparent contradiction between the 
expression levels of myc-TRF2ABAM in cells dependent on whether or not they 
were cell sorted 12 - 14 days after infection. A western blot in (Figure 16) 
demonstrates substantial expression of myc-TRF2ABAM at day 13 and (Figure 31) 
shows complete loss of myc-TRF2ABAM on day 12. This apparent anomaly is 
explained by the fact that in (Figure 16) the cells were not flow sorted 
immediately prior to harvest, whereas in (Figure 31) they were. (Figure 26) 
shows that on day 14 the small colonies were still expressing both GFP and myc- 
TRF2abam: these cells were plated on day 2 and not flow sorted again before 
being fixed for the experiment. The conclusion that can be drawn from these 
experiments is that NHEK expressing myc-TRF2ABAM inhibited in mid-late stage
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Days post 
infection
Vector
Only
Days post 
infection
Days post 
infection
Myc- 
TRF2 FL
Figure 31. TRF2 expression in NHEK infected with myc-TRF2 FL and myc- 
TRF2ABAM on days 8 and 12 after flow  sorting.
NHEK were flow sorted on day 8 or 12 and then immediately harvested for western 
blot analysis. Vinculin is used as a loading control in this western blot and shows 
even loading in all lanes. Between 8 and 12 days after infection, myc-TRF2ABAM 
expression is lost from NHEK despite the fact they are still expressing GFP. Some 
myc-TRF2 FL is still produced on day 12 although substantially less then that being 
expressed in day 8.
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proliferation are not strong enough to withstand the rigour of flow sorting and 
FACS analysis.
4.9 Sum m ary o f Chapter 4
Expression of TRF2 constructs in NHEK results in reduced proliferation. High 
expression levels of myc-TRF2 FL cause a more drastic reduction in proliferation 
than low levels of expression, for reasons as yet undetermined. Expression of 
myc-TRF2ABAM resulted in an even more dramatic reduction of cell proliferation, 
again with higher levels of expression being more effective then lower levels.
NHEK expressing myc-TRF2ABAM were not capable of growing larger than 50 cells, 
however NHEK expressing myc-TRF2 FL were. Plates of NHEK expressing myc- 
TRF2abam stained with Rhodamine B also contain large colonies, however in this 
case immunofluorescence demonstrated that such large colonies no longer 
expressed the myc-TRF2ABAM construct. Plates of NHEK expressing myc-TRF2 FL 
stained with Rhodamine B show varying colony sizes and immunofluorescence 
demonstrates that some, but not all, large colonies are still expressing the 
construct.
Brd-U incorporation formally established that the only NHEK infected with either 
Vector only, myc-TRF2 FL or myc-TRF2ABAM, and still proliferating on day 14 were 
those in the large colonies. Colonies of less then 50 cells did not incorporate 
Brd-U within a 48 hour time period.
Uncapped telomeres generated by myc-TRF2ABAM expression in NHEK induce 
senescence. Counting B-gal stained plates expressing Vector only, myc-TRF2 FL 
or myc-TRF2ABAM revealed a higher number of B-gal positive colonies in NHEK 
expressing myc-TRF2 FL, and even more so when myc-TRF2ABAM was expressed.
Paradoxically, NHEK expressing TRF2 constructs analysed by FACS analysis had 
normal cell cycle profiles similar to Vector only or uninfected cells. The most 
likely explanation is that the cells arrested as a consequence of expressing myc- 
TRF2 FL or myc-TRF2ABAM are lost during the FACS profiling.
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Chapter 5:
Examining the mechanism to inhibit NHEK proliferation 
used by myc-TRF2 FL or myc-TRF2ABAM
In NHEK, myc-TRF2 FL and myc-TRF2ABAM over-expression causes a reduction of 
cell proliferation to varying degrees. To evaluate how expression of the TRF2 
constructs was actually causing this phenotype within the NHEK, the DNA 
damage response was investigated to assess if it  was being elicited by the cells.
5.1 Im m unofluorescence studies o f the localisation o f low  and  
high levels o f  m yc-TRF2 FL or rnyc-TRF2ABm within N H EK
Using a protocol for immunofluorescence that permeabilises the NHEK before 
fixation, it was possible to detect punctate staining of both telomeric binding 
proteins TRF1 and TRF2, low expression levels - (Figure 32) and high expression 
levels - (Figure 33). In NHEK expressing the Vector only, punctuate spots of 
endogenous TRF1 and TRF2 were found to co-localise. As expected, much more 
TRF2 was detected in the cells expressing myc-TRF2 FL. The exogenous myc- 
TRF2 FL co-localised with TRF1 confirming its presence at the telomere. In 
NHEK expressing low levels of myc-TRF2ABAM, far less punctate staining of TRF2 
was seen, demonstrating the ability of the myc-TRF2ABAM to strip endogenous 
TRF2 from the telomere.
A differential effect was seen in the proliferation curves, particularly for cells 
expressing low vs. high levels of myc-TRF2 FL (Chapter 4 - Figure 20). Side by 
side comparison of different fields of view in this experiment demonstrate it is 
not possible to see more myc-TRF2 FL being bound where high levels are 
expressed as opposed to low levels, (Figure 34). Likewise, with myc-TRF2ABAM, 
there is no evidence that more endogenous TRF2 is stripped from the telomere 
when high levels of the construct are expressed.
Intriguingly, endogenous levels of both TRF1 and TRF2 are better visualised in 
NHEK expressing high levels of Vector only (as opposed to low levels), i t  is not 
clear why this is.
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Figure 34. Side by side comparison of low vs. high levels of myc-TRF2 FL and 
myc-TRF2ABAM in NHEK on day 4. These images were obtained as part of the same 
experiment as detailed in Figures 32 and 33. However, different fields of view are 
shown.
(a) -  (f) Both low and high expressing Vector only cells show co-localisation of TRF1 
and 2 again. Inexplicably, endogenous levels of TRF1 and TRF2 are higher in the 
Vector only high cells as opposed to Vector only low.
(g) -  (I) Both low and high levels of myc-TRF2 FL display an increase in TRF2 staining 
compared to Vector only, however myc-TRF2 FL high does not show an increased 
amount of TRF2 bound to the telomere compared with myc-TRF2 low.
(m) -  (r) Substantially less TRF2 staining occurs in NHEK expressing either low or high 
levels of myc-TRF2ABAM. Less punctate staining of TRF2 is seen outside the dapi 
stained nucleus in both images (o) and (r). It is possible that this staining is either myc- 
TRF2ABAM being produced or degraded.
TRF1 TRF2 Merge with lapi
tY
Figure 34. Co-localisation of TRF1 and 2 in NHEK expressing low and hijh 
levels of myc-TRF2 FL and myc-TRF2ABAM on da} 4.
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5.2 Evaluating DNA dam age in NHEK using 53BP1 induction as a 
m arker
In 2003, a DNA damage response was firmly established as part of the human 
fibroblast response to either naturally short telomeres (d'Adda di Fagagna et al. 
2003) or dysfunctional telomeres created using myc-TRF2ABAM (Takai et al. 2003). 
In both publications, the DNA damage response proteins 53BP1 and y-H2AX were 
shown to bind DNA and in one case these proteins were specifically shown to co- 
localise with TRF1 (Takai et al. 2003), indicating that the DNA damage response 
protein was binding at the telomere. These sites of co-localisation were 
denoted Telomere Induced dysfunctional Foci, (TIFs). Before trying to establish 
if TIFs were formed in NHEK, staining for 53BP1 was optimised after giving cells 
varying doses of y-IR. 1 Gy induces about 25 double strand breaks (Lobrich et al. 
1994). If the myc-TRF2ABAM was capable of removing the endogenous TRF2 from 
each telomere, then theoretically it  would be reasonable to expect 92 DSB in 
each cell. However, it is unlikely that each telomere within a cell becomes 
dysfunctional as a result of expressing myc-TRF2ABAM. Assuming 25-75% of 
telomeres become dysfunctional, a 1- 3 Gy y-IR dose (25 - 75 DSBs) would induce 
a comparable amount of DNA damage.
Using the mild immunofluoresence protocol where cells were fixed before being 
permeabilised, punctuate 53BP1 staining was seen 15 mins after a 1 Gy y-IR 
dose, (Figure 35). Untreated controls very infrequently demonstrated punctate 
53BP1 staining, e.g. (Figure 35)(a)(v.), for reasons undetermined. It is possible 
that these are NHEK under going differentiation, premature chromatin 
condensation or some other process in which 53BP1 is perhaps involved, but not 
yet characterised. The majority of NHEK given either a 1 or 8 Gy y-IR dose 
showed a punctate 53BP1 staining pattern, but not every single cell. Those that 
fail to respond may be in S phase and therefore not in a position to up-regulate 
production of 53BP1.
With a 15 min recovery time, the 53BP1 response after 1 Gy y-IR was fairly 
robust. Escalating doses of y-IR did not result in an obvious increase in the 
amount of 53BP1 localisation. For example, at the same time point, NHEK that
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Figure 35. 53BP1 activation in NHEK exposed to increasing doses of y-IR.
NHEK were subjected to various doses of y-IR and given 15 min recovery time before 
being fixed in PFA prior to immunofluorescence.
(a) (i.), (ii.) and (iii.) Typically, either no 53BP1 or a single point of 53BP1 localisation is 
seen in cells that have not been given a y-IR dose, (iv.), (v.) and (vi.) Very occasionally 
NHEK that have not been exposed to y-IR express 53BP1.
(b) (i.), (ii.) and (iii.) More than 10 distinct foci of 53BP1 can be seen in cells after as 
little as 1Gy IR.
(c) (i.), (ii.) and (iii.) Exposure to 8 Gy y-IR does not result in many more 53BP1 foci 
within a given cell.
(d) (i.) and (ii.) Staining NHEK for TRF1 was unsuccessful using the 2% PFA protocol 
which is optimal for 53BP1 staining.
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Dapi 53BP1 Merge
(a) OGy y-IR
■
(b) 1Gy y-IR
(c) 8Gy y-IR
M
(d) 16Gy y-IR and also stained for TRF1
(i.) TRF1 ( i i . 53BP1
Figure 35. 53BP1 activation in NHEK exposed to increasing doses of y-IR.
had received an 8 Gy y-IR dose appeared very similar to NHEK that had received 
1 Gy y-IR dose. The lack of escalation in the amount of 53BP1 localisation with 
increasing IR dosage suggests that either more time is required to see a 
differential effect, that the reagents in the experiment were limiting or that 
after as little  as 1 Gy y-IR the maximum 53BP1 response had been achieved.
Attempts at visualising the endogenous levels of TRF1 using this 
immunofluorescence protocol were unsuccessful. As seen previously in (Figure 
24), without permeabilising the NHEK prior to fixation, the TRF1 antibody failed 
to recognise the TRF1 protein.
5.3 Attem pting to identify  TIFs in N H EK  expressing m yc-TR F2^m
Using deconvolution microscopy Takai et al were able to observe TIFs 48 - 52 
hours after G1/S synchronised cells were infected with adenoviral myc-TRF2ABAM 
(Takai et al. 2003). Given the different approach to infecting cells taken in this 
thesis, a slightly altered method was also taken in trying to identify TIFs, 
outlined in (Figure 36). Because the NHEK were not synchronised, a longer time 
window was evaluated for trying to identify TIFs.
Knowing that permeabilising the cells prior to fixation was necessary to visualise 
TRF1 protein, the stringent immunofluorescent protocol was used when trying to 
identify TIFs, (Figure 37). The 50 hour time point shown in (Figure 37) (g) - (i) 
demonstrates the best example of 53BP1 staining seen in NHEK expressing the 
myc-TRF2ABAM. However, (j) - (I) is more representative of the 53BP1 staining 
commonly seen on the myc-TRF2ABAM plate.
A compromise must be made between the optimal techniques for detecting 
localisation of 53BP1 and TRF1 and therefore several issues exist that make it 
difficult to interpret this experiment: (1) Only large spots of 53BP1 can still be 
recognised using the stringent protocol, the finer spots seen when using the mild 
protocol where cells are fixed prior to permeabilisation are no longer seen. (2) 
The images for this experiment were performed relatively early in the course of 
this thesis and were taken using the Leica confocal which is not as sensitive for 
detecting small amounts of protein as the Olympus confocal which was acquired
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Figure 36. Timeline for TIF experiment.
The NHEK were co-cultured with the infectious PT67s for 43.5 hours at which point 
they were harvested for flow sorting. Flow sorting took 4.5 hours and then the GFP 
positive NHEK were plated onto 3T3 conditioned coverslips. 8 hours after being 
plated the cells had spread out and appeared “recovered” from the flow sorting. Not 
including within the timeline the 12.5 hours taken for both cell sorting and recovery, a 
set of Vector only, myc-TRF2 FL and myc-TRF2ABAM expressing NHEK were then 
harvested every 2 hours from 44 -  54 hours after infection.
- 134 -
Figure 37. Attempting to identify TIFs in NHEK expressing myc-TRF2 FL and myc- 
TRF2ABAM. NHEK were flow sorted after 43.5 hours of co-culture with infectious PT67s 
(day 1) and plated onto 3T3 conditioned coverslips without feeders. Cells displayed in 
this Figure were grown until a 50 hour timepoint was reached (day 1) and permeabilised 
prior to being fixed using a stringent immunofluorescence protocol. Dapi staining was 
used to identify the middle of the nucleus, and 1 pm depths were defined either side of 
this point. The Leica confocal then took ten 0.2 pm Z sections through this region.
(a) -  (c) In the Vector only, no 53BP1 staining is seen in this image, however spurious 
spots were seen in some cells indicating that 53BP1 will be activated at times in these 
cells. TheTRFI staining indicates telomeres.
(d) -  (f) No 53BP1 staining can be seen in cells expressing myc-TRF2 FL, however the 
TRF1 staining is much stronger then in the Vector only image.
(9) ~ (0 These images display the best evidence of 53BP1 staining in the entire 
experiment.
(j) -  (I) These images are more typical of the 53BP1 staining in the NHEK expressing 
myc-TRF2ABAM.
(m) -  (o) As a control, a set of vector only cells were given 4Gy y-IR and 15 min recovery 
time. Again, some 53BP1 staining was seen.
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Figure 37. Co-localisation of TRF1 and 53BP1 in NHEK expressing myc-TRF2 FL 
and myc-TRF2ABAM.
by the Beatson Institute towards the end of the thesis period, (3) Confocal 
microscopy had to be used instead of deconvolution microscopy, a technique 
that reduces background staining. Had deconvolution microscopy had been 
available it might have been possible to analyse the NHEK without 
permeabilising prior to fixation, thereby retaining the finer 53BP1 staining and 
visualising the TRF1 staining in the same sample.
5.4 Using y-IR to evaluate the DNA response to DSBs in NHEK
As DNA damage detection using immunofluorescence was restricted, proteins 
induced in a DNA damage response were evaluated at a molecular level using 
western blotting. After consulting several publications (dAdda di Fagagna et al. 
2003), (Takai et al. 2003) and (Yoon and Smart 2004) antibodies recognising the 
proteins, Table 7, were tested using NHEK that had been subjected to varying 
doses of y-IR and given varying recovery times.
Table 7: Commercially available antibodies that recognise proteins specifically involved in 
the DNA damage response evaluated using NHEK treated with y-IR
Antibody
53BP1
53BP1 (clone BP13)________________________________________________
C/EBP a (Keratinocyte specific DNA damage response downstream of p53) 
Chk 1
Chk 2___________________________________________________________
Chk1-phosphoS345________________________________________________
Chk2-phosphoT68 
H2AX- phosphoS139 
Histone H2A.X
NBS1____________________________________________________________
NBS1-phosphoS343
p53_____________________________________________________________
p53-phosphoS15
RAD17__________________________________________________________
RAD17-phosphoS645
SMC1___________________________________________________________
SMC1-phosphoS966_______________________________________________
The purpose of these experiments was to find the most sensitive marker of DNA 
damage in NHEK detectable in western blotting. The assays that worked the 
best are shown in (Figure 38). Antibodies that recognised SMC1- phosphoS966, 
Nbs1- phosphoS343, Chk1-phosphoS345 and Chk2-phosphoT68 showed that 
activation of these proteins occurred when NHEK were treated with 8 or 16 Gy y-
-137-
SMC1 -phosphoS966 
Total SMC1
Nbs1-phosphoS343 
Total Nbs1
p38 *
Chk1 -phosphoS345 
Total Chk1
p38 ^
Chk2-phosphoT68
Total Chk2 -
p38 ~
P53-phosphoS15
Total p53 
p38
m  u|_ ^  —
0 1 3 6 12 24 44 1 3 6 12 24 44 1 3 6 12 24 44
Y- Recovery time Recovery time Recovery time
IR (hours) (hours) (hours)
1 Gy y-IR 8 Gy y-IR 16 Gy y-IR
Figure 38. NHEK response to y-IR induced DNA damage.
The activation of DNA damage response proteins was analysed after 1, 8 or 16 Gy y- 
IR doses. The best commercially available antibodies (listed in Table 7) at detecting 
DNA damage, are shown above. The antibody against p53 phosphoS15 was clearly 
the most sensitive capable of detecting DNA damage, recognising the damage 
generated after as little as 1Gy. A p38 loading control was used on each separate blot.
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IR. However, they were not sensitive enough to detect the DNA damage 
generated after 1 Gy y-IR. Since the DNA damage response generated by myc- 
TRF2abam is expected to be more subtle then that triggered by an 8 or 16 Gy y-IR 
dose, attention focused on p53-phosphoS15. This was the only antibody capable 
of recognising a member of the DNA damage response pathway at doses of y-IR 
as low as 1 Gy.
5 . 5  p53-phosphoS15 levels in N H EK  expressing m yc-TRF2 FL and  
m yc-TRF2ABAM
Knowing from previous work in the literature that p53 activation is likely to 
occur soon after the expression of myc-TRF2ABAM, we examined NHEK on days 1 
and 2 after infection with TRF2 constructs, (Figure 39). NHEK expressing TRF2 
constructs were harvested immediately after flow sorting GFP positive cells. In 
control lanes, an incremental increase was seen in p53-phosphoS15 signal 
intensity 6 hours after 1 - 16 Gy of y-IR. However, there was a very slight, 
barely detectable increase in the amount of p53-phosphoS15 on day 2 in NHEK 
expressing myc-TRF2ABAM.
The expression levels of p53-phosphoS15 in NHEK expressing the TRF2 constructs 
were also examined in two additional experiments, (Figure 40). Again, the 
intensity of the p53-phosphoS15 signals were marginally elevated on day 2 in 
myc-TRF2ABAM in comparison to equivalent cultures expressing Vector only or 
myc-TRF2 FL. An increase in total p53 has often been reported in cells 
responding to DNA damage. However, this stabilisation of p53 was not seen 
here.
These 3 separate experiments all provided evidence of minor elevation of p53- 
phosphoS15 on day 2 after infection with myc-TRF2ABAM, however the evidence 
remains very subtle. In each experiment, the intensity of this signal is not even 
as strong as the signal in the control NHEK that received 1Gy y-IR.
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Figure 39. p53-phosphoS15 levels in NHEK on days 1 and 2 with myc-TRF2 FL 
and myc-TRF2ABAM.
NHEK were harvested immediately after flow sorting and their p53-phosphoS15 
levels evaluated. S15 phosphorylation is seen in y-IR controls after 1, 8 and 16 Gy. 
In the western blot, the p53-phosphosS15 band in myc- TRF2ABAM infected on day 2 
appears slightly more intense then in any of the bands in the vector only or the myc- 
TRF2 FL. Quantitation confirms this slight increase, but it is less then is found in the 
1 Gy control lane.
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Figure 40. p53- phosphoS15 levels in NHEK at various time points after
infection with myc-TRF2 FL and myc-TRF2ABAM.
(a) NHEK were harvested immediately after flow sorting on days 2 and 3, whereas 
cells harvested on day 13 were flow sorted on day 4 and grown for a further 9 days 
before being harvested. On day 2, in NHEK expressing myc-TRF2ABAM the level of 
p53 -phosphoS15 is greater than in untreated cells or in cells that are expressing 
vector only. However, it is not as high as in cells that have received 1Gy y-IR.
(b) NHEK were harvested immediately after flow sorting on days 2, 3, 4 and 5. Again, 
on day 2 the p53-phosphoS15 level in the NHEK expressing myc-TRF2ABAM is higher 
than that seen in either the untreated cells, but not higher than in cells that received 1 
Gy y-IR.
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5.6 Levels o f DNA dam age in NH EK expressing myc-TRF2; o r 
m yc-TRF2 FL w ithout cell sorting
The cell cycle analysis and TRF2 expression data at late timepoints after 
infection with myc-TRF2 FL and particularly myc-TRF2ABAM suggest that the NHEK 
experiencing the most telomere induced DNA-damage maybe too unstable to 
survive the flow sorting process (Chapter 4). Therefore, in one experiment,
NHEK were infected with TRF2 constructs and then harvested on days 1 or 2 
without any flow sorting, (Figure 41). On day 2, parallel cultures revealed that 
only approximately 30% of cells were GFP positive after infection with each of 
the three vectors (Vector only, myc-TRF2 FL and myc-TRF2ABAM). As in the 
previous Figure, low levels of p53-phosphoS15 are seen in all NHEK expressing a 
TRF2 construct, but this level is less than that seen in cells given a 1 Gy y-IR 
dose. On day 2, the p53-phosphoS15 signal in the NHEK expressing myc-TRF2ABAM 
cells is almost as strong as cells that received 8 Gy y-IR dose. As only -30% of 
the NHEK harvested were expressing the construct, this is the strongest evidence 
obtained for DNA damage induced by myc-TRF2ABAM.
5.7 F low  sorting as a m eans o f selection in later time points
Comparing the signals of p53-phophoS15 in (Figure 40) to those in (Figure 41) 
suggests that some myc-TRF2ABAM DNA damaged cells may be lost during the flow 
sorting process. It was shown in Chapter 4 that on day 10 the most likely reason 
for not detecting where in the cell cycle the NHEK had proliferation arrested was 
the low proportion of GFP cells still expressing the myc-TRF2ABAM. The difficult 
decision that needed to be made regarding how to harvest the cells while trying 
to establish if the p53-phosphoS15 signal seen on day 2 could be further 
validated is summarised in (Figure 42).
5.8 p21 levels in NH EK expressing m yc-TRF2 FL and  m yc-
When activated, p53 forms a tetramer capable of acting as a transcription 
factor. One gene tightly controlled by activated p53 is p21, a protein that
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Figure 41. p53-phosphoS15 levels in NHEK expressing myc-TRF2 FL and 
myc-TRF2ABAM on days 1 and 2 without flow sorting.
Feeders were removed from NHEK and cells harvested without being flow sorted. 
Parallel cultures that were flow sorted (on day 2) were 30% GFP positive on 
average. An increase in the level of p53-phosphoS15 is seen on day 2 in NHEK 
expressing myc-TRF2ABAM almost as high as the level seen after NHEK receive 
8Gy IR. P53-phosphoS15 levels in Vector only day 1 and 2, myc-TRF2ABAM day 1 
and myc-TRF2 FL day 1 and 2 remain less then those seen in NHEK that received 
1 Gy IR.
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Figure 42. The possible dynamics of the relationship between myc-TRF2ABAWI 
and GFP expression.
On day 0, expression of both myc-TRF2ABAM and GFP is most likely occurring in all 
cells infected with the myc-TRF2ABAM construct. Around day 2, as soon as effect of 
expressing myc-TRF2ABAM is realised by the NHEK, it applies a negative selection 
to those colonies. The cells that continue to express myc-TRF2ABAM and GFP stop 
proliferating, whereas the revertant cells that are not expressing myc-TRF2ABAM, but 
are still expressing GFP begin to grow without growth inhibition, at an exponential 
rate. When the GFP positive cells are harvested at later time points, this causes a 
diluting effect on the extract of the cells that are still expressing the myc-TRF2ABAM. 
As the time frame in which this shift takes place is unknown, day 6 could either 
have a profile as shown in (*1) where the ratio of cells still expressing myc- 
TRF2ABAM is still high enough that the proteins instigating the effect could be seen 
or day 6 could also be taking place at position (*2) where the ratio would not be 
high enough for an effect to be seen.
In addition to the diluting effect, there was evidence that the cells undergoing the 
most telomeric damage were lost during the flow sorting process.
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inhibits the activity of cyclin-CDK2 or -CDK4 complexes thereby preventing cells 
from exiting G1. If the activation of p53 seen on day 2 (albeit very weak) in 
NHEK expressing myc-TRF2ABAM was driving a DNA damage response, an increase 
in p21 in those cells by day 3 would be expected as a consequence.
(Figure 43) (a) looks at the p21 levels in which NHEK have not been flow sorted 
immediately prior to harvesting. No increase in p21 is seen on days 7, 11 or 14. 
Unfortunately it is not possible to comment if this is because there definitely is 
not an increase in p21 or if  an increase is not seen because of the diluting effect 
of the NHEK which are no longer expressing the myc-TRF2ABAM.
Using extracts from an experiment where an increase in p53-phosphoS15 on day 
2 in the myc-TRF2ABAM expressing cells had been demonstrated, we examined the 
p21 levels, (Figure 43) (b). Basal levels of p21 were easily detected in the NHEK 
and an increase in p21 levels was seen in control NHEK that had been treated 
with increasing doses of y-IR and given 6 hours recovery time. No increase of 
p21 was seen in the NHEK on days 1, 2, 3 or 13 after infection with myc-
-pj^p^ABAM
In contrast, a third experiment, (Figure 43)(c), clearly showed an increase in 
p21 expression in both myc-TRF2ABAM and myc-TRF2 FL expressing cells on days 5, 
6, 7 and 8 after infection compared with Vector only cells. The result shown 
here and in (Figure 43)(b) together might suggest that p21 is activated by the 
uncapped telomere, but not until 5 days after infection. However, it  seems 
unlikely that there should be a 3 day delay from p53-S15 phosphorylation on day 
2 and p21 up-regulation at 5-8 days. In addition to this point, the following 
issues also arise from (Figure 43)(c).
• The levels of myc-TRF2ABAM, and to a lesser extent, myc-TRF2 FL, 
decreased at later time points after infection. Despite the decrease, the 
p21 expression remained the same. One possible explanation is that the 
TRF2 constructs are being down-regulated and the initial expression of 
myc-TRF2ABAM already triggered a DNA damage response that continues to 
prevent cell proliferation. However, the FACS analysis in (Figure 30) 
(Chapter 4) provides evidence to the contrary.
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• In Chapter 4, (Figure 18) and (Figure 20), demonstrate that NHEK 
expressing myc-TRF2 FL proliferate more then those expressing myc- 
TRF2abam. |f this differential affect is caused by the p53 activation on day 
2 in the myc-TRF2ABAM expressing cells, then a higher level of p21 would 
be expected in these cells compared to the NHEK expressing myc-TRF2 FL.
As these points do not support the apparent up-regulation of p21 seen in (Figure
43)(c) it  can not be considered authentic.
While not providing evidence in support of a p53 response, the difficulty in 
obtaining evidence of p21 up-regulation also fails to provide evidence against a 
p53 response. The most likely explanation from the data gathered regarding p21 
is, akin to Section 4.8, any cells in the midst of a DNA damage response are too 
fragile to survive the flow sorting process. Unfortunately, an up-regulation of 
p21 was not seen in NHEK expressing myc-TRF2ABAM that had not been flow 
sorted, but this could be due to the diluting effect of cells no longer expressing 
the myc-TRF2ABAM.
5 . 9  Assessing the phosphorylation status o f Rb in NHEK  
expressing m yc-TRF2 FL and  myc-TRF2?Bm
Although it was deemed likely that growth arrested NHEK expressing myc- 
TRF2abam had not survived the flow sorting process based on their p21 status, it 
was decided that another marker of cell cycle status should also be examined.
Ultimately, the main downstream affect of the activation of p53 is controlled 
through the phosphorylation status of the Retinoblastoma (Rb) protein. When 
hyper-phosphorylated, Rb does not bind to E2F, a transcription factor that 
controls the expression of many genes that allow entry into the S phase of the 
cell cycle. Conversely, hypo-phosphorylated Rb remains bound to E2F, thereby 
repressing it and preventing cells from progressing from the G1 to the S phase of 
the cell cycle.
• Control experiments were first designed to evaluate the reliability of the 
antibodies against several phosphorylation sites known to be involved in 
Rb regulation. NHEK grown to either 50% or 80% confluence all showed
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Figure 43. p21 levels in NHEK at various time points after infection with myc-TRF2 
FL and myc-TRF2ABAM.
(a) NHEK were flow sorted and plated on day 2 and then harvested on days 7, 11 and 14 
after infection without subsequent flow sorting. No increase is seen in p21 in any of the 
cells.
(b) NHEK were harvested immediately after flow sorting on days 1, 2 and 3 whereas 
cells harvested on day 13 were flow sorted on day 4 and grown for a further 9 days 
before being harvested. In the controls, an increase in p21 levels is seen after 1, 8 or 16 
Gy y-IR compared with cells that were not given any IR.
(c) NHEK were harvested immediately after flow sorting on days 5, 6, 7 and 8. At these 
time points p21 levels appear to increase in NHEK expressing myc-TRF2ABAM and myc- 
TRF2 FL compared with those expressing Vector only.
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Figure 43. p21 levels in NHEK at various time points after infection with myc- 
TRF2ABAM and myc-TRF2 FL retroviruses.
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Figure 44. Phosphorylation status of Rb in NHEK expressing myc-TRF2 FL and 
myc-TRF2ABAM at middle time points.
This Figure uses material from the same experiment as (Figure 43)(b).
Control NHEK were grown to either 50% or 80% confluence or held at confluence for 3 
days. Sub-confluent NHEK all show the phosphorylated form of Rb as opposed to the 
confluent NHEK which do not show phosphorylated Rb at any of the 4 specific sites 
tested or in the supershifted positions in the total Rb lane.
GFP positive cells were flow sorted 5, 6, 7 and 8 days after infection with retroviral 
vectors and immediately harvested for western blotting. Myc-TRF2ABAM expressing 
NHEK show less phosphorylation in the total Rb lanes compared with Vector only or 
myc-TRF2 FL and less phosphorylation on day 8 at all 4 specific Rb phosphorylation 
sites tested. In samples harvested from day 5 to day 8, the amount of myc-TRF2ABAM is 
dramatically reduced. The amount of myc-TRF2 FL also reduced, but not by as much.
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Figure 44. Phosphorylation status of Rb in NHEK expressing myc-TRF2 FL 
and myc-TRF2ABAM at middle timepoints.
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phosphorylation of Rb at Serine sites 807/11, 795, 780 and 608 using phospho- 
specific antibodies, (Figure 44). NHEK held at confluence for 3 days did not 
show Rb phosphorylation using phospho-specific Rb antibodies. Antibodies 
against total Rb detected both the hyper- and the hypo-phosphorylated forms of 
Rb in sub-confluent cells as judged by their different electrophoretic mobility’s, 
whereas in confluent cells was Rb was hypo-phosphorylated. As demonstrated 
by these controls, the level of confluence has a dramatic affect on the level of 
Rb phosphorylation. Extreme care was taken in all experimental conditions that 
the NHEK were not confluent prior to harvest. Using the same cell extracts from 
the previous (Figure 43), NHEK expressing myc-TRF2ABAM and myc-TRF2 FL 
demonstrated a reduction in the amount of phospho-Rb at sites 795S, 780S and 
608S in myc-TRF2ABAM cells on day 8, (Figure 44). However, these changes in Rb 
phosphorylation are not evident from the blots using the total Rb antibody, 
(Figure 44). Again, it  seems unlikely that the hypo-phosphorylation would not 
take place until day 8, a delay of 6 days from the activation of p53.
In another experiment the level of Rb-phospho780S were assessed on days 8 and 
12 after infection with myc-TRF2 FL and myc-TRF2ABAM, (Figure 45). Again, the 
cells were flow sorted immediately prior to harvesting. In contrast with (Figure
44), Rb-phospho780S was not reduced on day 8 in myc-TRF2ABAM compared to 
controls, however a large reduction was seen in day 12. Again, the levels of 
myc-TRF2ABAM, and to a lesser extent, myc-TRF2 FL, decreased at later time 
points after infection.
5.10 Evaluating other m arkers o f DNA dam age in N H EK  
expressing m yc-TRF2 FL and  m yc-T R F 2^m
Although p53-phosphoS15 was shown to be the most sensitive marker of DNA 
damage following y-IR we decided to also investigate SMC1 and Nbs1 in case 
these proteins proved to be better than p53-phosphoS15 at recognising telomere 
specific, as opposed to radiation induced, DNA damage, (Figure 46). However, 
neither of these DNA damage response proteins were activated in cells 
expressing myc-TRF2ABAM as judged by SMC1 -phosphoS966 and Nbs1-phosphoS343 
antibodies.
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Figure 45. Phosphorylation status of Rb in NHEK expressing myc-TRF2 FL 
and myc-TRF2ABAM at late time points.
GFP positive cells were flow sorted 8 and 12 days after infection and harvested 
immediately. Compared with Vector only and myc-TRF2 FL, less Rb- 
phospho780S is seen in myc-TRF2ABAM cells on day 12. Myc-TRF2ABAM is not 
detected in day 12 and the amount of myc-TRF2 FL is reduced from day 8 to day 
12 .
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Figure 46. Markers of DNA damage other then p53-phosphoS15 in NHEK 
expressing myc-TRF2 FL and myc-TRF2ABAM.
NHEK were harvested immediately after flow sorting on days 1, 2 and 3 whereas cells 
harvested on day 13 were flow sorted on day 4 and grown for 9 further days before 
being harvested. Control experiments show an increase in levels of SMC1- 
phosphoS966 and Nbs1-phosphoS343 in cells that have received IR. After allowing 
for slight differences in loading, no increase is seen in either NHEK expressing myc- 
TRF2ABAM or myc-TRF2 FL. p16 levels increase in Vector only, myc-TRF2ABAM and 
myc-TRF2 FL on day 13.
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p16 is a cyclin dependent kinase inhibitor that prevents Cyclin (D) Dependent 
Kinase (CDK) 4 or 6 from phosphorylating RB. p16INK4A has been shown to 
contribute to a delayed, p53-independent response to telomere damage in 
fibroblasts (Jacobs and de Lange 2004). Unlike fibroblast cell lines, mammary or 
keratinocyte epithelial cells require inactivation of p16INK4A before they become 
immortalised (Kiyono et al. 1998), suggesting that p16INK4A might have an even 
more important role in detecting telomere initiated senescence in epithelial 
cells. Normal basal levels of p16,NK4A were found in NHEK expressing myc-TRF2 
FL and myc-TRF2ABAM. By day 13, elevated levels were seen in cells expressing 
Vector only, myc-TRF2 FL and myc-TRF2ABAM. The lack of a specific increase of 
p1 6'nk4a in nheK expressing myc-TRF2ABAM was surprising. The cells were not 
flow sorted on day 13 prior to harvest. As described in Section 5.8, it is 
therefore likely that the diluting effect of the NHEK that managed to down- 
regulate myc-TRF2ABAM would mask any genuine p16INK4A signal. A general 
increase in the level of p16INK4A is common in keratinocytes the longer they are 
cultured (Darbro et al. 2005). The increase of p16INK4A seen in NHEK expressing 
Vector only, myc-TRF2 FL and myc-TRF2ABAM from day 3 to 13 suggests that 
expression of the constructs is incurring a certain degree of stress on the 
culture.
5.11 Investigating cell death as a response in NHEK expressing  
m yc-TRF2dBAM o r m yc-TRF2 FL
The clonogenicity study, (Figure 21) and (Figure 22), establish that expression 
of myc-TRF2ABAM and to a lesser extent myc-TRF2 FL, reduces colony formation 
of NHEK. Two obvious explanations for this are: (1) Although an equal number 
of NHEK are plated on day 2 after flow sorting, less cells expressing myc-TRF2 FL 
or myc-TRF2ABAM are capable of adhering to the plate. (2) Once attached, as 
NHEK continue to try and replicate, they incur more and more DNA damage and 
therefore undergo apoptosis.
Preliminary investigations were made to determine if differences in cell 
adherence was playing a role in the different numbers of colonies found on the 
plates. All cells in the medium were collected the day after plating and 
evaluated to determine whether there were GFP positive cells, thereby 
distinguishing them from any feeders that had not attached to the plate.
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Between 0.0 - 0.5% of the GFP positive cells plated were found suspended in the 
medium and there was no obvious increase with either NHEK expressing myc- 
TRF2 FL or myc-TRF2ABAM. However, it is possible that after 24 hours any NHEK 
that did not adhere to the plate may no longer be expressing GFP.
Programmed cell death, or apoptosis, is highly regulated process that can be 
triggered by external or internal stimuli such as DNA damage. Caspase 3 is the 
final cysteine Asp- specific proteases (caspases) to be cleaved in the apoptotic 
pathway, (Figure 47). Detection of cleaved caspase-3 by western blotting is an 
indication that apoptosis is occurring within a cell population. As a positive 
control for the assay, NHEK were treated with cisplatin and then analysed for 
caspase 3 cleavage, (Figure 48). Treating NHEK with 10 pM cisplatin was enough 
to cause a small amount of caspase 3 cleavage and treatment with 50 or 100 pM 
cisplatin caused large amounts of caspase 3 cleavage.
The fact that NHEK are grown with feeders considerably complicates attempts at 
assessing cell death. In the experiment shown in (Figure 48), feeders were 
removed 2 days prior to the day of harvest. Therefore, on the harvest day, 
NHEK were trypsinised and collected with any cells that might be floating in the 
medium. Days 8, 10 and 12 were chosen because this is the point when NHEK 
expressing the TRF2 constructs first show a reduced rate of proliferation 
compared with Vector only cells. No cleaved caspase 3 products were in fact 
detected in NHEK expressing myc-TRF2 FL or myc-TRF2ABAM on days 8, 10 or 12. 
This implies that the NHEK are not undergoing apoptosis during these specific 
time points, at least not at levels where cleaved caspase 3 could be detected. It 
remains possible that apoptosis occurs at an earlier time point or in between the 
harvest times examined here.
5.12 Sum m ary o f Chapter 5
Detecting co-localisation of telomeres and DNA damage in NHEK using 
immunofluorescence requires different protocols when imaged using a confocal 
microscope. Unfortunately, visualising telomeres in NHEK using a TRF1 antibody 
requires stringent conditions, including permeabilising the cells before fixing 
them. This is not compatible with staining for 53BP1, a known marker of DNA 
damage and therefore it was not possible to detect TIFs in NHEK expressing myc-
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TRF2 . Some evidence was obtained for 53BP1 induction in NHEK infected 
with myc-TRF2ABAM, however it  was not representative of the entire experiment.
P53 activation is another read-out of many DNA-damage responses. Western 
blotting of p53-phosphoS15 in NHEK expressing TRF2 constructs revealed some 
evidence for p53 activation when myc-TRF2ABAM is expressed. However, no 
evidence was found for induction of expression of p21 or for hypo- 
phosphorylation of Rb, both well established downstream consequences of p53 
activation. Unfortunately, complications in harvesting a pure population of myc- 
TRF2abam positive cells at later time points prevents this lack of evidence acting 
towards or against the evidence of a p53 response.
No selective up-regulation of p16INK4A was witnessed as a consequence of 
expressing myc-TRF2ABAM. p16INK4A levels increased equally with time in NHEK 
expressing the Vector only, myc-TRF2 FL and myc-TRF2ABAM.
Experiments were performed to determine if changes in apoptosis or cell 
adherence were explanations for the reduced cloning efficiency of NHEK after 
myc-TRF2 FL or myc-TRF2ABAM expression. However, no evidence for apoptosis as 
evidenced by cleaved caspase 3, nor reduced cell adherence, was obtained.
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Figure 47. The role of cleaved caspase 3 in apoptosis.
This figure was copied in parts from 2 reviews:
1) Green, DR. Cell. 1998 Sep 18;94(6):695-8. Apoptotic pathways: the roads to ruin.
2) Siegel, RM. Nature Reviews Immunology. 2006 Apr;6(4):308-17. Caspases at the 
crossroads of immune-cell life and death.
The intrinsic apoptotic pathway is activated by internal stimuli which activate BCL-2 
associated protein X protein (BAX) and /or BCL-2 antagonist/killer (BAK). Either will 
trigger mitochondrial permeability transition and thereby the release of factors such as 
cytochrome C which then triggers activation of caspase 9 in the apoptosome.
The extrinsic pathway is triggered through activation of receptors at the cell membrane 
that in turn activate caspase 8. Both caspase 8 (extrinsic) and the apoptosome 
(intrinsic) are capable of cleaving pro-caspase 3. Once cleaved, caspase 3 is active 
and can carry out the apoptotic execution of the cell.
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Figure 48. Cleaved caspase 3 levels in NHEK expressing myc-TRF2 FL and 
myc-TRF2ABAM.
On day 2, NHEK expressing low or high levels of GFP were plated with feeders 
immediately after being flow sorted. Cells were grown with the feeders until 2 days 
before their harvest at which point they were removed. When cells were harvested, 
both adherent and cells in suspension were collected and pooled. Control NHEK 
were treated with increasing doses of cisplatin which induced the cleavage of 
caspase 3. In all blots shown, the sample treated with 100 pM of cisplatin is 
considerably under-loaded.
There is no evidence for caspase 3 cleavage on (a) day 8, (b) day 10 and (c) day 12 
of NHEK expressing either myc-TRF2ABAM or myc-TRF2 FL.
The same blots were also probed for TRF2 which was still expressed to varying 
degrees in all samples.
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Figure 48. Cleaved caspase 3 levels in NHEK expressing myc-TRF2ABAM 
and myc-TRF2 FL.
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Chapter 6: Discussion and Future Perspectives
6.1 Sum m ary and  Conclusions
When cells proliferate in the absence of a telomere lengthening mechanism, 
their telomeres shorten, a process which acts as a natural barrier to 
uncontrolled cell proliferation. Limitless replicative potential is one of the 
major hallmarks of cancer, most commonly achieved by up-regulation of 
telomerase which acts to lengthen telomeres (Hanahan and Weinberg 2000). 
TRF2 is the main protein responsible for telomere protection and keeps the 
telomere in what is referred to as a protected or “ capped” state. An 
“ uncapped” telomere can be created through expression of myc-TRF2ABAM, a myc 
tagged dominant negative version of the TRF2 protein. Engineered to lack it's 
myb-domain, myc-TRF2ABAM works by stripping endogenous TRF2 from the 
telomere.
In cultured human fibroblasts (mesenchymal derived), it  has been shown that 
p53 and p16INK4A are the major regulators of uncapped telomeres (Jacobs and de 
Lange 2004). However, the majority of cancers originate from epithelial tissue, 
including the most common 3 cancers in the UK (2002): breast, lung and 
colorectal. To investigate if  the same telomere-regulated senescence pathways 
used in normal fibroblasts, are activated in normal epithelium derived cells, this 
thesis has investigated the effects of artificially uncapping the telomeres in 
primary Normal Human Epidermal Keratinocytes, NHEK.
In every experiment: Vector only, myc-TRF2 FL and myc-TRF2ABAM were infected 
into NHEK using an optimised retroviral infection process. These IRES-GFP 
vectors were capable of expressing either myc-TRF2 FL or myc-TRF2ABAM and GFP 
as separate proteins (‘Vector only' expressed GFP only.) Subsequent to infection 
on day -1, TRF2 and GFP expression started on day 0 and NHEK expressing the 
constructs could be isolated as early as day 1 or 2 using flow sorting.
NHEK flow sorted and plated on day 2, demonstrated co-localisation of the 
telomere binding protein TRF1 and endogenous/exogenous myc-TRF2 FL. 
Immunofluorescence also confirmed that, myc-TRF2ABAM stripped the endogenous 
TRF2 away from the telomere.
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Low levels of expression of myc-TRF2 FL resulted in reduced proliferation ability 
and similar levels of myc-TRF2ABAM expression resulted in an even more drastic 
reduction in cell proliferation. Although the severity of the effect of expressing 
myc-TRF2 FL was unexpected, the degree of difference in proliferation between 
myc-TRF2 FL and myc-TRF2ABAM highlights the different effects they have at the 
telomere. The effect of the TRF2 constructs on proliferation of NHEK was 
determined by selecting and plating infected cells on day 2 and then performing 
cell counts at later time points.
Fewer and smaller colonies were seen in NHEK expressing myc-TRF2 FL 
compared with those expressing Vector only. The same effect, but even more 
pronounced, was seen when myc-TRF2ABAM was expressed. This provided further 
evidence that the uncapped telomeres severely limited replicative potential of 
the NHEK.
Small colonies found on plates of NHEK 10-14 days after infecting with the TRF2 
constructs were no longer proliferating. Incubating the cells with Brd-U at day 
12 (flow sorted and plated day 2) for 48 hours confirmed that smaller colonies, 
i.e. <50 cells, did not proliferate.
NHEK expressing myc-TRF2ABAM cannot grow to a colony size larger than 50 cells, 
whereas NHEK expressing myc-TRF2 FL are capable of developing into large 
colonies. Investigations using immunofluorescence on day 14 established that 
myc-TRF2 FL was still expressed in most colonies, small or large, although a 
mosaic pattern was observed in some larger colonies. In contrast, myc-TRF2ABAM 
was still expressed in all small colonies, but large colonies found on the same 
plate displayed either very little  or, more commonly, no myc-TRF2ABAM.
A larger number of senescent NHEK colonies were found in cultures that 
expressed the myc-TRF2 FL compared to Vector only as judged by Beta- 
galactosidase staining and colony size. Even more senescent positive cells were 
found in NHEK expressing myc-TRF2ABAM.
FACS analysis of NHEK 10 days after infection with Vector only, myc-TRF2 FL and 
myc-TRF2ABAM all had the cell cycle profiles of normal NHEK. The most probable 
explanation is that the proliferation arrested cells were destroyed during FACS
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analysis since the cells strong enough to survive the FACS analysis were no longer 
expressing myc-TRF2 FL or myc-TRF2ABAM and were expressing GFP only.
Telomere Induced DNA damage Foci, TIFs, were not found in NHEK expressing 
myc-TRF2ABAM. This may have been due to incompatibility of protocols for co­
localisation of TRF1 and 53BP1 and limitations in available technology made 
visualisation of TIFs unattainable within the timeframe of this thesis.
Activation of p53 in the form of phosphorylation at serine 15 was found in NHEK 
expressing myc-TRF2ABAM on day 2. Attempts to validate the activation of p53 
by demonstrating a consistent up-regulation of p21 were unsuccessful. 
Evaluation of Rb phosphorylation status in NHEK expressing myc-TRF2ABAM 
provided some evidence that the Rb was hypo-phosphorylated at late time 
points, however it  was not conclusive. It is possible that both of these known 
downstream targets of p53 were working to cause the proliferation arrested 
NHEK, but those cells could not be isolated using flow sorting due to their fragile 
state. p21 up-regulation was not seen in non-flow sorted cells either, however 
this could be an effect of the cell extract being diluted by NHEK not expressing 
the myc-TRF2ABAM construct.
Initial investigations to account for the differences in the number of colonies 
found on plates of NHEK expressing Vector only vs. myc-TRF2 FL or myc-TRF2ABAM 
did not provide any evidence of either less cell adhesion or apoptosis. No 
cleaved caspase 3 was found in preliminary experiments.
6.2 Strategy and  lim itations
The objective of this PhD was to characterise the effects of uncapping the 
telomere in a normal human epithelial cell system. NHEK cultured with Swiss 
3T3 feeders was the cell system selected as it is of epithelial origin and can be 
grown for a limited time in tissue culture without any genetic modification (i.e. 
without knocking down p53, p16INK4A or immortalising with telomerase). The 
TRF2 constructs donated to us by T. de Lange's lab were sub-cloned into the 
IRES-GFP vectors so that it would be possible to detect protein expression in the 
cells as soon as it occurred. The strategy enabled isolation of the NHEK 
expressing the relevant construct at early time points by flow sorting.
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6.2 ./ Working w ith  keratinocytes
As with all scientific endeavours, limitations occurred that complicated the 
interpretation of the work performed. NHEK can be grown two different ways, 
either using a serum-free system with collagen IV-coated plates or in medium 
with serum and a feeder layer, as used in this thesis. Of the two methods, 
culturing NHEK with feeders has been shown to provide a closer setting to the 
natural environment (Rheinwald and Beckett 1981) which is one reason it was 
selected. In addition to that, previously published retroviral infection protocols 
have shown high infection rates were capable of being obtained using the feeder 
system (Levy et al. 1998). As the myc-TRF2ABAM was expected to have 
detrimental effects on cell proliferation, high infection rates were made a 
priority. Two major drawbacks came with choosing this approach. Firstly, the 
time taken to prepare feeders, and even more time consuming is the time taken 
to remove the feeders from the tissue culture plates prior to harvest. As part of 
the infection process, removal of the PT67's took 15 min per 14 cm dish. In 
addition to limiting the number of samples that could be prepared within an 
experiment, this also added variability in the timing of treatment between 
samples within an experiment, e.g. 4 plates of Vector only might have their 
feeders removed, be trypsinised and sat on ice for 2 hours before the cells 
expressing the myc-TRF2ABAM reached the same state, or vice versa. The other 
major difficulty with the feeder system mentioned in the chapter 5 was trying to 
establish if  the NHEK were failing to adhere or if  they were undergoing 
apoptosis. It is common for a small amount of lethally irradiated feeders to 
detach from the tissue culture plate at a slow and constant rate. When no 
longer adherent to the plate it is difficult to decipher if the cells are 3T3 feeders 
naturally lifting from the plate or apoptotic NHEK.
Having subsequently learned [since optimising the infection process for this 
project] that NHEK grown in serum free systems can be infected if  centrifuged 
with retroviral supernatant (Ken Parkinson- unpublished), with the benefit of 
hindsight, I would have completed the experiments using a serum and feeder 
free system.
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6.2.7? Flow Sorting
Unexpectedly, flow sorting the cells became a major limitation within the 
project. Cell yields as poor as -20% on average (of the GFP positive population) 
and bacterial contamination were re-occurring problems.
In addition to these struggles, the suspected loss of the proliferation arrested 
NHEK expressing myc-TRF2ABAM during the flow sorting process at late time points 
was another setback. The extent of this problem at earlier time points was 
difficult to ascertain, because NHEK infected with myc-TRF2ABAM and isolated 
using flow sorting (as late as day 5), were capable of adhering to both tissue 
culture plates/plastic coverslips and demonstrated the characterised lack of cell 
proliferation/cell localisation, appropriate to the specific vector it was 
expressing. It was therefore counter-intuitive to think the cells experiencing the 
effect of the myc-TRF2ABAM construct could not survive the flow sorting process.
A FACS profile to reveal where in cell cycle the NHEK expressing myc-TRF2ABAM 
had arrested was unobtainable at day 10. Levels of Brd-U incorporation 
remained the same, regardless of whether or not the NHEK were expressing 
Vector Only, myc-TRF2 FL or myc-TRF2ABAM. Degradation of the proliferation 
arrested cells during the FACS analysis procedure seems the only likely 
explanation to this anomaly and is supported by increasing amounts of cell 
debris in the FACS profiles. It was bewildering that the profile could not be 
obtained as (by eye), the patterns from the Rhodamine B staining at day 10 (day 
16 is shown in (Figure 21) suggested that the revertent colonies would not yet 
contain enough cells to completely dilute the growth arrested cells.
6 .2 .Hi Over-expressing a Dominant Negative Protein
Myc-TRF2ABAM is an invaluable tool in studying the uncapped telomere. With its
expression, an uncapped telomere can be created almost instantaneously 
compared to growing cells for long periods of time so that their telomeres 
naturally shorten, during which time an accumulation of genetic mutations could 
occur. However, there are at least 2 major drawbacks to taking this approach in 
studying the uncapped telomere.
Firstly, the telomere is not only deprived of TRF2, it also deprived o f other 
telomere binding proteins which perform their own functions at the telomere 
and use TRF2 to anchor to the telomere during that time; Apollo (van Overbeek
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and de Lange 2006), SNM1B (Freibaum and Counter 2006) and hRAP1 (Li et al. 
2000) are 3 known examples. As a key member of the shelterin complex, it is 
more then likely that preventing TRF2 from binding at the telomere, either using 
TRF2ABAM or RNAi directed against TRF2, these effects w ill be seen.
Secondly, use of myc-TRF2ABAM to uncap the telomere may be a powerful tool for 
mimicking the uncapped telomere, but perhaps not be the best tool for assessing 
the structural changes that take place at a critically short telomere. Telomere 
structure has been shown to be responsible for initiating senescence in the 
fibroblast (Karlseder et al. 2002), and likewise SMURF2 is a protein capable of 
inducing senescence that is only up-regulated by critically short telomeres and 
not in cells expressing the JRF2ABAM (Zhang and Cohen 2004). Ultimately, any 
proteins suspected of inducing senescence based on experiments performed 
using jrf2abam would require confirmation in senescent cells with critically short 
telomeres before being proclaimed as a senescence inducing gene.
In a recent publication from the de Lange lab it was noted that “The role of 
TRF2 in vivo has not been tested. It is also not known whether the T-loop 
configuration occurs at all the telomeres and persists throughout the cell cycle.” 
(Hockemeyer et al. 2006). It is widely believed, but still not proven, that the 
critically short telomere is no longer capable of folding into a T-loop structure 
and this is the event that leads to telomere uncapping.
6.3 How the thesis relates to the literature and  future experim ents
6 .3 .i In a b ility  o f  cells w ith  uncapped telomeres to  p ro life ra te
The most important contribution this work makes to the field of telomere
biology is the establishment that uncapped telomeres in NHEK prevent the cell 
from further proliferating. It has been presumed that telomeres in epithelial 
cells would respond in the same way as fibroblasts, however until now this has 
remained undetermined. Proliferation curves of NHEK expressing myc-TRF2ABAM 
show a very slight increase just prior to 14 days in culture, as do similar 
proliferation curves for IMR90s published by the de Lange lab (Smogorzewska and 
de Lange 2002). Investigation by immunofluorescence established that at day 
16, larger colonies on the myc-TRF2ABAM plates had reverted and were either: (1) 
no longer expressing GFP, nor myc-TRF2ABAM or (2) were still expressing GFP, but
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no longer expressing myc-TRF2 . The NHEK were not kept under antibiotic 
selection pressure as the IMR90 cells were, so it is without doubt that the NHEK 
will have a larger amount of revertent cells. The growth of NHEK in colonies, as 
opposed to dispersed all over the plate, made analysis of heterogeneity within 
the population more obvious when examined using immunofluorescence, and 
emphasised the proliferation arrest seen when TRF2ABAM was still being 
expressed. It is likely, that the tiny escalation in proliferation also seen by the 
de Lange lab was also caused by revertent cells.
6.3. // Detecting apoptosis
Using adenoviral TRF2ABAM in vivo in mouse liver, Lechel et al published that 
apoptosis was associated with higher expression levels of TRF2ABAM, and cell 
senescence was associated with low levels of TRF2ABAM expression (Lechel et al. 
2005). The publication used TUNEL (Terminal deoxynucleotidyl transferase- 
mediated dUTP-biotin Nick End-Labeling) to determine apoptotic cells. As 
TUNEL labels double strand breaks generated when the apoptotic cell degrades 
its DNA, it is possible that the uncapped telomeres are being labelled with dUTP 
and falsely described as apoptotic. Karlseder et al demonstrated apoptosis in 
HeLa cells after jrf2abam expression using TUNEL and a sub-G1 population in the 
FACS profile, but showed negative TUNEL staining and no sub-G1 staining for 
IMR90 cells (Karlseder et al. 1999). This would suggest that TUNEL might not be 
sensitive enough to detect uncapped telomeres, however an additional method 
to confirm the presence of apoptotic cells is preferable. Looking for cleaved 
caspase 3, as used in this thesis, did not provide evidence of apoptosis, nor did it 
manage to rule it out. Because the time window where cleaved caspase 3 is 
detectable during apoptosis is so short, it  possible that it  may have been missed. 
No evidence of a sub-G1 population was found in the FACS profiles for NHEK 
expressing myc-TRF2ABAM, however it is improbable that apoptotic cells will 
survive both feeder removal and flow sorting.
Biroccio et al, determine the percentage of apoptotic cells using flow cytometric 
analysis of annexin V staining, an intracellular protein that is translocated to the 
external surface of the cell during apoptosis (Biroccio et al. 2006). Given the 
difficulties this project faced with FACS based protocols, this would also not be 
a suitable alternative. However, Annexin V staining can also be identified on the 
outside of the cell when using immunofluorescence, another future option to
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identify apoptotic cells. Likewise, examining propidium iodide uptake into live 
cells or identifying DNA ladders typical of apoptotic cells are all other 
alternatives for identifying if an apoptotic population of cells is produced as a 
result of uncapping the telomere.
6.3. / / 7  Lack o f d i-cen trie  chromosomes
The de Lange lab has demonstrated using normal human fibroblasts that 
expression of JRF2ABAM results in an increase of p53 and p16INK4A. They also 
witnessed chromosomal fusions, which were obvious in anaphase cells labelled 
with dapi. Conspicuous by its absence, was the lack of anaphase bridging in 
NHEK expressing myc-TRF2ABAM (Chapter 4). This is the first time telomere 
uncapping has been investigated at an early stage of growth in a primary 
epithelial cell system. The NHEK are derived from newborn foreskin and 
therefore more likely to contain the full repertoire of DNA damage response 
than other established cell lines that have been passaged for longer. The lack of 
anaphase bridging suggests that the response pathways activated following 
recognition of telomere damage do not allow progression through the cell cycle 
and therefore the end joining seen in other cell lines, e.g. IMR90 (fibroblasts) 
and HTC75 (fibrosarcoma) to occur. However, these points require a more 
thorough investigation. An important consideration is that filtering prior to flow 
sorting may have removed cells already experiencing the di-centric 
chromosomes. The dapi staining in the immunofluorescence demonstrates that 
after being plated as a single cell suspension, the NHEK expressing myc-TRF2ABAM 
were still able to form small colonies that growth arrested without any evidence 
of di-centric chromosome formation in anaphase. An experiment where NHEK 
are infected with myc-TRF2ABAM and then left for a week to develop without flow 
sorting is now needed to specifically investigate TRF2 construct expression 
correlation with the presence of di-centric chromosomes. Knockdown of 
Tankyrasel in parallel cultures would serve as a nice control as this has been 
shown to generate mitotic arrest through telomere association in anaphase with 
dapi through a different mechanism (Dynek and Smith 2004).
6.3.7V P53 response in cancer
In NHEK expressing TRF2ABAM, p53 was found to be phosphorylated at Serine 15 
signifying its activation at an early time point. From the literature, the p53 
response undoubtedly contributes to the senescent phenotype and this may have
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grave implications for telomerase based therapies which intend to specifically 
prevent cancer cell growth by reducing telomeres to a critically short length. If 
cells rely on p53 (even in part) which is mutated in >50% of all tumours (Levine 
1997), it  is not clear what w ill induce senescence in these tumour cells. Using a 
dominant negative version of hTERT, Hahn et al demonstrated that four 
telomerase positive cell lines were unable to continue proliferating without their 
telomerase activity (Hahn et al. 1999). The lag time between when the cells 
started expressing the construct and either growth arrested or experienced cell 
death was dependent upon their telomere length. Telomere shortening and an 
increase in chromosomal fusions after -20 population doublings were seen using 
the ovarian cancer cell line, 36M (Hahn et al. 1999). Critically, p53 was not 
present in two of these cell lines, yet despite the lack of p53, both cell lines 
contained cells with flattened morphology that had stopped proliferating and 
demonstrated a degree of apoptosis (as is consistent with cells in crisis). This 
result makes it  clear that pathways other then p53 play a role in preventing 
further cell proliferation.
6 .3 .v  DNA damage response and telomerase
A fairly new theme under investigation is the involvement of proteins from the 
field of telomere and telomerase biology in DNA damage repair. In addition to 
the discovery of TRF2 at non-telomeric sites of DNA damage (Bradshaw et al. 
2005) there is also evidence that telomerase is involved in DNA repair. Ectopic 
expression of hTERT leads to transcriptional changes in a subset of genes and 
changes the interaction of telomeres with the nuclear matrix. These changes 
are associated with reduced spontaneous chromosome damage during G1, 
enhanced kinetics of DNA repair and an increase in nucleotide triphosphate 
levels (Sharma et al. 2003). Complete suppression of hTERT prevents the 
cellular response to DNA double strand breaks, not by altering telomere 
integrity, but by affecting its overall configuration of chromatin. Cells lacking 
hTERT exhibit increased radio sensitivity, diminished capacity for DNA repair and 
fragmented chromosomes, all factors which demonstrate that the loss of hTERT 
impairs the DNA damage response (Masutomi et al. 2005).
Given the dramatic reduction in cell proliferation that uncapped telomeres are 
proven to instigate, it  is surprising the DNA damage response in the cells is so 
difficult to detect. Western blot assessment of DNA damage response proteins
-168 -
published by the de Lange lab (Smogorzewska and de Lange 2002) and 
demonstrated in this thesis after expressing myc-TRF2ABAM appears minimal. 
Neither the human fibroblasts used in the Smogorzewska publication nor the 
NHEK used in this thesis express hTERT exogenously, as cells used to study the 
DNA damage response commonly do. The lack of exogenous hTERT may provide 
an explanation for why the DNA damage responses seen in these cells is so 
subdued. It is possible that expectations of the scale of the DNA damage 
required to generate a cell cycle arrest have been skewed by the use of cells 
which constitutively and unnaturally over express hTERT. Nevertheless, it  is 
evident NHEK can induce a large DNA damage response in response to IR 
(Chapter 5), so perhaps double strand breaks at the telomere are effected 
differently by exogenous expression of hTERT. Further investigation, 
particularly with regard to the effect of flow sorting on DNA damage protein 
level assessment is required before further statements regarding this subject can 
be made.
Furthermore, NHEK were shown to have a low level of telomerase activity. This 
is most likely attributed to by cells from the basal layer, as transit amplifying 
cells have been shown to down-regulate their telomerase activity (Harle-Bachor 
and Boukamp 1996). This mosaic pattern of telomerase activity makes NHEK 
unique from established cell lines where all cells are likely to have some level of 
telomerase activity. However, it is also possible that the small amount of 
telomerase activity could be contributed to by even a tiny amount of 3T3 feeder 
contamination. A control which there was not enough time to investigate would 
have been to examine the telomerase activity in the same cells grown using the 
serum free system. This also would have served as an excellent control for the 
telomere length analysis.
Direct comparisons can never be made between human and mouse cells, 
particularly in telomere biology where the effects of uncapped telomeres are 
distinctly different. However, if  telomerase is capable of modifying chromatin 
as part of the DNA damage response, this could have implications for the mTR7', 
genetically altered mice which are usually bred for 3-4 generations to make 
their telomere lengths comparable with humans before being used in 
experiments.
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6.3 . v i Over-expression o f  myc- TRF2 FL
Each experiment in this thesis used myc-TRF2 FL as a control. Over-expression 
of TRF2 resulted in reduced proliferation rates compared to Vector only 
controls: a similar, if  slightly less dramatic, effect was observed by the de Lange 
lab in IMR90 cells (Smogorzewska and de Lange 2002). NHEK showing low and 
high levels of expression of myc-TRF2 FL and myc-TRF2ABAM were examined in 
this thesis. Higher levels of myc-TRF2 FL expression were equally as effective at 
reducing cell proliferation as low expression levels myc-TRF2ABAM (specifically 
(Figure 20), Section 4.2). Although the immunofluorescence performed was not 
quantitative, there did not appear to be a greater level of myc-TRF2 FL bound to 
the telomere in NHEK expressing higher levels of the protein. This suggests that 
even low levels of myc-TRF2 FL expression can be saturating; thus greater levels 
of expression that can not bind to the telomere may in fact sequester the 
limited amount of other telomere binding proteins in the nucleoplasm, rather 
then at the telomere, thereby effectively exerting a dominant negative effect.
Mice which over-express TRF2 in the skin demonstrate a severe phenotype in 
response to light, consisting of premature deterioration, hyper-pigmentation and 
increased skin cancer, all characteristics of the human disease Xeroderma 
pigmentosum (Munoz et al. 2005). Their telomeres were markedly shorter, 
displayed loss of the G-strand overhang and increased chromosomal fusion. 
Over-expression of TRF2 in mice keratinocytes where XPF was deleted prevented 
the telomere shortening and end to end fusions (Munoz et al. 2005). The 
experiments from the mouse model therefore indicate that excessive amounts of 
TRF2 lead to increased amounts of processing at the telomere by members of 
the XPF/ERCC family. This could be a contributing factor in the decrease of 
proliferation rates in NHEK expressing myc-TRF2 FL.
6.3.V// FACS analysis to  de tect senescence
What remains unexplained is why the NHEK in this study were not durable 
enough to survive FACS analysis after being growth arrested for 10 days, when 
clearly the IMR90 used in the de Lange lab study were. It is possible that the 
IMR90s also contained revertant cells within the population that were no longer 
expressing the myc-TRF2ABAM, but were still expressing the antibiotic resistance 
and therefore hardy enough for FACS analysis on day 15. The de Lange lab 
published the following statements regarding expression of myc-TRF2ABAM in
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IMR90 cells: “ FACS analysis on day 15 revealed cells with either a 2N or 4N DNA 
content, a profile matching that of cells undergoing replicative senescence (data 
not shown). It is possible that the population of cells with a 4N DNA content 
represents tetra-ploid cells rather then cells arrested in G2/M.” (Smogorzewska 
and de Lange 2002). Although it is tempting to think the FACS profiles shown in 
this thesis might also simply be displaying NHEK arrested in G1 and G2/M, this is 
excluded since the NHEK in question were still proliferating as judged by 
incorporation of Brd-U. Immunofluorescent analysis of Brd-U incorporation over 
a 48 hour period revealed that only large colonies (established to be reverted in 
other experiments) had incorporated Brd-U. Therefore the FACS profiles seen 
here, demonstrating Brd-U incorporation, are dominated by revertent cells, not 
the proliferation arrested NHEK which were intended to be analysed.
FACS analysis of senescent cells is not prevalent in the literature, suggesting 
such data might be difficult to obtain. However, one publication that examines 
human prostatic epithelial cells, HPECs, grown from early passage to 
senescence, defined as those which remained sub-confluent for greater then a 
month. Such senescent HPECs were accompanied by a gradual loss of cells in S 
phase and an accumulation of cells containing 2N DNA (Sandhu et al. 2000), 
though similar percentages of cells in G2 were found in both growing (12%) and 
senescent (14%) cells. Crucially, they demonstrated that senescent cells are 
durable enough for FACS analysis and showed a lack of Brd-U incorporation.
y-Ionising radiation, which induces double strand breaks, cause a G2 arrest in 
NHEK. It is particularly disappointing that a FACS profile could not be 
determined where uncapped telomeres caused proliferation arrest as it would 
have been of particular interest to determine if the uncapped telomere also 
provoked growth arrest at G2. Had time allowed, alternatives to FACs analysis 
could have included immunofluorescence to detect G2 specific proteins, thereby 
identifying such cells (e.g. CEN-PF, a protein that localises to kinetochores in 
late G2, remains kinetochore-bound until anaphase, and is degraded at the end 
of mitosis (Bomont et al. 2005)).
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6.4 Future Perspectives
The goal of the research presented in this PhD was to characterise the result of 
uncapping telomeres in a normal primary epithelial cell system. Senescence was 
established as one of the cellular outcomes, most likely triggered by activated 
p53. Due to time restraints, it  was not possible to rule out differentiation or 
apoptosis as other outcomes that occur as a result of telomere uncapping in 
NHEK or determine where in the cell cycle the NHEK had stopped proliferating. 
These are all important aspect of the response which should be addressed.
Examining the effect of uncapped telomeres in cancer cell cultures to further 
characterise the response to uncapped telomeres when various pathways such as 
p53 and p16INK4A are no longer functional is another investigation that can take 
place. Both apoptosis and senescence have been demonstrated as responses and 
better characterisation of the pathways behind these cellular decisions are 
required. The objective of drugs which inhibit telomerase activity is to 
specifically target the telomeres of cancer cells so that their critical short length 
induces either cell proliferation arrest or apoptosis. Use of jRF2ABAM would offer 
an interesting insight into what happens when the telomeres are long and 
uncapped vs. uncapped because they are critically short. With new found 
evidence that telomere binding proteins are mis-regulated in cancer cells, these 
studies might offer valuable insight into alternative ways the telomere can be 
de-regulated and contribute to cancer cell progression.
Proliferative tissues continuously progress through the cell cycle and are more 
exposed to carcinogens (e.g. carcinogens in food, smoke, UV light, etc.), so it is 
not surprising the majority of human cancers are derived from epithelial cells. 
It stands to reason they may have more mechanisms of preventing uncontrolled 
cell proliferation then fibroblasts. In a similar way to the work published by 
Jacobs and de Lange, it would be interesting to establish if  knocking down p53 
and p16INK4A is enough to allow NHEK to continue proliferating, despite having 
uncapped telomeres, as it was in human fibroblasts (Jacobs and de Lange 2004). 
This would serve to indicate if there are more pathways to control cell 
proliferation in epithelial cells as opposed to fibroblasts.
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The original plan was that this telomere investigation would move on to a 
microarray analysis of myc-TRF2ABAM induced gene expression changes at an early 
time point, in between the point at which myc-TRF2ABAM is expressed (as judged 
by GFP expression) and the phosphorylation of p53. This might have established 
more as yet unknown pathways, which activate the chain of events which 
prevent the NHEK from further proliferating. However, in the end, time and 
funding was not available to pursue this option during this thesis. Identification 
of other possible p53 target genes as well evaluating the up-regulation of known 
ones (e.g. p21) would have proved interesting. Nonetheless, the Blasco lab 
performed a microarray investigation with Generation 3 (G3) Terc'/_ mice in 
which uncapped telomeres were induced by loss of Ku86 (Ku86'/_ mice). The 
different transcripts observed in double mutant G3 Terc'/7Ku86/' cells 
compared with wild-type cells showed a predominance of genes involved in cell 
adhesion, cell-to-cell and cell-to-matrix communication, as well as increased 
metabolic turnover and augmented antioxidant responses (Franco et al. 2005). 
It would be interesting to investigate if  the same genes are up-regulated in NHEK 
uncapped using myc-TRF2ABAM.
Other techniques could be used to further evaluate the changes that occur as a 
result of uncapping the telomere. Activation of the DNA damage response 
pathway involves up-regulation of proteins such as 53BP1 and p21, but equally 
important processes within the pathway's activation are also phosphorylation of 
proteins such as p53 and NBS1. Another approach to characterising the 
uncapped telomere would be to compare the post-translational modifications 
such as phosphorylation, ubiquitination, sumoylation, and equally as 
importantly, looking for de-phosphorylation, de-sumoylation or de-ubiquitination 
of proteins that may be downstream of an uncapped telomere signal. 2-D gel 
electrophoresis can be used in proteomics analysis to directly quantitate 
differential phosphorylation patterns. It is possible to label two separate 
samples with different probes and run them together so that proteins that have 
been phosphorylated differently don't co-localise and are easily identifiable 
through mass spectrometry.
MicroRNA is an emerging new field of cell regulation. Naturally occurring small 
non-coding RNA gene products are found in diverse organisms and play key roles 
in regulating the translation and degradation of mRNAs (Bartel 2004). Unique
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microRNA molecular profiles in lung cancer diagnosis and prognosis have recently 
been established (Yanaihara et al. 2006) thereby associating this new field to the 
general mis-regulation seen in cancer cells. MicroRNA arrays now exist for 
evaluating the MicroRNA status of different cells. As array evaluation is a 
straightforward way of detecting changes in MicroRNA, it  is another technique to 
be considered in discovering changes that result after uncapping the telomere.
Characterisation of uncapped telomeres is important so that if  drugs inhibiting 
telomerase activity succeed in creating critically short telomeres in tumour 
cells, but fail in preventing cell proliferation, the process will be well 
characterised and the missing components within the tumour cell readily 
identifiable. Ultimately, this w ill aid not only in devising cancer therapeutics, 
but also in understanding how they need to be optimised.
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